DNET_DataAnalysisUkraineBioLab - NetDevInfraWGinOSSConsortium/NetDevInfraWiki GitHub Wiki
-
æ»ã
-
å®é²æŠäº
ãšã³ãã£ã³ã° > ã€ãã³ãïŒã1.5ãïŒã2.3ã2.6ã2.9ãïŒ > ãšãããŒã°1ã2- The Twitter FilesãWe didn't start the fire
- ãã€ãªã»ã©ããšã³ãïŒã¯ã¯éšå
- CIA activities in Japan - Wikipedia
- Gen. Wesley Clark, Democracy Now! interview, 2007
- ã¢ã¡ãªã«ã¯æ¥æ¬ã®åœæ°æ§ã粟ç¥çã«å»å¢ããã®ãïŒ - Zhihu
- Extending Russia: Competing from Advantageous Ground | RAND
- ç§ã¯2021å€ã«2åæ¥çš®ããŠä»¥éã¯ããŒã¿ãã广ãªããšå€æãæ¥çš®ãäžæ¢ïŒç¹ã«å¯äœçšããããã£ããšããèš³ã§ããªãïŒã
- 以éãå¯äœçšã»ã¯ã¯æ»ïŒè¡æ ãå¿ççïŒãæ»äº¡è¶ éããã€ãªã©ããæ©èœç²åŸç ç©¶ãªã©ãã€ããã®æ å ±ãã¯ã©ã¯ã©ãšã
- ...ãšèšãäºã§ãããªãããã€ãªã»ã©ããšã³ãïŒã¯ã¯éšåã®ã¹ã¯ã©ããã2023/1ããéå§ããŸããã
- Died BECAUSE OF COVID ã§ã¯ãªã Died WITH COVID å ±éãæªã ã«ç¶ãã
- /20 仿¥ãçŸåšã®ã2é¡çžåœãããå£ç¯æ§ã€ã³ãã«ãšã³ã¶ãšåãã5é¡ãã«åŒãäžããæ¹éã瀺ããã
- /26 ã³ããææ31äžäººè¶ å ±åæŒããïŒæŽã«èŽæ»çã»éçåçäžãã£ãŠããã®æ
- /27 Project Veritas ãã¡ã€ã¶ãŒè£œè¬ã®æ©èœç²åŸç ç©¶ããªãŒã¯ïŒJordon Trishton WalkerïŒ
- /28 ã³ãã¯ã¯æè³å®¶ã®ãã«ã»ã²ã€ããçªç¶ããŠã¯ã©ã€ãæ¿åºã¯è æããæ¿åºãšèšãåºãã
- /9 5/8ããã³ããã5é¡ç§»è¡ãã§æªçœ®ç·©åãž
- /9 ãã¹ã¯ççšç·©å 3/13 ã«èª¿æŽãå±å å€åããå人ã®å€æã«
- ã³ããæ»ã®2å²ãæªæ¥çš®è ïŒã³ããæ»ã®8å²ãæ¥çš®è ïŒã¯ã¯å¹æãªããïŒã®æïŒ
- /15 ã¢ãããã¹ã¯ãå䟡éç€ºãž åœæ§èšŽããæèšŽç¢ºå®
- /1 æ°åã³ããææã§è³å å ç«çްèã«ç°åžžããäžæ¢ç¥çµã®åŸéºçã®äžå ïŒ
- /11 ãã€ãã³ãã³ããéåžžäºæ çµäºæ³æ¡çœ²å
- /21 5é¡ç§»è¡ã®æ¥æ8æ¥ããæ è¡æ¯æŽã¯ã¯ãã³èšŒæäžèŠ
- /21 CBC ãžã£ãŒããªã¹ãã®èšŒèšãCBCã«ãããå€§èŠæš¡ãªåãšãããã¬ã³ããæŽé²
-
/5 WHOã®ãããã¹ãæ°åã³ãããç·æ¥äºæ 宣èšããçµäºãããšçºè¡š
-
/6 CDC ã®è²¬ä»»è ã§ãã Rochelle Walensky å士ã6/30æ¥ä»ã§èŸä»»
-
/8 æ°åã³ããã5é¡ã«ç§»è¡ã3å¹Žè¶ ã®ç¹å¥å¯Ÿå¿çµäºãã€ã³ãã«ãšã³ã¶ãšåç
-
/12 ã¢ã¡ãªã«åœå®¶éåžžäºæ 宣èšè§£é€âã³ããææç¶æ³èœã¡çããâ
1500äžäººãäœæåŸå±€åãå ¬çå»çä¿éºããå€ããç¡ä¿éºãã®æãã -
/15 ãã·ã§ã«ã»ã¯ã¬ã³ã¹ããŒãžã®ãå¥ãã®è³ªå
https://brownstone.org/articles/farewell-questions-for-rochelle-walensky/ -
/15 ç é¢ã§æ»äº¡ããæ°åã³ããæ£è ã®ã»ãšãã©ã¯äººå·¥åŒåžåšã«ãã£ãŠæ»äº¡ããŠããããšãç ç©¶ã§å€æ - Slay News
https://slaynews.com/news/most-covid-patients-died-hospital-killed-ventilators-study-finds/ -
/29 ç±³ç§åŠè ããã³ãããã¯äžã«æ£è ã® 60% ãééã£ãæ²»çãåããïŒäººå·¥åŒåžåšã®äœ¿çšïŒ - Pravda
- /5 æ°åã³ããPCRç¡ææ€æ»è£å©éã倧éªã§ã43ååã®äžæ£ç³è«ã§äžäº€ä»
- /6 倧éªåºã§ã¯è£å©é70ååäžã42ååãäžæ£è«æ±âŠã³ããçŠãæŽãã人éã®âãã§ããŸããâæ°è³ª
- /7 æ°åã³ããç¡ææ€æ»ãæ±äº¬ã«ç¶ã倧éªã§ãäžæ£ç³è«ã®çããçŽ43ååãäžäº€ä»ãšãããã¡11ååã®è¿éæ±ããã
- /8 The DisInformation Chronicleãã€ã¹ã©ãšã«ã®æ°ããªããŒã¿ïŒ50æ³æªæºã®å¥åº·ãªäººã®æ°åã³ãããŠã€ã«ã¹ã«ããæ»äº¡ã¯ç¢ºèªãããŠããªã
- /8 èªæ²»äœãžéå€§è«æ±ã®ããœããäººæ°æ°Žå¢ãïŒèåœå ±åããããšãããåå§èšå ããšãã«ãã«9ååã®è³ å蚎èš
- /9 ããŒã¯ã»ã¶ãã«ãŒããŒã°ãç§åŠç確ç«ã®é »ç¹ãªèª€ããCOVIDèª€å ±æ€é²ã®ç€ŸäŒçä¿¡é ŒãæãããšèªããïŒåç»ããïŒ
- /10 ã¶ãã«ãŒããŒã°ãäœå¶åŽãFacebookã«æ°åã³ãããŠã€ã«ã¹ã®æçš¿ãæ€é²ïŒäœçŸäžãã®æçš¿ãåé€ïŒããããèŠè«
- /10 BBCãããªã¹ã»ãžã§ã³ãœã³æ°ãã³ãããŠã€ã«ã¹å¯Ÿå¿ã®èª¿æ»çµæãåããè°å¡èŸè· - RT
- /12 ãããŒã F. ã±ãã㣠Jr.
- ç®èŠãã¯ç¶ããã¶ãã«ãŒããŒã°ã®ãããªäœå¶åŽã®äººç©ãã¡ã¯èªåãã¡ã欺çã®ç¶²ã«å æ ããŠããããšã«æ°ã¥ãå§ããŠããã
- å»åž«ãã¡ãç®ãèŠãŸããŠããŸãã圌ãã®ãã¡äœå人ããã³ããæä»£ã®æ±è·ã«å¯ŸããŠå£°ãäžããŠãããç§ãã¡ã¯éšãããŸãããã
- /15 è¿ããŒæ¯åºé·ãã³ããäºæ¥ã§5ååè¶ è©åçãã§3äººé®æ
- /16 è±äžé¢å§ããžã§ã³ãœã³å éŠçžãèåœèª¬æãšããŒãã£ãŒåé¡ã§æçµå ±å
- /16 è±ãžã§ã³ãœã³å éŠçžãæ°åã³ãã察çã®èŠå¶ãç¶ãäžãéŠçžå®éžã§ã®ããŒãã£ãŒâæå³çã«ããã®çåŒç¹°ãè¿ããâå ±åæž
- /20 ããªã¹ã»ãžã§ã³ãœã³è°å¡è³æ Œãå¥å¥ªãç¹æš©å§å¡äŒã®ããŒãã£ã²ãŒãå ±åæžãåãå ¥ããããšãã³ã¢ã³ãºãå§åç倿°ã§æ±ºå®ã§ã
- /20 ã©ã³ãã»ããŒã«ããã«ã»ã²ã€ãã¯ã人éé¢ããæŽçªã§ãŠã€ã«ã¹ãèŠã€ãã倧éœåžã«æã¡èŸŒãããšããæå€§ã®è³éæäŸè ã ãã
- /20 ã¹ã€ã¹ã®å å倧è£ã»ä¿å¥å€§è£ã§ããã¢ã©ã³ã»ãã«ã»æ°ãã¿ãªã«ãæã蟌ã¿ãèŸä»»ãçºè¡šããïŒã¹ã€ã¹åœæ°ã®æ°åºŠãé«ããïŒã
- /29 ãã€ãã§æ°ããªæ å ±å ¬éããã€ãã®ã³ããå°éå®¶äŒè°ã®è°å®æžãå ¥æããããšã«æå
- /30 ããªãã®æèãèšè«ãçæŽ»ãã³ã³ãããŒã«ããããšãã詊ã¿ã®èåŸã«ã¯ CISA ããã£ã
https://brownstone.org/articles/cisa-behind-attempt-to-control-thoughts-speech-life/
- /2 ã³ããç¡ææ€æ»ã®äžæ£ãåœããåãå ¬éé£ãç©ã«âŠå éšé¢ä¿è ãæããæ°Žå¢ãã®å®æ
- /4 æ°ãªãŒã¹ãã©ãªã¢è°å¡ãžã§ã³ã»ã©ããã¯ãæ»äº¡çã®çµ±èšãéå°æ»äº¡ãã¯ã¯ãã³ãšã€ãã«ã¡ã¯ãã³ãç¶²çŸ
ã
åœæ°ã«ãã³ãŽã£ããæä»£ã«ããã«è©æ¬ºã«ãã£ããã説æãããã©ããã¯æ°ã®å瞟ã¯å€§ãããäžçã¯ç®èŠãã€ã€ããã - /5 è±åœãžã§ã³ãœã³å éŠçžã®ã³ãããŠã€ã«ã¹èŠåéåã«é¢ããæ°ããªèª¿æ»ãéå§
- /14 åºç«ç é¢æåž«ãã³ããè£å©éã§ãã©ã³ãå®¶é»ãªã©28äžååãäžæ£çŽå ¥ã§æ²ææå
- /18 åŒéãããã¡ãŠããçšéã§å€§çµ±é ã¬ãã«ã®èŠåã享åãé£éŠä¿å®å®ããªã ãžã³éè¿ãš24æéäœå¶ã§èŠè·
- /21 åœé²ç·çã®æ°åã³ãããŠã€ã«ã¹ææçããŒã¿ã¯ä¿¡é Œæ§ãäœããšç£èŠåœå±ãææ
- /22 ç±³åœããã³ãããã¯åžžèšæ©é¢ãåµèšãåäºåæã¯WHã®æ°åã³ãããŠã€ã«ã¹ææç察çããŒã ã®ä»»åãåŒãç¶ã
- /10 é»éåæµ·éãæ°ã³ãé¢é£ã³ãŒã«ã»ã³ã¿ãŒæ¥åã§1å5000äžåè¶ ã®éå€§è«æ±âŠåæµ·éãèª¿æ» / è¿éæ±ããæ¹é
- /18 é»éåæµ·éã®éå€§è«æ±ã§ãç¥äºã¯/18ã®èšè äŒèŠã§ãéã/17ã«ç«ã¡å ¥ã調æ»ãå§ããããšãæããã«ããã
- /21 ããœãã®ã³ããã»ã¯ã¯ãã³ã»ã³ãŒã«ã»ã³ã¿ãŒæ¥åã®éå€§è«æ±åé¡ã§åå§èšå ããšãã«ãæ¥åæéäžã«å¥åº·é£åãåç²§åã®é»è©±å¯Ÿå¿
- /21 äžåœãè
ºãã¹ããåå±
3人ææâéé¢ã§æææ¡å€§ããâåœå±çºè¡š
- çŸä»£ã®å»çäœå¶ãäºé²æªçœ®ã®é²æ©ã«ãããã³ãããã¯ã®ãªã¹ã¯ã¯äœæžãããŠããã
- æªæ²»çã®èºãã¹ãã®æ»äº¡çã¯50ïŒ ä»¥äžã«éããããçŸä»£ã®å šäžçã®çµ±èšçãªæ»äº¡çã¯10ïŒ ä»¥äž
- /24 尟身èãæ°åã€ã³ãã«å¯ŸçäŒè°ã®è°é·ãéä»»ã9æã®å 飿æç屿©ç®¡ççµ±æ¬åºçºè¶³ã«åããå°éå®¶äŒè°ãå·æ°ã
- /29 DailyMailããæ°åã³ãããŠã€ã«ã¹ã«ããæ»äº¡ãã®99%ã¯äž»ã«ãŠã€ã«ã¹ãåå ã§ã¯ãªããCDCã®ããŒã¿ã瀺ãã
- /30 æ°åã³ãããŠã€ã«ã¹ãç¡ææ€æ»æãäºæ¥å·¡ãå·šé¡äžæ£ã®åçºãèªåã®åŸãåºããŠã³ããè£å©éç³è«
- /3 TelegraphçŽããè±åœè«å ±æ©é¢ãããœãŒã·ã£ã«ã¡ãã£ã¢äžã®å察æèŠãç£èŠãåé€ããæ¿åºæ©é¢ãšååããŠããã- RT
- /4 2023幎åŸåãèŽæ»æ§ã®æ°åã€ã³ãã«ãšã³ã¶ãäžçã«4çš®é¡çºçãããäžçä¿å¥æ©é¢ïŒWHOïŒãå ±åããã
- /6 ãã³ã°ã©ãã·ã¥ãå²äžææªã®ãã³ã°ç±æµè¡ã«èŠèããããWHOãããããææççºã¯æ°å屿©ã®çé±ã®ã«ããªã¢ã
- /6 ä»å°ã§ã€ã³ãã«äŸå¹Žã®178åãç°äŸã®å€ããã§åŠçŽééããæ°åã³ããã¯é«æ¢ãŸãã
- /8 ãã³ãªãŒã»ãã¯ãã¹ã¿ãŒç¥äºããµãŠã¹ã«ãã©ã€ãå·ã¯æ°åã³ãããŠã€ã«ã¹ã®çŸ©åã«åŸããªãã
- /14 ãªãŒã¹ãã©ãªã¢ã»ã«ã³ã¿ã¹èªç©ºããã³ãããã¯äžã§2020幎åé ã«1,700人ã®å°äžæ¥ååŸæ¥å¡ãäžæ³è§£éã®å€æ±º
- /19 DailyMailãã¢ã³ãœããŒã»ãã¡ãŠããšåœŒã®åŠ»ã¯ããã³ãããã¯äžã«200äžãã«ã®å©çãäžãããçŽè³ç£ã¯1,100äžãã«ã
- /23 æ°åã³ãããŠã€ã«ã¹ã«ææãåŽçœèªå®ãåãã女æ§ãåŸéºçã®çç¶ãéãé·æåãããšããŠå·ç è£å幎éã®æ¯çµŠã決ãŸã£ãã
- /25 8630äžååã®ã³ããã¯ã¯ãã³ãç Žæ£ãžïŒ2000ååå以äžã®è¡çšãïŒãããŠç§ã®è¿œå æ¥çš®ãåå°ã§éå§ãããã
- /27 äžåœã®ããŒãã³ãããæ¿çãæšé²ããCDCææçéŠåžå°éå®¶ãåå°åæ°ïŒ60ïŒãå京27æ¥ã«ããèããã§æ»å»
- /1 ç¬ç«å ¬èŽäŒã§æé«ç§åŠé¡§åãããªãã¯ã»ãŽã¡ã©ã³ã¹ãã¹ãã«ã»ãããæã£ãŠããªãã£ãããªã¹ã»ãžã§ã³ãœã³ã¯ã³ããã«é«éœ¢è ãæ®ºããããã£ããã- RT
- /22 DailyMailãäžåœã®åŠæ ¡ã§å¥åŠãªèºçãèå»¶ãåæ±500ãã€ã«ã«äœçœ®ããå京ãšéŒå¯§çã®ç é¢ã¯ãç æ°ã®åäŸãã¡ã«å¯Ÿå¿ãææ¥ã®äžæ¢ãæ€èšããåŠæ ¡ãããã
- /29 NYPçŽã®å ±éã«ãããšãäžåœãåŒåžåšçŸæ£ã®æ¥å¢ã«å¯ŸåŠãããšãšãã«ã欧å·ããªã©ã³ãã§ãåã©ãã®èºççäŸã®æžå¿µãã¹ãæ¥å¢ãå ±åãããŠããã
- /2 å ±åå äžé¢è°å¡ããã€ãã³ã«å¯Ÿãåå äžæã®åŒåžåšçŸæ£ãäžè¯äººæ°å ±ååœïŒPRCïŒå šåã«èå»¶ããŠããããšãçç±ã«äžåœãžã®æž¡èªå¶éãèŠè«
- /7 æ°åã³ãããçºç±å€æ¥ãè£å©éã§å»åž«ãè皌ããå ±é ¬äžä¹ããã§ãã£ãšç é¢åå ¬è¡š
- /10 æ°ããªç ç©¶çµæïŒæ°åã³ããã®ããã¯ããŠã³ã§è±åœã®å€ãã®äœæ°ãããè²§ãããçµæžçã«çµ¶æããé害ã粟ç¥çŸæ£ã®çœ¹æ£çãé«ããªã£ãŠãã
- /11 è±åœã®ã¹ããã¯éŠçžãã³ãã第1æ³¢ã§åœæ°ã«å€é£ã奚å±ããèªèº«ã®æ¿çãææç¬¬2æ³¢ã®åå ã§ã¯ãªããšæè·ãå®¶æã倱ã£ã人ã ã«å¯ŸããŠãæ·±ãéºæŸã«æãããšè¿°ã¹ãã
- /16 APéä¿¡ãå®¶è³ã®é«éš°ãšãã³ãããã¯ã«ããæŽå©ã®åªå€±ã«é¢é£ããç±³åœã®ããŒã ã¬ã¹æ°ã¯12%å¢å ãã2007幎ã®å ±åéå§ä»¥æ¥æé«æ°Žæºã«éããã
- /18 åé¢ãã³ããçŠã§æ¬äŒè°ã§ã®ãæŒããã¿ã³åŒãã®æç¥šãäŒæ¢ãã2020幎4æä»¥éãæ³æ¡ãªã©ã®æ¡æ±ºã§äŒæŽŸãè°å¡ã®è³åŠã®èšé²ãæ®ããŠããªãããšãåãã£ãã
- /22 æ¥å¹ŽåºŠåœåäºç®æ¡ã§ãã4å åæžããã1ã»5å åãèšäžãããèŠéããšãªã£ãäºåè²»ã䜿é远ããªãã¯ããã管çç°¿ãåºãŠããŠâŠçåºãå人ã¡ã¢ã§ããïŒç¬ïŒ
-
/18 æ°åã³ãããŠã€ã«ã¹ã¯2020幎4æã«çªç¶ãèŽåœçãã«ãªã£ãããã§ã¯ãªã
- çŸåšãææèŽæ»ç (IFR) 㯠0.3 - 0.5 ããŒã»ã³ãçšåºŠãŸã§åçã«æžå°ã
- å¹³åäœåœãçããŠãã人ã ã«ãšã£ãŠã¯ãã»ãŒèŽæ»æ§ã®ãŠã€ã«ã¹ã«ãããªãã
- ãã®ãŠã€ã«ã¹ã§ã¯ãªããå¥ã®äœããæ°åã³ãããŠã€ã«ã¹ã®ç ç²è ãšããã人ã®ã»ãšãã©ã殺害ããŠããã
- 人工åŒåžåšãã¬ã ãã·ãã«ãé®éå€ãèºçæ£è ã«æçç©è³ªãäžããªããè±æ°Žçãå€ç«ããããã¯ããã€ç
- ãã¹ãŠã®è¶ éæ»äº¡ãæ°ãããšãmRNAãã¯ã¯ãã³ãã¯ããããæ°çŸäžäººã®æ»äº¡ãåŒãèµ·ãããããšã«ãªãã
-
/20 RFKãããã³ãããã¯ãžã®åããšå¯Ÿå¿ããšããæ¿çã¯ãæã£ãŠããã»ã©åªãããã®ã§ã¯ãããŸããã
å¥åº·ç®çã§ã¯ãªãå µåšåããããã«å±éºãªãŠã€ã«ã¹ãåéããå察掟ã黿¢ããæ¿åºã®å¯Ÿå¿ãéçºããããšãå«ãŸããã -
/31 ãã¯ã¬ã¬ãŒé圹倧äœãã°ããŒããªã¹ããåœé屿©åå®ã®æšé²åãšããŠç æ°Xãå©çšããŠããããæ°åã³ãã®20åã®èŽæ»ããšçå¥åŠãªããšã«åœŒãã¯ãšãŠãå ·äœçã ã
-
/31 ã广çã§æ³çææåã®ãããã³ãããã¯åå®ããå§åããæžç°¡ã®çœ²ååœã¯äžçã®æå°è ãã«ç· çµãæ±ãããæ°åã³ãã§åœééåžžäºæ 宣èšãããŠããäžž4幎ã
- /1 ã¹ã¯ãŒãïŒ éæ¹ããªããè¡çšãã§æœ€ã£ãç é¢ãªã¹ããã³ããçŠã«å·šé¡ã®è£å©éãåãåããªããæ£è ãåãå ¥ããªãã£ãã幜éç åºãã倧åé¡ã
- /3 ã補è¬äŒç€Ÿã®ãã¬ãåºåã®çã®ç®çã¯è¬ã売ãããšã§ã¯ãªãããã¥ãŒã¹ã¡ãã£ã¢ãè²·åããããšã ããå 補è¬äŒç€Ÿé¢ä¿è ãå ¬ç¶ã®ç§å¯ãã¿ãã«ãŒã»ã«ãŒã«ãœã³ã«èªã£ãã
- /5 ç±³çŸç 察çã»ã³ã¿ãŒïŒCDCïŒã¯æ±äº¬ã«æ±ã¢ãžã¢ã»å€ªå¹³æŽå°åäºåæãéèšãé§æ¥ç±³å€§äœ¿å ¬éžã§ãã³ãã£ã»ã³ãŒãšã³æé·ãæŠèŠæ¬äžåçåŽåçžãåºåžããŠèšå¿µã€ãã³ãã
- /18 RFKãžã¥ãã¢ãWHOã¯äžççãªãšãªãŒããå€åœå¢åã«ãã£ãŠä¹ã£åãããŸãããã ããããããã€ãã³ãWHOã®ãã³ãããã¯æºåæ¡çŽã«çœ²åããã®ã黿¢ããªããã°ãªããªãã
- /20 æ°åã³ãã察å¿ã®èª²é¡ãèžãŸããææçãçœå®³ãªã©é倧ãªäºæ ãçºçããå Žåãåœãèªæ²»äœã«å¿ èŠãªæç€ºãè¡ãããšããç¹äŸãçã蟌ãã å°æ¹èªæ²»æ³ã®æ¹æ£æ¡ããŸãšãŸã£ãã
- /25 å»å¹Ž5æã«5é¡ã«åŒãäžããããæ°ã³ãææçãæ¥åžžãåãæ»ãã€ã€ãããšã¯èšãçŽ4幎ã«åãã è¿·èµ°ãæ²æ±°ãªããšããŠãããã®ãïŒååŽçãšå°éå®¶ãã¡ãæã«ãã婿š©ã®å®æ ãšã¯ïŒ
- /26 æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã¯ãå¿èãè³ãè¡æ¶²çŸæ£ã®å¢å ã«é¢é£ããŠããã
- /28 äžåœã®é£æååºã¯çŸåšãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãã¹ããŒã远跡ã¢ããªã®QRã³ãŒããšé¡ã¹ãã£ã³ã䜿çšããŠã¯ã¯ãã³ãã¹ããŒãã確èªããããšã顧客ã«çŸ©åä»ããŠããã
- /6 ç±³åœæ¿åºã8æ¥ã«ã³ããã®æ²éåãåããç±³åœéµæ¿å ¬ç€ŸãéããŠçºéãããç¡æã®COVID-19æ€æ»ã®éµäŸ¿æ³šæã忢
- /11 ããŒãã£ã³ã»ã¯ã«ããŒããç§ã¯ããããŒããŒã倧åŠã®å»åŠéšææã§ã¯ãªãã倧åŠã®ã¢ãããŒã¯çå®ãæå³ããããªã¿ã¹ã ããçå®ã¯ããªããè§£éããã
- /17 2022幎床ãŸã§ã®åœã®ã³ãã察çäºç®ã«é¢ããŠãäŒè𿀿»é¢ãªã©ã«äžé©åãšèªå®ãããæ¯åºããå°ãªããšãçŽ1600ååã«ã®ãŒãããšãè§£ã£ãã
äºæ¥è ãäžåž¯ã«æ©ããéãé ãããšãåªå ããããšãäžå ã ããå°éå®¶ããã¯ãéäžã§å¶åºŠãèŠçŽãããšã§äžéšã¯é²ãããšã®ææãããã - /26 TelegraphçŽããã€ãã®å ¬è¡è¡çæ©é¢ã§ããããã«ãã»ã³ããç ç©¶æã¯ãããã¯ããŠã³ã¯å©çããã害ãããããå¯èœæ§ããããšé·æã«ãããæ³å»·éäºã®æ«ã«ææžãçºè¡šã
- /29 Our Country Our ChoiceãWHOã®ãã³ãããã¯é²æ¢æ¡çŽãŸã§ããš59æ¥ãããªãã«ã¯ãããæ¢ããåããããŸãã
- /2 ãããµã¹å·ã§é³¥ã€ã³ãã«ãšã³ã¶ã«ããåã®ããææäŸãçºçãããããµã¹å·ãå¥åº·èŠå ±ãçºä»€ã
- /15 ææ¡ææ°èãæ¥æ¬èµ€ååç€Ÿãæ°åã³ãããŠã€ã«ã¹ææç以éåããŠæµ·å µéã岩åœèªç©ºåºå°ã§è¡æ¶²æ¡å
- /23 圌ãã¯çŸåšãWHOã®ãã³ãããã¯æ¡çŽã«å€æŽãå ããã圌ãã¯åŸéããŠããã圌ãã¯åœæ°ã®æè°ã«è³ãåŸããããã ã
- ä»åŸãWHOã®å§åã¯ææåãæããªããã®ãšãªããååœã¯çµå±WHOã«åŸãããšã匷å¶ãããªããªãããšã«ãªãã
- ãŸããWHOããèª€å ±ããåºããŠãããšã¿ãªã人ã ã«å¯Ÿããæ€é²ãè¡ãèšç»ãåãäžããã
-
/4 CDCãç é¢ã¯ãã¯ãCOVID-19ããŒã¿ãå ±åãã矩åã¯ãªããã
-
/9 WHOã«ã€ããŠã®çå®ãããã¯äžçå ±ç£äž»çŸ©ãšåŒã°ããŠããŸãã
- ãªãŒããŒã®ãããã¹å士ã¯ãå®ã¯å ±ç£äž»çŸ©ã®ããã¯ã°ã©ãŠã³ããæã£ãŠããŸãã
- 圌ã¯ãšããªãã¢ã®ãã«ã¯ã¹äž»çŸ©ç¬è£æ¿æš©äžã®å ±ç£äž»çŸ©æ¿æš©ã§åããŠããã
- çŸåšã®WHOã®ãªãŒããŒã¯ãå ±ç£å ãšããŠå§ãŸã£ãTPLFå ã«ãåå ããã
- WHOãžã®æ åå¯ä»ã®88%ã¯ãã«ã»ã²ã€ãã«ãããã®ã§ããããšã倿ããã
- ãã«ã»ã²ã€ããå ±ç£äž»çŸ©ã®èæ¯ãæã€èª°ãã«ãèªåã®äººçãã©ãçããã¹ãããæ±ºããŠãããããã§ããã
-
ãã³ãããã¯æ¡çŽ
- /10 å°æ¥ã®ãã³ãããã¯ãžã®å¯Ÿå¿ã«é¢ããç»æçãªåœéåæãçµãŒããšããŠããåœã ã¯ãåæããŸãšããæéããªããªã£ããããããã»ã¹ãåç¶ãããæ¹æ³ã«ã€ããŠè°è«ãå§ããã
- /12 WHOã¯ããã³ãããã¯æ¡çŽã®æç¥šã«å ç«ã£ãŠè²æ©ããããã22ã®å·åžæ³é·å®ã¯ãæçµçã«ããããã®ææ®µã®ç®çã¯å ¬è¡è¡çãä¿è·ããããšã§ã¯ãªããããšå察æžç°¡ã§è¿°ã¹ãã
- /12 WHOã®ãã³ãããã¯æ¡çŽã¯æ»ãã ããïŒä»ã®ãšããïŒããã埩掻ãããå¯äžã®æ¹æ³ã¯COVID 2.0ã®ã·ããªãªã§ãããã£ãšéªæªãªãã®ãæ²¹æã¯ã§ããŸããããŸã 宿ã«ã¯çšé ãã®ã§ãã
- /14 è±åœã®ä¿å¥å€§è£ãå°æ¥ã®ãã³ãããã¯ãžã®åãã«é¢ããäžçä¿å¥æ©é¢ïŒWHOïŒã®ææ¡ãããŠããåå®ã¯ãçŸæç¹ã§ã¯ãåãå ¥ããããªããã
- /16 ã¹ãããã¢éŠçžã¯ãã³ãããµãŒã«ã¹ãã調æ»ãããšçºè¡šããã圌ã¯ãŸããWHOã®ãã³ãããã¯æ¡çŽãæåŠããŠãããšãè¿°ã¹ãã仿¥ã圌ã¯è€æ°åæãããŸããã
- /17 ã«ã€ãžã¢ãå·ã¯WEFãšWHOã®è°é¡ãçŠæ¢ããæ³æ¡ãäžé¢ãšäžé¢ã®äž¡æ¹ãééãããå·å ã§ã¯ç®¡èœæš©ãæš©åãæããªããããã¯å€§ãã¥ãŒã¹ã§ãããMSMã¯å ±éããŠããŸããã
- /17 22å·ã®åžæ³é·å®ãæ¡çŽã«çœ²åããããšãæåŠãè±åœãã¹ãããã¢ãæåŠããªãŒã¹ãã©ãªã¢ã®æ¿æ²»å®¶æ°åããæ¿åºã«æåŠããããæ±ããæžç°¡ã«çœ²åã
- /24 å°æ¥ã®ãã³ãããã¯ãžã®å¯Ÿå¿ã«é¢ããç»æçãªåœéåå®ã®äº€æžïŒãã³ãããã¯åå®äº€æžïŒã¯ãåæãªãçµäºãååœã¯åæã«åããŠåŒãç¶ãåªåã
-
/18 ããã¯ãã¹ãŠåã ã£ãïŒNIHã®å æé·ã¯ãæ°åã³ãããŠã€ã«ã¹ã®ãã³ãããã¯äžã«ã瀟äŒçè·é¢ã眮ããããšã®ç§åŠç蚌æ ã¯äœããªããšèªããã
-
/18 ãã¡ã€ã¶ãŒã®å å¯ç€Ÿé·ãã€ã¯ã»ã€ã§ãŒãã³å士ã¯ãCBDCãããžã¿ã«IDãåœé£ã¢ãžã§ã³ã2030ãæåŠããããçã«èšŽããŠããŸãã
ã2030幎ãŸã§ã«ãåœå€ã«åºãããšã¯ã§ããªããªããå人ã®äº€éææ®µãææããããšããªããªããããããããšãããžã¿ã«IDã§è¡ãããšãã§ããããã«ãªãã -
/23 ãã¥ãŒãžã£ãŒãžãŒå·ã®æ°åã³ãããŠã€ã«ã¹å¯Ÿçå¶éãç¡èŠãããžã ã®ãªãŒããŒãã80件以äžã®å®¹çããè§£æŸãSNSã«ãç¥äºã¯ã¯ãœãããããšæçš¿ãç¥çŠã
-
/24 WHOå ±åæžãæ°åã³ãããŠã€ã«ã¹ææçã®ãã³ãããã¯ã§æšå®1300äžäººãæ»äº¡ãæ¥éã«ååã¢ã¡ãªã«å€§éžã§æå€§ã2020幎ã«äžç第3äœã2021幎ã«äžç第2äœã®æ»å ã«ã
-
/25 WHOã®å çåœã¯ãææçã®äžçç倧æµè¡ïŒãã³ãããã¯ïŒã®äºé²ã察å¿ãå®ããããã³ãããã¯æ¡çŽãã®æ¡ææ¡ã«ã€ããŠãç®æšã®24æ¥ãŸã§ã«åæã§ããªãã£ãã
-
/26 WHOã®ãã³ãããã¯æ¡çŽã¯å€±æããïŒååœãæ°ããªãã³ãããã¯åå®ã§åæã«éããããšãã§ããã倧ããªé²å±ãèŠããããããã¯èªç±ã«ãšã£ãŠã®çŽ æŽãããåå©ã§ãã
-
WHOããåœããŸããåœæ°éå
- /31 WHOããåœããŸããåœæ°éå 倧決起éäŒ åå£äžå代è°å£«æšæ¶
- /31 æ¥æ¬ã¯WHOã«å¯Ÿããäžçæå€§å€§èŠæš¡ãªæè°è¡åãè¡ã£ããå 倧è£ã¯ãç©ãã«ãã£ãŠäº¡ããªã£ã人ã ã«å¯ŸããŠè¬çœªããæŒèª¬ãè¡ã£ããçå®ãæããã«ãªãã€ã€ããã
- /31 æ¥æ¬äººã¯ä»æ¥ãäžçä¿å¥æ©é¢ã®ãã³ãããã¯åå®ãšã°ããŒããªã¹ãã«ããæš©åææ¡ã«æè°ããããã«æ±äº¬ã«éçµãæ¥æ¬ã¯åœæ°ã«å¯ŸããèŽåœçãªåœ±é¿ã«é¢ããç ç©¶ããªãŒãã
-
/1 æ±äº¬éœå ã®æ¥æ¯è°·å ¬åã§å€§èŠæš¡ãªæ±ºèµ·éäŒãã³ãã¯ã¯æ¥çš®ãªã©ã«é¢ããŠWHOãæšé²ããIHRæ¹æ£ããã³ãããã¯æ¡çŽã«å察ãã人ã ãååŽçåããé座åšèŸºã«ãããŠç·Žãæ©ããã
-
/2 ãã¡ãŠãæ°ãåäŸã®ãã¹ã¯ççšã瀟äŒçè·é¢ã®ç¢ºä¿ãªã©ãCOVIDã®æšªæŽãªã¬ã€ãã©ã€ã³ãã§ã£ã¡äžããããšãèªãã â ãããã¯åãªãä»®å®ã«åºã¥ããŠãããç§åŠã«åºã¥ããŠããªãã£ã
-
/3 DailyMailãã¢ã³ãœããŒã»ã«ããã©ã»ãã¡ãŠãå士ã6ãã£ãŒãã®ç€ŸäŒçè·é¢ãåäŸã®ãã¹ã¯ççšãªã©ã®ã³ãã察çã«ãŒã«ããã§ã£ã¡äžããããšåçœ
-
/4 DailyMailçŽããã¡ãŠãæ°ãåŠæ ¡ãäŒæ¥ã®ééãªã©ã®ã³ãã察çã¯å³ãããããããããªããã2020-2021幎åé ã®ãã³ãããã¯ãžã®å¯Ÿå¿ã§åœå±ãç¯ãããã¹ãçããèªããã
-
/4 å ¬èŽäŒã§ãã¡ãŠãå士ã®åŸãã«åº§ã£ãŠãããJail Fauciãã·ã£ããçãŠãã女æ§
-
/5 DailyMailãäžé¢ã®æåå ±åå å¡ã¯ãã¡ãŠãå士ãCOVID-19ã®æµè¡äžã®è¡åãšè°äŒãžã®èåœã®å ±åã§é®æãããå¯èœæ§ããããšããèããæ¯æã
-
é³¥ã€ã³ãã«ãšã³ã¶
- /6 WHOãã¡ãã·ã³ã®59æ³ç·æ§ãH5N2é³¥ã€ã³ãã«ãšã³ã¶å€ç°çš®ã«ããåã®ããææäŸã§æ»äº¡ã家犜ãä»ã®åç©ãšã®æ¥è§Šã¯ãªãã£ããšããã
- /7 WHOã H5N2åé³¥ã€ã³ãã«ãšã³ã¶ã«ææããç·æ§ãè€æ°ã®èŠå ã§æ»äº¡ãããšçºè¡šã調æ»ã¯ç¶ç¶äžããããžã®ææã¯åããŠç¢ºèªã
- /7 WHOã¯é³¥ã€ã³ãã«ãšã³ã¶ã«é¢ããè©æ¬ºãè¡ã£ãŠããã圌ãã¯åœéœæ§ãå€ãåºããšããŠåºãæ¹å€ãããŠããPCRæ€æ»ã䜿ã£ãã
-
- 圌ã¯4/24ã«æ»äº¡ãã 2) åœŒã¯æ¢ã«3é±éå¯ãããã§å ¥é¢ããŠãã 3) 圌ã¯é³¥ã€ã³ãã«ãšã³ã¶ã§ã¯ãªãåå ã§æ»äº¡ããå¯èœæ§ãé«ãã
- ããããé³¥ã€ã³ãã«ãšã³ã¶ã§ã¯ãªãã£ãã«ãããããããã圌ã¯é³¥ã€ã³ãã«ãšã³ã¶ã§æ»ãã ã
- é³¥ã€ã³ãã«ãšã³ã¶ã«çœ¹ã£ãŠæ»ã¬ããšïŒåœéœæ§ïŒã¯ãé³¥ã€ã³ãã«ãšã³ã¶ãåå ã§æ»ã¬ããšãšã¯ãŸã£ããç°ãªãã
-
- /8 éå ±ïŒã¡ãã·ã³ä¿å¥å€§è£ã¯ãç·æ§ãæ°ããé³¥ã€ã³ãã«ãšã³ã¶ã®æ ªã§æ»äº¡ãããšããWHOã®äž»åŒµãåŠå®ã
ãã®ç·æ§ã¯æ°é±éå¯ãããã®ç¶æ ãç¶ããŠããã2åç³å°¿ç ãšè äžå šãæ£ã£ãŠãããã€ãŸããWHOã¯åãã€ããã
-
/8 æ°ããªé»åã¡ãŒã«ã«ããããã¡ãŠãã2020/3ã«ããããã·ã¯ãããã³ãäžåœã§ã³ãããŠã€ã«ã¹ã®æ²»çã«å¹æçãšç¥ããããŠããããšãæããã«ãªã£ãã
- ãã©ã³ã¹ãåææ®µéã§å¹ããŠããšäœ¿çšãããŠãŸããããã¯ãã³ãæ¢ãã
- ãã©ã³ããèªèº«ãéœæ§ã«ãªã£ãæãããããã·ã¯ãããã³ãšäºéããã¿ãã³Dã§å埩ãããšæ å ±ãåºããŠããã
-
/12 ãžã§ãŒãžã¢å·ã¢ãã©ã³ã¿ã®æ°äž»å æ€å¯å®ãã³ãã察çè³é1500äžãã«ãçãã çœªã§æç
- ãã®ãå ¬åå¡ãã¯ããŒã«ã¹ãã€ã¹ãš10ã«ã©ããã®ãã€ã€ã¢ã³ãã®æèŒªãè³Œå ¥ããã
- 人ã ã¯ããã€ãã³ã2020幎ã«ãªãããããå€ãã®é»äººç¥šãç²åŸããŠåå©ãããšèããŠããã®ã ãããïŒ
- 8/14 åæé®®ã¯12æã«åæ±éšã®äžæ± æ·µåžãªã©ãžã®å€åœäººèгå 客åãå ¥ããåéãããè€æ°ã®æ è¡äŒç€Ÿã14æ¥æããã«ããã
- 9/1 çµæžçèªç±ãšæŠç¥çãšã³ãã¯ãŒã¡ã³ãã«çŠç¹ãåœãŠãéäŒããªãããã¬ã¹ã»ãšãã¹ããã§ãRFKæ°ã¯ãCOVID-19ãã³ãããã¯ãžã®å¯Ÿå¿ã«é¢ããè°è«ãåçãããååŒ·ãæŒèª¬ã
- 9/4 äžé¢æè²åŽåå§å¡äŒã¯ãããœã¿å·ç¥äºã§ãããªã¹æ°ã®å¯å€§çµ±é åè£ããã£ã ã»ãŠã©ã«ãã«å¯ŸããŠã2å5000äžãã«ã®æ°åã³ããææžè©æ¬ºã«é¢é£ããèšé²ã«ã€ããŠå¬åç¶ãåºããã
- 9/4 NYPãäžé¢æè²åŽåå§å¡äŒã¯ãããœã¿å·ç¥äºã§ãããªã¹ã®å¯å€§çµ±é åè£ããã£ã ã»ãŠã©ã«ãã«ã2å5000äžãã«ã®æ°åã³ããææžè©æ¬ºã«é¢é£ããèšé²ã«ã€ããŠå¬åç¶ãåºããã
- 9/7 äžççµæžãã©ãŒã©ã ïŒWEFïŒã¯ãCOVID-19ãã³ãããã¯ã¯åœæ°ã圌ãã®ãæ°äžçç§©åºããåãå ¥ãããã©ããã®è©Šç·Žã§ãã£ããšèªããã
- 9/20 NYPãå ç¥äºã¢ã³ããªã¥ãŒã»ã¯ãªã¢ããã³ãããŠã€ã«ã¹ã«ããä»è·æœèšã§ã®æ»äº¡è æ°ãéå°è©äŸ¡ããå ±åæžãå人çã«æ¹ããããŠããããšãé»åã¡ãŒã«ã§å€æ
- 9/20 NYTãNYåžã®ãã³ãããã¯å¯Ÿç責任è ããæ°ã³ãæææ¡å€§é²æ¢ã®ããNYåžæ°ã«èªå® åŸ æ©ãæç€ºããªãããSEXããŒãã£ãŒããã³ã¹ããŒãã£ãŒã«åå ãããããŠããã
- 9/24 æ°äž»å å¡ã§ãNYåžå ã³ãã察ç責任è ã§è¶ 匷硬ãªããã¯ããŠã³ã®ç«åœ¹è ã®ãžã§ã€ã»ãŽã¡ã«ãæ°ãããã¯ããŠã³æã®ããŒãã£ãŒåå ãçºèŠããŠãã1é±éåŸã補è¬äŒç€Ÿããè§£éã
- 10/26 ããã¥ã¡ã³ã¿ãªãŒãããããšãããã¡ãŠãå士ããå ¬éãåœå²äžææªã®å»åž«ã®ãã¹ãŠãæããã«ãFacebook/Metaã¯æ¢ã«äºåç·šã®æŸæ ããããã¯ã
-
/3 åœåã®èšç»ã§ã¯ã10幎éã®å°éã®åŸã匷å¶çã«äººã ãéé¢ãã£ã³ãã«å容ãããã£ãããšã¯ã¯ãã³ãæ¥çš®ããäºå®ã ã£ãã
-
FEMA
-
/5 WARPSPEED ã FEMA ãã£ã³ãã黿¢! - å¿ èŠã®æ ç»...
https://rumble.com/v5li3ni-warpspeed-stopped-the-fema-camps-must-see-film....html- 誰ãç¥ããªãããšãããã®é©ãã¹ãæ ç»ã§ã€ãã«æããããïŒãã³ãããã¯ã®çã®æå³ã¯ãçŸåšé²è¡äžã®ãŠã€ã«ã¹ã®äºçš®ã«ãã10幎éã®éé¢ã ã£ãã
- ãã®æ°å¹ŽéãäœçŸäžäººãã®å察掟ãã¯ã¯ãã³æªæ¥çš®ã®äººã ãæ€ç«æãFEMAã®å容æã«éããããè¡æ¹äžæãšãªããäºåºŠãšé£çµ¡ãåããªããªãã®ã ã
- ïŒ2023/5/5ïŒãããããã©ã³ãæ°ãæåã«ã¯ã¯ãã³ã倧éé åžããã®ã§é£äžã®ã°ã¬ãŒãã»ãªã»ããã®å®å šãªå®æœèšç»ããã£ããå£ããŠããŸã£ãã
- ïŒ2024/4/17ïŒãã©ã³ããäœçŸäžäººãã®åœãæã£ããšèšãã®ã¯ãå®éã« FEMA ã®æ»ã®å容æããæã£ãããã ãçŸåšããã®èšç»ã¯WARPSPEEDã«ãã£ãŠç¡ååãããŠããã
-
/7 CDCãã³ããçŠã«ãããŠèšç»ããŠããå šåœçãªéé¢ãã£ã³ãã®æ§æ³ãæ¹å€çã«æ€èšŒã
èšç»ã¯ãé®èœã¢ãããŒãããšããŠãé«ãªã¹ã¯è ãäœãªã¹ã¯ã®äžè¬äœæ°ããéé¢ããå°çšã®ãã°ãªãŒã³ãŸãŒã³ãã«ç§»åãããå 容ã ã£ãã- ããã«ã¯å®¶åºãå°åã¬ãã«ã§ã®éé¢ãå«ãŸããæçµçã«ã¯ãã£ã³ãåã®é颿œèšãææ¡ãããŠããã
- ããã§ã¯ç©è³ã®é 絊ãè¡ããããã®ã®ãå€éšãšã®æ¥è§Šã¯å¶éããã宿è¡äºãžã®åå ãçŠæ¢ãããå¯èœæ§ã瀺åãããŠããã
- ãã®ã¢ãããŒãã¯æææ¡å€§ãé²ãæå³ãããäžæ¹ã§ãéé¢ããã人ã ã®ã¹ãã¬ã¹ãå€ç«æãå¢å¹ ãããªã¹ã¯ãææãããŠããã
- ãŸãããã®æªçœ®ãã人éçããšãããäžæ¹ã§ãå®éã«ã¯åŒ·å¶çã§ãããšåãåãããããªãæžå¿µã瀺ãããŠããã
-
-
/9 ãã©ã³ãã¯ãäžåœãæ¯é ããè æããçµç¹ãWHOãšã®é¢ä¿ãæã¡ã䞻暩ãå®ãããã®è¡åèšç»ã瀺ããŠããããã³ãããã¯æ¡çŽã«ãã£ãŠã¢ã¡ãªã«ã®äž»æš©ã䟵害ãããå±éºããããšæ¹å€ã
倧統é ãšããŠä»¥äžãå®è¡ããæåã瀺ããïŒãã³ãããã¯æ¡çŽã®ç Žæ£ãå ¬è¡è¡çãçç±ã«äžçæ¿åºã䞻暩ã䟵害ããã®ã黿¢ãWHOããã®å®å šè±éã䞻暩ãå®ãåœã ã®æ°ããªå¥åº·é£åã®æ§ç¯ -
/11 ãªã©ã³ãã®é«å®ã¯ãCOVID-19ããè»äºäœæŠãã§ãã£ãããšãèªãããªã©ã³ãã¯ãã³ãããã¯ã®éäžãNATOã®æç€ºã«åŸã£ããšäŒããããŠããã
ãªã©ã³ãã®ãã«ãŒã«ã»ã¢ã²ãä¿å¥çžã¯è°äŒã§ãååœã®ãã³ãããã¯å¯Ÿçã¯ãNATOãã«æ²¿ã£ããã®ã§ãã£ããšè¿°ã¹ãããã©ã³ãã¯èª°ãããæ©ãã²ãŒã ãèŠæããŠããã -
/11 ä¿éºäŒç€Ÿãã«ãŒã¯ãã¹ã»ãã«ãŒã§30幎以äžITã¹ãã·ã£ãªã¹ããšããŠåããŠãããªãµã»ãã ã¹ããŒã¯ãå®å šæ§ã广ããªãããšã蚌æãããCOVIDã¯ã¯ãã³ã®æ¥çš®ãæåŠããããã«è§£éãããã
- ãã ã¹ããŒãããã«ããªãã¯ä¿¡ä»°ã«å¯Ÿãã宿差å¥ã§å瀟ã蚎ããåŸããããã€ãã®é£éŠè£å€æã¯åœŒå¥³ã«å€é¡ã®æå®³è³ åãèªããã
- 倿±ºã«ã¯ããã«ãŒã¯ãã¹ã»ãã«ãŒã·ãŒã«ãã»ãªãã»ãã·ã¬ã³ã«å¯Ÿãã1000äžãã«ã®æ²çœ°çæå®³è³ åã170äžãã«ã®éžå€±è³éã100äžãã«ã®éçµæžçæå®³è³ åãå«ãŸããŠããã
-
/12 ã€ãŒãã³ã»ãã¹ã¯ã¯ãã¢ã³ãœããŒã»ãã¡ãŠãã起蚎ããããšããæåã確èªããã°ããã ãäžçã«è§£ãæŸããã人é¡ã«å¯Ÿããæå€§ã®ç¯çœªã«å¯Ÿãã責任远åãè¿«ã£ãŠããïŒ
-
/14 ã圌ïŒãã¡ãŠãïŒã¯äžåœã®æŠæŒ¢ã§ã®ä»äºã«è¿ãå Žæã§åŒéãã¹ãã ãšæããããã©ã³ã倧統é ã®æ¬¡æåžæ³é·å®ãããã»ã²ãŒãæ°ã¯ã2025幎ã«ãã¡ãŠãæ°ã«è²¬ä»»ãåããããšçŽæã
-
/16 ç±³åœæ¿åºããèèãè èã«æ¯æ§ããããšãããè¬ãã¬ã ãã·ãã«ããç é¢ã§äœ¿çšãããããã«ãç é¢ã«20%ã®ããŒãã¹ãæäŸããŠããã
- ã¬ã ãã·ãã«ã¯ã³ããæ²»çè¬ãšããŠå°å ¥ãããããStella Paulã«ãããšè èãèèã«æ·±å»ãªãã¡ãŒãžãäžããå€ãã®æ£è ã®æ»äº¡ã«ã€ãªãã£ããšã®ææãããã
- WHOã¯2020幎11ææç¹ã§ã¬ã ãã·ãã«ã®äœ¿çšãæšå¥šããªãæ¹éã瀺ããŠããããHHSã¯ãã®è¬ãæäžããç é¢ã«ããŒãã¹ãä»äžããçµæžçã€ã³ã»ã³ãã£ããäžããŠããã
- å»åž«ã®ããŒã¿ãŒã»ãã«ããŒæ°ã«ããã°ããã®ããŒãã¹ã¯ç é¢ã«ãšã£ãŠå€§ããªåçãçããã®ã§ãã¬ã ãã·ãã«æäžã«ããå ¥é¢è²»çšãå€§å¹ ã«å¢å ããã±ãŒã¹ããã£ãã
-
/19 ãœãã¹ã®æ¯åãã¢ã¬ã¯ãµã³ããŒã¯ãRFKã®æ¿çãé£éŠæ¿åºæ©é¢ã®å€§å¹ ãªæ¹é©ã«ã€ãªããå Žåãæ°ããªãã³ãããã¯ã®å¯èœæ§ãèŠåãã€ãŒãã³ã»ãã¹ã¯ã¯ãããè©æ¬ºçæµè¡ãšåŒãã ã
-
/2 WHOã®ãããã¹äºåå±é·ã¯ããã³ãããã¯æ¡çŽã«é¢ããåè°ãçµç€ã«å·®ãæãã£ãŠãããšè¿°ã¹ããæ¡çŽæ¡æã®é²å±æ¬¡ç¬¬ã§ã幎æ«ãŸã§ã®æ±ºçãç®æãã
- æ¡çŽã¯ãã³ãããã¯ã®äºé²ãæºåã察å¿ãç®çãšãã194ãåœã3幎以äžã«ããã£ãŠäº€æžãç¶ããŠããã
- çŸåšãç ç©¶éçºãè³é調éãæè¡ç§»è»¢ãç åäœãžã®ã¢ã¯ã»ã¹ãšå©çé åãäž»èŠè°é¡ãšãªã£ãŠããã
- 亀æžã§ã¯ã西åŽè«žåœãšè²§ããåœã ã®éã§æèŠã®å¯Ÿç«ãããã補è¬ç£æ¥ãé¢ããæè¡é©æ°ãšå ¬å¹³ãªå¯Ÿå¿ã®ãã©ã³ã¹ãçŠç¹ãšãªã£ãŠããã
- ãªãã¯ã¹ãã¡ã ã¯ã補è¬äŒç€Ÿã®å©çã§ã¯ãªãå šäººé¡ã®å¥åº·ãåªå ãã¹ããšèšŽããã
- äžæ¹ãWHOã¯åœéçãªè¡ååºç€ãšããŠã®æ¡çŽã®æçŸ©ã匷調ããæ©æã®åæãåŒã³ãããŠããã
-
/30 ãã«ã»ã²ã€ã財å£ã¯ãJHU CHSããã³WHOãšååãã2025幎ã«èŽåœçãªãã³ãããã¯ãçºçããããšãæ³å®ããã壿» çãªäŒæããšããã·ãã¥ã¬ãŒã·ã§ã³ã宿œã
-
/1 幎æ«ã«æ²³é倪éããéã³å±ã®ç§ãåŸéºçã«ã€ããŠè²¬ä»»ããšããªã©ãšçºèšãããããšã¯ãããŸããããªã©ãšããã°æçš¿
-
/13 BBC ãã¥ãŒã¹éå ± : ã¯ã¯ãå¿è¡ç®¡æ»ã®éå°ãªåå ã®å¯èœæ§ãé«ã
-
/18 ã¯ã¯æ»ã蚺å¯å»åž«ãç çè§£åå»åž«ããå æé¢ä¿ãããã§å ±åããŠãããPMDAã¯1äŸãèªããŠããªãã
-
/27 CDC坿é·ãã¯ã¯ãã³å¯Ÿçå§å¡äŒã®ãã å³¶è¢ããã¯ã¯ãã³ã衰匱æ§çŸæ£ãåŒãèµ·ãããŠããããšãèªããã
-
/28 åã¯ã¯ãã³ã«æ ¹æ ãªãããšãæ²³éããžã¿ã«çžãæ ¹æ ãªãæŒèª¬
-
/30 ã€ã³ãåœå倧è£ããã¡ã€ã¶ãŒç€Ÿã¯æ¿åºãè è¿«ãå 責æ¡ä»¶ãåãŸããããšããããã€ã³ãã¯å°å ¥ãæåŠãã³ããã¯æ¢ã«åæ
-
ã¯ã¯ãã³æšé²æŽŸã®4-5åç®æ¥çš®é¢è±ã®èŠ³æž¬ãå¢å ã
-
2022/12 - 2023/1蟺ãã®è¶ éæ»äº¡ãã€ãããããã
-
æ¯ãè¿ã£ãŠ3, 4, 5åç®ã®ããŒã¹ã¿ãŒæ¥çš®ã«åãããŠè¶ éæ»äº¡ãçºçã
-
WEFã§ã¯ã¯æ¥çš®çãé«ãåœã®æåèŠå ããæ¥çš®çãäžããã®ã«ç§åŠïŒç説æïŒã¯äžèŠããšå€æã
-
/2 çŠå³¶é å žææãååŽçã«å¯Ÿãã蚎èšèšè äŒèŠ
-
/7 é±åçŸä»£
- ãå¿èãæº¶ããïŒãããŒãªãŒã®ãããªè¡æ ãå»åž«ãã¡ããããããã¯ã¯ãã³æ»ãã壮絶éºäœã®å£°
- è¬ã®ãèºçããèè¡°ããé«ç±ãâŠã¯ã¯ãã³æ¥çš®åŸ1~2ãµæã§çªç¶æ»ããé«éœ¢è ãã¡
-
/9 ãã¬ãŒã·ã¢å éŠçžã鮿ãã³ããæ¿çã§æ±è·å®¹çãå»ºèšæ¥è ãæ¯æŽãèŠè¿ãã«è³ééæµã
-
/10 ããœãã33ååã®ãã³ãã婿š©ããæã«ããæå£ãæç³åžé·ãæããïŒèœéžè°å¡ã䜿ã£ãŠå¶æ¥ã
-
/10 äžæµŠç éº å€«ã®äŒç€Ÿã«ãã³ãã絊ä»éçŽ550äžåãäžæ£å絊çæãäžæµŠç éºã売ãäžãæäœããã°ããããšé©ãã®çºèš
-
/10 æ°åã³ããã¯ã¯ãã³æ¥çš®ãšæ»äº¡ãé¢ä¿åŠå®ã§ãããåçåŽåçã®å ¬è¡šè³æã§åã®èªå®
-
/10 ç¹ãäŒãéºæãã¯ã¯ãã³æ¥çš®åæ¢ãææžãªã©æ¿åºã«èŠæïŒææžå¶åºŠã«6219ä»¶ã®ç³è«
-
/12 ãã€ãã®ã³ãã¯ã¯æ¥çš®çŸ©ååã®äž»èŠãªæšé²è ã ã£ãä¿å¥å€§è£ã«ãŒã«ã»ã©ãŠã¿ãŒãããã¯ã¯ã¯ãã³å¯äœã®åé¡ãèªããã
-
/16 ãã¡ã€ã¶ãŒç€Ÿã®æ©å¯ææžã§2022幎åé ã«ãå¿ççãªã¹ã¯äžæãã®ã³ãã¯ã¯å¯äœçšãšããã³ã¹ãæã£ãŠãããšå€æã
-
/18 ã³ãã¯ã¯å€§é廿£ãå°ãªããšã7783äžåå廿£ã2000ååè¶ ãè æ°ã1æ¥100äžåã倧å·ä»€ã圱é¿ã
-
/23 ãµãŠã¹ãŠãšã¹ãèªç©ºã®ãã€ããããé£è¡äžã«æçžŠäžèœã«ãéå»2é±éã§5人ç®ã®ãã€ãããã®æçžŠäžèœ
-
/24 ä»é±æ«ã®ãªãŒã¹ãã©ãªã¢äž»èŠçŽã®äžé¢ãæåã¯è¶³ã®çã¿ã ã£ãã
- ã·ãããŒã®åŠçãšã€ããŒã»ã»ãžãŠã£ãã¯ã¯ãã³ããã»ã¯ã¯ãã³æ¥çš®åŸã®æ°æ¥éãè¶³ã®åèžãŸãã®éåæããå»è ã«è¡ãå¿ èŠããããšèããã
- ãã®çã¿ã¯ããã«è»œããã³ãã«å€ããã4é±éåŸã«ãšã€ããŒã2åç®ã®ãã¡ã€ã¶ãŒæ³šå°ãåããåŸã«èããæªåãããè ãšè¶³ãçã¿ãäžè¢ã®æèŠã倱ã£ãŠããã
- 6æ¥åŸããã³ãã®ããã«ãšã€ããŒã¯ç«ã€ããšãæ©ãããšãå°é£ã«ãªã£ãŠãããããã«ãããããè»æ€ åã«åãäžããªããã°ãªããªããªã£ãã
- èŠåã¯äœäžããæã¯ãã³ããã圌女ã¯2åºŠå ¥é¢ãããªãããªã»ã³ã¿ãŒã§2ã¶æãéãããããããŠ9ãµæåŸãåœŒå¥³ã¯æ¯ãåŒãåã£ãã
-
/27 ãããŒã F. ã±ãã㣠Jr.ãšChildren's Health DefenseïŒCHDïŒãæ€é²ã®çãã§ãã€ãã³/ãã¡ãŠã/æ¿åºé«å®/é£éŠæ¿åºæ©é¢ã«éå£èšŽèš
-
/28 ã¢ã¹ãã©ãŒãã«ã®COVID-19ã¯ã¯ãã³æ¥çš®åŸãè¥ã女æ§ã®å¿èæ»ã®ãªã¹ã¯ã3åã«
-
/28 é廿æªèŠæš¡ã®æ»äº¡è æ°ã1æã®äººå£åæ çµ±èšã§è¡æã®æ°åãïŒæ»äº¡16äž8970äººãæšå¹Žãšæ¯ã¹ãŠ2äž4978人å¢å
-
/29 WHOãäžãªã¹ã¯ã®æäººã«ã³ããã¯ã¯ãã³ã®è¿œå æ¥çš®ã¯äžèŠãšçºè¡š
-
/29 äžé¢ã¯ããã©ã³ãå倧統é ã®åœå®¶Covid-19ç·æ¥äºæ ãçµäºãããæ³æ¡ïŒ2020/3ïŒãæ¿èªã
-
/29 ïŒæ¥æ¬ïŒäŒè𿀿»é¢ãã³ããã¯ã¯ãã³ç¢ºä¿éã®ç®å®æ ¹æ ãååã«ç¢ºèªã§ãã
-
/30 æ¥çµã瀟é·100人ã¢ã³ã±ãŒãã§ãã¹ã¯ã»åºåŒµå¶éãæ€å»ã3å²
- /10 ãã¯ã¯ãã³æãŠïŒãããçªç¶ãæããªããŠãããã«âŠWHOãã€ããããæ¹é転æã決ãã驿ã®èæ¯
- /23 æ²»çæåç·ã®å»åž«ãèŠããã¯ã¯ãã³åŸéºçã®å®æ
| å°è±æ²¢æŽåœ¢å€ç§ ããã°
倿°æ±ºã¯ã倿°æŽŸã«ããç¬è£ã§ãããé節æå®³äºè±¡ ã800人ã«1人ããæšé²æŽŸã¯è»œãèããŠããã®ã!? - /24 WSJãè¥è ã®éã§æ¥å¢ããæå€ãªä¿¡ä»°å¿ãåå ã¯ãã³ãããã¯ãžã®å¯Ÿå¿ãïŒ
- /25 ãã¡ã€ã¶ãŒãCOVIDã¯ã¯ãã³æ¥çš®çŸ©ååã®ãããŒæŽ»åãè¡ãå£äœã«è³éæäŸ
- /27 ãªãŒã¹ãã©ãªã¢ã§500人ãäžçåã®COVIDã¯ã¯ãã³å·å®³éå£èšŽèšã«åå ãã¯ã©ãŠããã¡ã³ãã£ã³ã°ã§11äžãã«ä»¥äžã調é
-
/3 ãã¯ã€ãããŠã¹ãç±³åœä»¥å€ã®åžæ°ã®å ¥åœã®æ¡ä»¶ããCOVID-19ã¯ã¯ãã³æ¥çš®èšŒææç€ºããªãããšçºè¡šã
-
/5 ããŒã¿ãŒã»ãããã
- FauciãCOVIDã®èµ·æºã«é¢ããæ©å¯æ å ±ãé ããŠããã
- FauciãšPfizerã¯COVID-19ã¯ã¯ãã³ã®å¯äœçšãæããã«ããªãã£ãã
-
/11 ãããŒã F. ã±ãã㣠Jr.ã®ã ãŒãã¡ã³ããCOVIDã®ç¯çœªãå¿ããããªããåºç¯ãªæ°é£åãèªçã
-
/17 ã5é¡ç§»è¡ããžã®äžæºãé ããªã人ã ïŒã¯ã¯ãã³ãæ¥æ¬ã§åŠåãããPfizerãã³ããããã«ãç¶ãããæ¥æ¬å»åž«äŒ
-
/18 ãžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ãCOVID-19ãã¯ã¯ãã³çšéãç±³åœã§å šåœçã«å ¥æäžå¯ã«
-
/15 NHKãã¥ãŒã¹ãŠãªãã9ã§ã¯ã¯ãã³æ»ãã³ããæ»ãšåãåãããããã«å ±é
- /16 çªçµå ¬åŒãµã€ãã§è¬çœªã
- /16 NHKãã¥ãŒã¹ãŠãªãã9ãè¬çœªæŸéãã¯ã¯ãã³æ¥çš®åŸæ»äº¡è ãæææ»ã®ããã«äŒããã®ã¯äžé©å
- /21 NHKç·å±é·ããã¥ãŒã¹ãŠãªãã9ãBPO審è°å ¥ãã¯ãçæ¯ã«åãæ¢ããã
- /24 NHKããã¥ãŒã¹ãŠãªãã9ãã®âæé âçæã«ã³ããã¯ã¯ãã³è¢«å®³è
éºæãæãã®åçº - ãã€ãªãŒæ°æœ®
ãNHKå ±éå±ã§ã¯ãã¯ã¯ãã³ã®ãã¬ãã£ããªæ å ±ã¯äžååºããªãããšããæé»ã®äºè§£ããããïŒNHKé¢ä¿è ïŒ
-
/25 ã»ã«ã³ããªãããªã³æ å ±ãµã€ããè¶ éæ»äº¡ã®åå ãšå¯Ÿç - 欧米ã§ã¯ã¯ãã³æ¥çš®ã«ããå¹³å寿åœã®äœäžã瀺ãããŠããã
-
/26 豪å·äžé¢ãå²äžæé«ã®è¶ éæ»äº¡ç17%ã3äžäººãmRNAã¯ã¯ãã³ã§æ»äº¡ããŠããçæã«ã€ããŠèª¿æ»ããææ¡ãåŠæ±º
-
/27 ååŽçãæ°åã³ããã¯ã¯ãã³æ¥çš®åŸæ»äº¡ã®14人ã«äžæé決å®ãæ¯çµŠåèš67人ã«ã
-
/27 ã¯ã¯ãã³æ¥çš®çŽåŸã«æ»äº¡ã女åäžåŠçã®äºäŸã§å æé¢ä¿ãšçºè¡šïŒ3åç®ã®æ¥çš®ããæ°æ¥ã§å¿èºåæ¢ãåžæ³è§£åã§å šèº«ã®èåšçç
- /1 NHKããã¥ãŒã¹ãŠãªãã9ãã®âæé âçæãã¯ã¯ãã³ã®ãã¬ãã£ããªæ å ±ã¯åºããªãæé»ã®äºè§£ãã
- /4 ã€ã³ã»ã³ç€Ÿè£œCOVID-19ã¯ã¯ãã³ãç±³åœã§ã®è²©å£²çµäºã®ãç¥ããã
- /4 ããªã³ããã¯ãã¯ã¯ãã³ã®äžéšäœ¿çšè ãåããå¯äœçšãå·¡ããæ¯åœãã€ãã§åã®æ³çè«æ±ã«çŽé¢ã
- /18 æ¥æ¬å°å ç§åŠäŒãæ°åã³ããã¯ã¯ãã³ããã¹ãŠã®å°å ã«æ¥çš®æšå¥šã
- /26 å®å šæ§ãžã®æžå¿µããïŒå®éšäžã®ïŒè¥æºæ²»çè¬ã®éçºãäžæ¢ããã¡ã€ã¶ãŒæ ª5%以äžäžèœã
- /27 ã³ããã¯ã¯ãã³æ¥çš®åŸæ»äº¡ã®è¢«å®³èªå®100人ãè¶ ãããååŽçãæ å ±éç€ºã«æ¶æ¥µå§¿å¢
- /30 ãã¡ã€ã¶ãŒç€Ÿå
瀟å¡ãCOVID-19ã®æ©å¯æ
å ±ãå©çšããã€ã³ãµã€ããŒååŒã§é®æ
æ°åã³ããææçæ²»çè¬ãã¯ã¹ããããã®èšåºè©Šéšã§è¯å®çãªçµæãåŸããšèšãå éšæ å ±ãæŒæŽ©
-
/5 CDCã¯æ»äº¡èšºææžãæ¹ããããåå ãããCOVIDã¯ã¯ãã³ããåé€ãã
-
/7 ã³ããã¯ã¯ãã³ã®å¯åå¿ã蚎ãã声ãçžæ¬¡ãïŒ
æ¥çš®3æ¥åŸã«æ¥æ§åŸªç°äžå šã§å€«ã亡ããã劻ã蚎ã
ãã¯ã¯ãã³ä»¥å€ã®åå ã¯èããããªãã£ãã -
/14 ååŽçãã³ããã¯ã¯ãã³æ¥çš®åŸæ»äº¡37人ã«äžæéãæ¯çµŠèš109人ã
-
/14 ãã¬ããŒãé¡å ±åå ããããªãå·ã§ã®ã¯ã¯ãã³éæ³åãæ±ããæžç°¡ãããµã³ãã£ã¹å·ç¥äºã«éãããšã«ã€ããŠæç¥šã
-
/15 ç±³åœé£éŠè£å€æã®åœä»€ã«ãããã¡ã€ã¶ãŒç€Ÿæ©å¯ææžã®å ¬éã匷å¶ãããåŸã
ç±³åœé£åå»è¬åå±ïŒFDAïŒã¯é žåã°ã©ãã§ã³ãCOVIDã¯ã¯ãã³ã«å«ãŸããŠããããšãç¢ºèª -
/17 ã€ã¹ã©ãšã«ã§å¿èçºäœãè³åäžãã¯ã¯ãã³æ¥çš®åŸã®çœ¹æ£çãé©ç°çã«å¢å
- ã€ã¹ã©ãšã«ã¯äžçã§æãã¯ã¯ãã³æ¥çš®çãé«ãåœã®ã²ãšã€ã§ãåœæ°ã®81.5ïŒ ã1å以äžã®æ¥çš®ãåããŠããã
- 人ã ã«ããå®éšçãªã¯ã¯ãã³æ¥çš®ã¯æžå°ããŠããã«ãããããããæ»äº¡è æ°ãšææè æ°ã¯å éãç¶ããŠããã
- 21-22幎ã®çœ¹æ£çã®æ¥å¢ã¯å¯ŸåŠã説æããããŠããªãã23幎ã«ã¯åœæ°ã®å€§å€æ°ãã¢ã³ãã¯ã¯ãã³æŽŸã«ãªã£ãŠããã
-
/20 ããŒã¹ã«ãã©ã€ãã®å€§èŠæš¡ãªãã¡ã€ã¶ãŒã®è¬åå·¥å Žãç«å·»ã§ç Žå£ã
ç±³åœã®ç é¢ã§äœ¿çšããããã¹ãŠã®ç¡è泚å°å€ã®1/4ã補é ãã責任ãè² ã£ãŠããã -
/21 NHKãã¯ã¯æ»ãã³ãæ»ã®ããã«èŠèŽè ã«èª€èªãããäžé©åå ±éã§å ±éå±è·å¡ããæ²æåŠå
-
/23 ã±ãã㣠Jr. ããããã·ã¯ãããã³ãšã€ãã«ã¡ã¯ãã³ãæå¹ãšãã¡ãŠããèªããŠãããã
2åãã«ã®äŒæ¥ã¯æœ°ããŠããã ããããããã®è¬ã¯åœãæã£ãå¯èœæ§ããããè²»çšã¯ããã3ãã«ã§ãã -
/25 ã€ãŒãã³ã»ãã¹ã¯æ°ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãšããããŒã»ãžã§ãŒã ã¹ã®å¿åæ¢ãšã®é¢é£æ§ã瀺å
-
/26 ãã¡ãŠãå士ãšã³ãªã³ãºåNIHæé·ãå«ãCOVIDãããå°éå®¶ã¯ãã€ã€ãªãã£å°åæãéã3å2500äžãã«ãçŸéåããã
-
/28 ãã¡ãŠãã®ãã¹ãªãŒããšæ±è·ã®èª¿æ»ãæ±ãã10äžäººä»¥äžã®è«é¡çœ²åãæºãå»åž«ãšé£éŠè°äŒè°å¡ãåè¡åœæé«è£å€æã«éçµã
-
/30 ã¢ãã«ãã 2016 幎ã«ç¹èš±ãååŸããé åã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã®éºäŒåã³ãŒãã®äžéšãšçŽæ¥äžèŽã10ååã®1ã®ç¢ºçã
-
/31 Modernaã®CEOã¯ã2019幎ã«ãã³ãããã¯ãèµ·ããããšãç¥ã£ãŠãããšèªããŠããã2019幎ã«10äžååã®COVIDã¯ã¯ãã³ãçšæããŠããïŒ
- /2 æ¥æ¬å»åž«äŒãã¯ã¯ãã³æå¹æ§åŒ·èª¿ãå¯åå¿åŒ·ãåºãäººã¯æ éã«ã
- /4 豪å·äžé¢å ¬èŽäŒã§ããã¡ã€ã¶ãŒç€Ÿå¡ãäžè¬é åžãšç°ãªãç¹å¥ãããã®ã¯ã¯ãã³ãæäžãããããšãå ±éå®ãèªããã
- /6 ã¯ã¯ãã³è¿œå æ¥çš®ã«é¢ããæ³å€§æŽ¥åžé·ããã®ã¡ãã»ãŒãžãå¯åå¿ã®ããŒã¿ãåèã«æ¥µããŠæ éã«å€æããŠãã ããã
- /10 ç±³ã¢ãã«ãæ¥æ¬æ³äººã®éŽæšèçŸç€Ÿé·ã12æ31æ¥ä»ã§èŸä»»ãåŸä»»ã¯æ±ºãŸã£ãŠããªãã
- /13 ãã¡ãŠãå士ãšã³ãªã³ãºå士ã倧æè£œè¬äŒç€Ÿãäžé²äŒæ¥ããå°ãªããšã58ä»¶ã®ã¯ã¯ãã³äœ¿çšæã®æ¯æããåããŠãã
- /18 ã±ãã㣠Jr.ã¯ãã€ãŠã¡ãŒã¬ã³ã»ã±ãªãŒã«ããªããã¡ãŠããæ©ææ²»çã«åé¡ãæ±ããã®ãã説æããããšãããã
- é£éŠæ³ã«ã¯ãå¯Ÿè±¡çŸæ£ã«å¯ŸããŠæå¹ã§ããããšã瀺ãããŠããå»è¬åãäœããã®ç®çã§æ¿èªãããŠããå Žåã«ã¯ãã¯ã¯ãã³ã«ç·æ¥äœ¿çšã®èš±å¯ãäžããããšã¯ã§ããªãããšãããã®ãããã
- ã€ãŸãããã誰ããããããã·ã¯ãããã³ãã€ãã«ã¡ã¯ãã³ãCOVIDã«æå¹ã§ããããšãèªããŠããããã¯ã¯ãã³ã«ç·æ¥äœ¿çšèš±å¯ãäžããããšã¯éæ³ãšãªããæ¿èªãããããšã¯ãªãã£ãã
- /21 ãã€ãã³ç±³æ¿æš©ã¯æ°åã³ãããŠã€ã«ã¹ã®æ°ããªææã®æ³¢ã«å¯Ÿå¿ããç±³åœæ°å šå¡ã«ä»ç§ã®ã³ããã¯ã¯ãã³è¿œå æ¥çš®ãä¿ãæ¹é
- /5 ãã©ã³ãæ°ãæ°åã³ãã¯ã¯ãã³ã¡ãŒã«ãŒã«å®å šæ§ããŒã¿ã®å ±æãèŠè«ãæ¿åºããæ¯å¹Žã¯ã¯ãã³ã®æšå¥šãäºæ³ãããŠããã
- /7 ãžã«ã»ãã€ãã³ã¯ã2åã®ååæ¥çš®ãš2åã®è¿œå æ¥çš®ãåããåŸãCOVID-19éœæ§ãšå€å®ãããã
- /7 ã¡ãŒã¬ã³ã»ã±ãªãŒãã³ãã¯ã¯è¿œå æ¥çš®åŸãèªå·±å ç«çŸæ£ããã¯ã¯ãã³ãåããããšãåŸæããŠããã
- /7 äžè¬ç€Ÿå£æ³äººã¯ã¯ãã³åé¡ç ç©¶äŒããªã¹ã¯ãããå©çãåããšååŽçã¯ãã£ãšèšã£ãŠããããããããã®å©çãšã¯äœãªã®ãã
- /8 ã¯ã¯ãã³åé¡ç ç©¶äŒä»£è¡šçäºã»çŠå³¶é å žå»åž«ããæ žé žå»è¬ãªããŸã£ããäžå®å šãªãè¬ã§ããªããã®ãã°ããŸããŠïŒæ®ºäººã§ãïŒã
- /9 æ°åã³ããã¯ã¯ãã³ãå šãŠã®ã¯ã¯ãã³è¢«å®³èªå®æ°çޝèšãè¶ ããïŒå¥åº·è¢«å®³èªå®ã¯4098ä»¶ã«ïŒåçåŽåçã¯èªç²èŠè«ã
- /10 æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ãæåŠããæåž«ã«æªæãéãæ¯æã£ãŠåŸ©è·ãããªããã°ãªããªããå·æé«è£å€äºå€æ±º
- /11 çŠå³¶ææãã¯ã¯ãã³é¢é£æ»ãçããã2,000äººã¯æ°·å±±ã®äžè§ã ïŒããããã¯ã¯ã¯ãã³æ¥çš®åŸçå矀ããåœã¯ã ããŸããããå£ä»€ãã
- /11 æ¥åè¬æ¥ãã©ã°ã»ãã¹è§£æ¶ãžãæ¥æ¬ãé åããæ²»éšã®å Žã«ãäžäºå»è¬å審æ»ç®¡ç課é·ãæ¥æ¬äººP1èŠåŠè°è«ã«æåŸ
- /14 ã¡ãŒã¬ã³ã»ã±ãªãŒããã¡ãŠã·ãŒå士ãããã¯ããŠã³å¯Ÿçãã¯ãŒãã»ã¹ããŒãäœæŠã®åµèšã«ã€ããŠåããã ãäžããã©ã³ãã¯çå®ãèªãã
- /20 âã³ããã¯ã¯ãã³æ¥çš®ã§çæŽ»ã«æ¯éâ ç¥å¥å·çã«äœã40代ã®å¥³æ§ãªã©ãåœãšèªæ²»äœã補è¬äŒç€Ÿã«6000äžåäœãã®æå®³è³ åãæ±ãã蚎ã
- /24 CBCãã¬ããåå€å±åžã«äœã50代ã®ç·æ§ãã¯ã¯ãã³æ¥çš®åŸã«äžå身äžéãåœã¯è©äŸ¡äžèœå€ææ±ãïŒãæ¥çš®åŸã«è °ããäžãåããªããªã£ãŠããŸããã
- /25 ãªãã£ãŒãã»ããŒã·ã¥ãã³ïŒéºäœæŽåŸ©åž«ïŒãžã®ã€ã³ã¿ãã¥ãŒïŒæ»äœã® 50% ã«æªåé«ããçœãç·ç¶æ§ã®å¡ããèŠããã
- /26 ã³ããã¯ã¯ãã³æ¥çš®åŸæ¥æ»ã»æç¥ã調æ»å§ãå ±åæžå ¬è¡šãé©åæ²»çãªãæåœã§ããå¯èœæ§
- /26 ã€ãŒãã³ã»ãã¹ã¯ãã¯ã¯ãã³çŸ©ååã«å¯Ÿãã匷ãå§¿å¢ã衚æãã¯ã¯ãã³æ¥çš®ãåããªãããšãéžæããåŸæ¥å¡ãè§£éããããã¯ååæã«è¡ãæ¹ãè¯ããã
-
4 ææ¡ææ°èãæ¥æ¬ã®å€ãã®åºå°ã§COVID-19ã¯ã¯ãã³ã®æŽæ°ããã€ã«ãªããäžæ
- æ¥æ¬äžã®äžéšã®è»çšäºé²æ¥çš®ã¯ãªããã¯ã§ã¯ã倧éã®æ³šæãæ»ã£ãŠãããããã¯ã¯ãã³ã®å ¥æãå°é£ã«ãªã£ãŠããã
- äŸå€ã¯æ±äº¬è¥¿éšã«ããåšæ¥ç±³è»åžä»€éšã®æšªç°åºå°ã§ç¬¬374å»çã°ã«ãŒãã«ãã¡ã€ã¶ãŒè£œã¯ã¯ãã³ã11æã«å°çäºå®
-
5 CDCã誰ã瀟äŒã«åå ã§ããããæ±ºå®ããŠãããã³ãããã¯æä»£ã®ã¯ã¯ãã³æ¥çš®èšŒææžãæ°åã³ãããŠã€ã«ã¹ææçã¯ã¯ãã³æ¥çš®ã«ãŒãããçµäº
-
/10 MilitaryTimes.comããããªãå·é£éŠè£å€æã«æåºãããåææžã«ãããšãåœé²ç·çã¯æ°åã³ããã¯ã¯ãã³æ¥çš®çŸ©å蚎èšã180äžãã«ã§åè§£
-
/13 ææ¡ææ°èãæ°åã³ãããŠã€ã«ã¹ææçã«ããé圹è»äººä¿å¥å±ãéå¶ããã»ãšãã©ã®å»çæœèšã®äººå¡äžè¶³ãæªåããããšãIGã®å ±åæžã§å€æ
-
/18 åçåŽåçãæ²»éšã®æ¯æŽæ¥åãè¡ããã¡ãã£ãã¡ãŒããã«ç«ã¡å ¥ãæ€æ»ãè¡ããæå€§123ä»¶ã®æ²»éšã§ããŒã¿æ¹ãããªã©ã確èªããããšçºè¡šããã
- /15 MTGäžé¢è°å¡ãCOVIDã¯ã¯ãã³ãå°å ããã³ææ¥æã®äºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ã«è¿œå ããããCDCãå§åããå Žåããã®ä¿é²ã宿œãæœè¡ã«å¯Ÿããè³éæäŸãçŠæ¢ããä¿®æ£æ¡ãæåºã
- /21 ãããµã¹å·åžæ³é·å®ãæ¬æ¥ãç§ã¯ãããµã¹å·ã¡ãã£ã±ã€ããéšããåäŸãã¡ã«ç²æªãªå»è¬åïŒâ ã¯ã¯ïŒãæäŸãããšããŠããã¡ã€ã¶ãŒç€Ÿãšããªã¹ã»ãã¡ãŒã瀟ã«å¯ŸããŠèšŽèšã
- /28 米海è»å»å®ãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã®ãã€ãããã®å¿èé¢é£åé¡ã®é©ãã¹ãå¢å ã瀺ãåœé²çã®ããŒã¿ãæŽé²ïŒå¿çç151ïŒ å¢ãå¿äžå š973ïŒ å¢ïŒåç»ïŒ
-
/1 ãããµã¹å·ã®ã±ã³ã»ãã¯ã¹ãã³åžæ³é·å®ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®æå¹æ§ãèåœè¡šç€ºããå ¬å ±ã®èšèª¬ã®æ€é²ãå ±è¬ãããšããŠãã¡ã€ã¶ãŒãå蚎ãããã
-
/5 NHKã®å ±éçªçµããã¥ãŒã¹ãŠãªãã9ãããã¯ã¯æ»éºæãã³ãæ»éºæã®ããã«äŒããåé¡ã§BPOã®æŸéå«çæ€èšŒå§å¡äŒãæŸéå«çéåããã£ãããšçµè«ããæèŠæžãçºè¡šã
-
/5 åå±ã®åæãåããéºæããã³ã¡ã³ããBPOã®æèŠæžã«ããéãã3人ã®éºæã®èšèãããã24ç§ã§äŒãããªã©ããåŸãªãã人ã®åœããããŠæ»ãããŸãã«è»œãèŠãŠãããšæããããåŸãªãã
-
/5 DailyMailãå è±éŠçžããªã¹ã»ãžã§ã³ãœã³ã¯2021/3ã«ããªã¥ãã»ã«ãè±åœãžã®ã¯ã¯ãã³çºéã黿¢ãããšè è¿«ããããšãåããè»äºé¡§åã«ãªã©ã³ãã®æ°ã³ãã¯ã¯å·¥å Žã襲æãèŠè«ããŠããã
-
/9 ãã©ã®åœã§ãåãã§ããã¯ã¯ãã³æ¥çš®ã®æ²ç·ã«ç¶ããŠãæ»äº¡ã®æ²ç·ãæãããŠããŸããããŠã€ã«ã¹åŠè ãªã¥ãã¯ã»ã¢ã³ã¿ããš
-
/12 å ã€ã¿ãªã¢ä¿å¥å€§è£ãã¯ã¯ãã³æ¥çš®ã®éå§åœåããã¯ã¯æ»ãç¥ãããæ¥çš®ãã£ã³ããŒã³ã®ããåœæ°ãããããé ãããæç€ºããŠããããšã§ã殺人容çã®ææ»ãåããŠããã
-
/12 FDAã¯ã16æ³ä»¥äžã察象ãšãããã¡ã€ã¶ãŒç€Ÿã®æ°ã³ãã¯ã¯ã®èªå¯ã«ãããŠäŸæ ããææžã®æçµããããæ¿èªã®800æ¥ä»¥äžåŸã«å ¬è¡šã
ãã®ææžã¯ãFDAãå¿èç ã®ãªã¹ã¯ãè©äŸ¡ããã«ã¯å®å šæ§ç£èŠã·ã¹ãã ããäžååãã§ããããšãèªèããŠããããšã瀺ããŠããã -
/14 ãã¡ã€ã¶ãŒæ ªã2023å¹Žã®æå®å€ãæŽæ°ãå¹Žåæ¥48ïŒ æžã
-
/14 æ¥æ¬ã«ããããã¡ã€ã¶ãŒã¯ã¯ãã³ã«ããæ»äº¡ã®70ïŒ ã¯æ¥çš®ãã10æ¥ä»¥å ã«å ±åãããã
-
/15 ã€ã¢ã³ã»ãŽã¡ã³ããšã«ãšããã¯ã¯ãã³æŽ»åå®¶ã®ã«ãã人ãžã£ãŒããªã¹ãã33æ³ã§æ¥æ»
-
/15 å®åçãªå»ççãæ¬åœã«ã¢ã¡ãªã«ã®ä¿¡é Œãåãæ»ãããšãèãããªããå¿èçªç¶æ»ãã¿ãŒããããç ç©¶ããå¿ èŠãããã
-
/15 倧éªå»ç§å€§åŠãšäº¬éœå€§åŠã®ç°äžæŠææãšå®®æŸ€å乿æãã³ããã®äºçš®ã¯ãã¹ãŠäººçºçãªãã®ã§ãããšããçŽãããªã蚌æ ãçºèŠ
-
/18 æ¥æ¬çžæ²åäŒã¯18æ¥ãå é¢èã»å¯ºå°Ÿã®é£å±±èŠªæ¹ïŒ60ïŒã17æ¥ååŸ8æ27åã«ããã£è¡æ§å¿äžå šã®ããæ±äº¬éœå ã®ç é¢ã§æ»å»ãããšçºè¡šã
-
/18 ãã€ãã®ã¡ãŒã«ãŒBioNTechãã¯ã¯ãã³ãžã®ã¢ã¯ã»ã¹ãé«ããããšãç®çãšããŠã¢ããªã«åã®ã¯ã¯ãã³çç£ãããèšç«ããéèŠãªã¹ããããå®äºãšçºè¡šã
-
/19 ãã¡ã€ã¶ãŒç€Ÿãšãã€ãªããã¯ç€Ÿããã³ãããã³ãããã¯æã«æ³šæããã¯ã¯ãã³ã®ä»£éãæ¯æã£ãŠããªããšããŠãããŒã©ã³ãæ¿åºãšãã³ã¬ãªãŒæ¿åºãæèšŽã
-
/18 ã³ããé¢é£ã®ç³è«åçä»¶æ°çޝèšã¯9613ä»¶ïŒæ»äº¡äŸã¯1040ä»¶ïŒãå¶åºŠé©çšãèªããããã®ã¯5499ä»¶ãåŠèª881ä»¶ãä¿ç77ä»¶ã§ã3å²åŒ·ã®3156ä»¶ã¯å¯©æ»ã«å ¥ããŠããªãã
-
/22 ææ¡ææ°èãæµ·å µé岩åœèªç©ºåºå° - æ¥æ¬ã§ã®åŸè»äžã«COVID-19ã¯ã¯ãã³ãæåŠããåž°åœåœä»€ãç¡èŠããæµ·å µéé圹è»äººã仿ãå ã®å€åå°ã§é®æãããã
-
/23 ããŒã©ã³ããšãã³ã¬ãªãŒã¯ãã以äžã®æ°åã¯ã¯ãã³ã®åãå ¥ããæåŠããŠããããã¡ã€ã¶ãŒã¯çŸåšãæ°çŸäžååã®æäžæéãæ¯æã£ãŠããªããšããŠåœŒãã蚎ããŠããã
-
/23 å®éãEUã¯2å1,500äžäººåã®æéåãã¯ã¯ãã³ã廿£ããŠãããEUã¯ã2027幎ãŸã§ãã¡ã€ã¶ãŒããããã«æ³šå°å€ãè²·ãç¶ããããšã矩åã¥ããå¥çŽãçµãã§ããã
-
/30 åèåžã®æå Žã§ã¯å¬ã®ææã®ãç«è¬åŸ ã¡ããæ·±å»åããŠããããšãããæå ŽãäŒæ¥ã®ãååŒãã®æ¥ã«ãç«è¬ãè¡ã察å¿ã仿ããå§ããŠããã15幎åã®1.6åã
-
/1 çŸã»å ç±³è»äºº231äººãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³åŒ·å¶æ¥çš®ãå·¡ãè»æå°è ãã«è»æ³äŒè°ããããããèŠæ±ãè»äººã¯ãããã®è¡çºã§é倧ãªè¢«å®³ãåããã
- 2024/1/1 ãã®è»äºç説æè²¬ä»»å®£èšã®çœ²åè ããç±³åœæ°ãžã®å ¬éæžç°¡ãããæ²æ³ã¯é埳çã§å®æçãªåœæ°ã®ããã ãã«äœãããããã以å€ã®äººã³ãšã®æ¿æ²»ã«ã¯ããŸã£ããäžé©åœã§ããã
- COVID-19ã¯ã¯ãã³ã®åŒ·å¶æ¥çš®ã宿œããŠããéãè»ã®æå°è ãã¡ã¯æ³åŸãç Žããæ²æ³äžã®æš©å©ãèžã¿ã«ãããã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ããåŠå®ããäžæ¬æãªå»åŠå®éšãèš±å¯ããã
-
/2 å é±ãã·ã³ã¬ããŒã«èªç©ºã®ãã€ããããéå»7ãæã§5人ç®ã®æ»äº¡ããªããã©ã€ããŒãã»ãžã§ããææã®ãšãªãŒããã¡ã¯ã¯ã¯ãã³æ¥çš®ãåããŠããªããã€ãããããéããªãã®ã ããïŒ
-
/3 ãããã ã®å ä¿å¥å€§è£ã37äººãæ°Žææ¥ãé«é¡ãªæ°åã³ãããŠã€ã«ã¹ææçæ€æ»ãããã®è£œé ãšé åžã«é¢äžããçãã§ããã€ã§è£å€ã«ãããããã
-
/3 ãããªãå·å ¬è¡è¡çç·å±ã®ãžã§ã»ãã»ã©ããå士ãmRNAåæ°åã³ãããŠã€ã«ã¹ææçã¯ã¯ãã³ã®å®å šäžæ¢ãæ±ãã声æã®äžã§ããããã®ã¯ã¯ãã³ã¯äººéãžã®äœ¿çšã«ã¯é©ããŠããªããã
-
/6 ææ¡ææ°èã第18å»çã°ã«ãŒãã«ãããšãä»é±æ²çžã®åæçŽåºå°ã§å°å æ£è 4人ã«èª€ã£ãã¯ã¯ãã³ãæ¥çš®ãããã
ã¯ãªããã¯ã¯FBïŒå ¬åŒïŒã§ãééããçºèŠããããšããã«ãã¯ãªããã¯ã®ã¹ã¿ããã¯åäŸã®å¥åº·ãšå¹žçŠã確ä¿ããçåãæžå¿µã«å¯ŸåŠããããã«ä¿è·è ã«é£çµ¡ããããšçºè¡šã -
/10 ãŠã¬ã³ãã¯ã¯ã¯ãã³ã®éèŠäœè¿·ãåããŠã740äžãã«çžåœã®æéåãã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã廿£ããäºå®ãæ¥å¹ŽãŸã§ã«ããã«å€ãã®åšåº«ã倱å¹ããäºå®ãšçºè¡šã
-
/10 NYPããã¡ãŠãæ°ãæ°åã³ãããŠã€ã«ã¹ã®ã6ãã£ãŒãã瀟äŒçè·é¢ã¯ãã€ãæè¿çŸãããããªãã®ãããããç§åŠçæ ¹æ ã«æ¬ ããŠãããšïŒè°äŒã§ïŒèªããã
-
/12 ãããã ã®å ä¿å¥å€§è£ã«æ²åœ¹18幎ã®å€æ±ºãèšãæž¡ãããä»ã®ä¿å¥åœå±è ã宿¥å®¶ãæ°å人ããé«é¡ãªæ°åã³ãããŠã€ã«ã¹ææçæ€æ»ãããã®è²©å£²ã«é¢ãã£ããšããŠæ²åœ¹å
-
/12 ã¬ãã¬ã€ç«åŠåŸ®çç©ç ç©¶ã»ã³ã¿ãŒäž»ä»»ç ç©¶å¡ããã·ã¢ã®æ°åã³ãããŠã€ã«ã¹ã»ã¯ã¯ãã³ãã¹ããŒããã¯Vãã®äž»ä»»éçºè ã®äžäººãããªã¹ã»ãããã£ãããŒæ°ã82æ³ã§æ»å»ãããšçºè¡šã
-
/12 ã¬ãªã»ããŒãã³æ°ãWSJãå»åž«ãã¡ã¯è¥è ã®çã®æ¥æ¿ãªå¢å ã«å°æããŠãããšãããããããã³ã¯ã¯ãããïŒä»ã«ããå¿ççãè³åäžãè¡æ ã
-
/15 ã©ã³ãã»ããŒã«äžé¢è°å¡ããã¡ãŠãåå£«ã¯æ°ã³ãææçã®ãã³ãããã¯ãžã®å¯Ÿå¿ã誀ããæ©èœç²åŸç ç©¶ã«è³éãæäŸããæ±ºæãäžãããšããŠãååæã«è¡ãã¹ãã ããšçºèš
-
/16 RFKãå»åž«ãã¯è¥è ã®éã§ã¬ã³ãå¢å ããŠããããšã«ãå°æãããŠããããããããããçãã¯åœŒããèŠãããšããªãå Žæã«ãããããããŸããã
-
/19 Bloombergããã¡ã€ã¶ãŒã®å åŸæ¥å¡ããåç€Ÿã®æ°åã³ãããŠã€ã«ã¹ææçæ²»çã«é¢ããæ©å¯æ å ±ãå©çšããŠéæ³ãªãªãã·ã§ã³ååŒãè¡ã£ããšããŠæçœªå€æ±ºã
-
/22 ç±³åœäŒè°å¡ã¯å¹³åããŠè£œè¬æ¥çãã 35,000 ãã«ä»¥äžãç±³åœäžé¢è°å¡98åã1人åœããå¹³å76,000ãã«ä»¥äžã®å¯ä»ãåãåã£ããããã¯çµããããªããã°ãªããŸããã
-
/22 2021幎以éãç¹ã«è¥è ã®ããçäŸãå€§å¹ ã«å¢å ãçŸåšãã¡ã€ã¶ãŒã¯æããå€ã®æš©å©ãå¯ä»ããåŸã430åãã«ã®ã·ãŒãžã§ã³ç€Ÿãšã®ååŒã«OKãåŸãŠããã
-
/23 ãããã»ãã€ãªãŒã¯ãã¯ã¯ãã³å·¥å Žã建èšããããã®ãã«ã»ã²ã€ãã®æ°ååãã«ã®å¯ä»ã«æè¬ããïŒ2020/7ïŒã
-
/26 ç±³åœé£åå»è¬åå±ïŒFDAïŒã¯ãã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ããåŸãããšãªãç¹å®ã®èšåºè©Šéšã宿œããããšãèªããèŠåãæçµæ±ºå®ã
-
/31 ãã¡ã€ã¶ãŒã30æ¥çºè¡šãã2023幎10-12æææ±ºç®ã¯ãæçµæçã33å6900äžãã«ïŒçŽ5000ååïŒã®èµ€åãå幎åæã¯49å9500äžãã«ã®é»åãã³ãã補å売äžé«äœè¿·ã§ã
-
/31 èµ€ååãåœé瀟äŒã¯ããã³ãããã¯æã«é£æãå»çãæ å ±ãæè²ãæäŸãã人ã ã«åªå çã«äºé²æ¥çš®ãè¡ãã¹ãã§ãããã
- /15 ç±³æ¿åºãCOVID-19ã¯ã¯ãã³ã®é·æå¹æã«ã€ããŠç©æ¥µçãªãµãŒãã€ã©ã³ã¹ãè¡ã£ãŠããªãããšãèªãããæå®³äºè±¡ãç£èŠã§CDCãšFDAã®æ åœè ã«è³ªåã
- /16 ã³ãã¯ã¯ã®ã·ã§ãã£ã³ã°ã¯ãçŸå®ããFDAãšãã¡ã€ã¶ãŒã®ææžã蚌æ ãèšåºå»ãFDAã«ãããšãã¹ãŠã®éºäŒåæ²»ç補åã«ãªã¹ã¯ð€ã
- /19 ãšã³ããŒããŒãéºäœãã"å¥åŠãªçœãç¹ç¶ç¶ã®å¡"ãåãé€ãè¡æçãªåç»ãå ¬é - ã2021幎åé ãŸã§ãããèŠãããšã¯ãªãã£ãã
- /20 ããžã¿ã«åºãã¹ããŒããã©ã³çšã®ãæ°åã³ããã¯ã¯ãã³æ¥çš®èšŒææžã¢ããªããµãŒãã¹ã3ææ«ã§çµäºãããšçºè¡šããããŽãã ã£ãïŒç¬ïŒ
- /20 NZã®GVDNã®å°éå®¶ãå€§èŠæš¡ãªæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ç ç©¶ã§ãå¿èãè³ãè¡æ¶²çŸæ£ã®ããããªå¢å ãšã®é¢é£ãæããã«ã
- /21 è¡æçãª40人ã®åäŸãæ»äº¡ããèšåºè©ŠéšãæŽé²ãããšãã«æ ç¹ã眮ããã¡ã€ã¶ãŒã®åŸæ¥å¡ãã¢ã³ãã»ãµããã®TikTokã¢ã«ãŠã³ãããã
- /21 ã¢ã¡ãªã«èµ€åå瀟ã¯çŸåšãç®è¡è ã«ã³ãã¯ã¯ãæ¥çš®ããããšããããå°ããŠããŸãïŒèªå·±è€è£œã¯ã¯ãã³ã®ç¢ºèªãããïŒïŒã
- /21 èµ€ååã®è·å¡ã«ãããšãã¯ã¯ãã³æ¥çš®ãåããŠããªããè¡æ¶²ãå ¥æããå¯äžã®æ¹æ³ã¯ãã¯ã¯ãã³æ¥çš®ãåããŠããªãèªåèªèº«ãå®¶æã«ããç®è¡ã
- /22 倫ãåç€Ÿã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«å¯ŸããããŸããªåå¿ãã§äº¡ããªã£ããšããŠã女æ§ãã¢ã¹ãã©ãŒãã«ã蚎ããŠãããšBBCãå ±ããã
- /27 ãªãŒã¹ãã©ãªã¢ã®ã¯ã€ãŒã³ãºã©ã³ãå·ã®ææ¥ãµãŒãã¹ã«æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®æ¥çš®ã矩åä»ããã®ã¯éæ³ã§ãããšå€äºã倿
- /27 Bloombergããã³ãããã¯ãã4幎ãäžç©ãªãã¿ãŒã³ã®èŽæ»çãªå¿èç ãè³åäžã®æ³¢ãåŒãèµ·ãããç§åŠè ãã¡ã¯ãã®çç±ãè§£æããããšããŠããã
-
/2 ç¥å¥å·çå¹³å¡åžãæ²³é倪éäºåæåã§ãã¯ã¯ãã³ãã¢ã(æè°éäŒ)ãè¡ããããæåŸã¯å€§ä¹±é寞åïŒç¬ïŒ
-
/4 ãã¡ãŠãæ°ã¯çŸåšãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãå®éã«ç¹ã«è¥ãç·æ§ã«å¿ççãåŒãèµ·ããããšãèªããŠããã
-
/4 çç©åŠè ã®ãã¬ããã»ã¯ã€ã³ã¹ã¿ã€ã³å士ã¯ãã¯ã¯ãã³ãéå«ççã«ç§ãã¡ã«æŒãä»ããããŠããããšã«æ°ã¥ãããšãã®ããšãèªãã
-
/7 京éœå€§åŠåèªææã®çŠå³¶é å žæ°ãæ°åã³ããã¯ã¯ãã³åŸéºçã®èª¿æ»çµæã«ã€ããŠã®è«èããæåãæèæ¥ç§ã4æå·ã§çºè¡šã
-
/8 ç±³åœã®å»åž«ãã¯1,000人以äžã®æ£è ã蚺å¯ããçµæãææåŸã§ã¯ãªããã¯ã¯ãã³æ¥çš®åŸã«çäŸã®70ïŒ ã§ããã³ã°ã³ãããŠã€ã«ã¹ããçºçããããšãçºèŠã
-
/8 CDCã¯COVID-19ã¯ã¯ãã³æ¥çš®åŸã®å¿ççã«é¢ãã148ããŒãžã®ç ç©¶ãçºè¡šãããããã¹ãŠã®ããŒãžãå®å šã«ç·šéïŒå šæ å ±ããã¹ã¯ïŒãããŠãããããã¯æ°èšé²ã«éããªãã
-
/12 ã³ãã¯ã¯ã«å¯Ÿããä¿¡é Œæ§ã厩ããã«ã€ããã¥ã«ã³ãã«ã¯æ¹åŒã®æ³å»·ãæ±ãã声ã匷ãŸã£ãŠãããå æ ãã人ã ãæ²é»ãå®ã£ã人ã ã¯ä»ãæ²æ²¡è¹ããéããããºãã«äŒŒãŠããã
-
/14 ã¿ãã«ãŒã»ã«ãŒã«ãœã³ãçŠæã®è³ªåã圌ã¯ããå®å šã§å¹æçããšäž»åŒµãã人ã ããããããã¹ãŠã®ã¢ã¡ãªã«äººæ®ºå®³ããæåãããšããŠåäºè²¬ä»»ãåãããªãçç±ãç¥ãããã
-
ãããžã§ã¯ãã»ããªã¿ã¹ãšãªããŒãã»ã¡ãã£ã¢ã»ã°ã«ãŒãã®å å·¥äœå¡ã§ã以åã¯ãã¡ã€ã¶ãŒã§ã¯ã¯ãã³é åã«æºãã£ãŠããç§åŠè ã§ãããžã£ã¹ãã£ã³ã»ã¬ã¹ãªãŒãæªå ¬éé²é³ãæŽé²ã
-
/12 2021幎ã®ãã¡ã€ã¶ãŒã®è£œå€ç§åŠè ãã©ãã³ã»ãã«ããªæ°
- ã圌ãã¯ç§ã次ã«é£²ãããã«ç¹å¥ã«èšèšããæåéãå¢ãããŠããã
- ãå¿èã«åœ±é¿ãåãŒããç§ã¯æ»ã¬ã§ãããããããŠã誰ãããã«ã€ããŠè©±ããªããã
-
/12 2021幎ããã¡ã€ã¶ãŒã®äž»ä»»ç§åŠè ãã«ã³ãŠã©ãŒã«ã»ã®ã«æ°
- ãã©ã®ãããªãã®ã«ãªãã®ãèŠåœãã€ããŸããã§ãããã
- ãmRNAã¯ã¯ãã³ã¯50幎åãããããŸãããå¯äœçšãç¥ãããŠãããããèšåºè©Šéšã«ã¯äœãé²ã¿ãŸããã§ãããã
- ãã¯ã¯ãã³ãã§ãããŸã§ã«ã¯10幎ããããŸããäœå¹Žãã®èгå¯ãå¿ èŠã§ã...ç§ãã¡ã¯ãã¹ãŠãåæã«è¡ã£ãŠããŸããã
- ããã¡ã€ã¶ãŒã®CEOã[BioNTechã®CEO]ã§ããçããæã£ãŠããªãã§ããã...ãããŒã²ãŒã ã«ããªãã€ã€ãããŸããã
-
-
/14 1979幎ãããã·ãŒå·ã®ããé¡ã§11人ã®ä¹³å ãSIDSã§æ»äº¡ãå šå¡ãåææãåãããã®åã¯ã¯ãã³ãæ¥çš®ãWyethïŒçŸPfizerïŒã®å¯Ÿå¿ã¯æ¬¡ã®ãšããã
調æ»åŸ ã¡ã®ã¯ã¯ãã³ããªã³ãŒã«ãã代ããã«ãé èœãããã以äžèŽåœçãªã¯ã©ã¹ã¿ãŒãçºçããŠãæ°ã¥ãããªãããã«ããããã忣ãããããåœä»€ããã -
/14 JFKã®è§£èª¬ïŒãã®äºä»¶ã¯ãWyethïŒçŸPfizerïŒã«ãã¹ã¢ãŒã«ãããã«ãŒã«ããæ¡çšãããåå ãšãªã£ããã®ã
- ããããããªãããããã¹ãŠ1ã€ã®éœåžã«éãŸããæ»äº¡è ãç¶åºããããšããªãããã«ãããããå°åããšã«åãããšããç€Ÿå æä»€ã§ããã
- CDCã¯ãŸããDTPã¯ã¯ãã³ãšSIDSã®é¢é£ãæ€åºãããªãããã«ãããããç¬èªã®æ¹éãæã¡åºããã
- CDCã¯SIDSãSUIDãSUDCãªã©ããã€ãã®æ°ãã蚺æãµãã«ããŽãªãŒã«åé¡ããSIDSçäŸã®ççºçå¢å ãäžéããé èœããã
-
/16 2024幎床ããå§ãŸãã³ãã¯ã¯å®ææ¥çš®ã«ã€ããŠååŽçã¯ã¡ãŒã«ãŒå瀟ã®èŠç©ããåççµæããã1äž5300å/åçšåºŠã®è²»çšãšãªãèŠèŸŒã¿ãå ¬è¡šã
èªå·±è² æ é¡ã¯æå€§7000åãšããåœã¯å·®é¡åã®8300åãåžçºæã«å©æãåžçºæãç¬èªã«è£å©ããå Žåãããã7000åãããããã«å°ãªããªãå¯èœæ§ãããã -
/24 éœåžäŒèª¬ç³»YouTuberãã³ã€ãããŒãïŒç»é²è æ°126äžäººïŒããæ°åã³ãããŠã€ã«ã¹ã®ã¯ã¯ãã³ãæšå¥šããâæ¡ä»¶âã«ã€ããŠæŽé²ããæ³¢çŽãåŒãã§ããŸãã
-
/30 ã€ã¿ãªã¢ãã³ãã¯ã¯æ»äº¡äºæ ïŒ2021/5/25-6/18ïŒã調æ»ãã¢ã¹ãã©ãŒãã«ã®ã³ãã¯ã¯ãè¡æ ãåŒãèµ·ããå¯èœæ§ãããããšã¯ããã®æç¹ã§ãã§ã«ããç¥ãããŠããã
-
/1 Politicoãæ¬§å·æ€å¯ããã«ã®ãŒã®ãã¡ã€ã¶ãŒã²ãŒãææ»ãåŒãç¶ãããŠã«ãºã©ã»ãã©ã³ã»ãã¢ã»ã©ã€ãšã³ãšãã¡ã€ã¶ãŒã®ç€Ÿé·ãšã®éã®ããã¹ãã¡ãã»ãŒãžã®ããåãã調æ»ã
-
/3 ç±³åœçŸç 管çäºé²ã»ã³ã¿ãŒïŒCDCïŒã¯ããããŸã§é ãããŠããæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®åŸã®é¡é¢éº»çºããã®ä»ã®æå®³äºè±¡ã«é¢ããå ±åæžãå ¬è¡šã
-
/8 COVID-19ã®æ²»çè¬ãšããŠã€ãã«ã¡ã¯ãã³ãæçšããªãããä¿ãSNSãžã®æçš¿ããå»åž«ãšã®åè§£åŸã«ç±³åœé£åå»è¬åå±ïŒFDAïŒã«ãã£ãŠåé€ãããã
-
/8 è±åœæ¿åºèŠå¶åœå±ã¯ã補è¬å€§æãã¡ã€ã¶ãŒã2020/11ã«XïŒTwitterïŒäžã§ç¡èªå¯ã¯ã¯ãã³ã宣äŒããããå®å šæ§ãå¯äœçšã«é¢ããæ å ±ãäžåæäŸããŠããªããšèªå®ã
- ãã¡ã€ã¶ãŒã¯ãå·èŠå¶åœå±ãã5床ç®ã®å±è²¬ãåããåŸ ç¡èªå¯ã®ã³ããã»ã¯ã¯ãã³ã宣äŒãããšããŠè¬çœªã
- ãã®åãã«ãããå瀟ã¯è±åœã®åŠæ¹è¬å®æœåºæºå±ïŒPMCPAïŒããåã³æ²æåŠåãåããããšã«ãªã£ãã
-
/9 CDCã¯æ°åã³ãã¯ã¯ãšè³é³Žããšã®é¢é£æ§ã®å¯èœæ§ã®çºèŠãé èœãå®å šæ§ããŒã¿ãªã³ã¯ã»ã·ã¹ãã ã®ããŒã¿åæäžã«åŸãããçºèŠã«ã€ããŠåœæ°ã«äžåç¥ãããªãã£ãã
-
/10 ãã®ç·ãã¹ã€ã¹ã®NAZIã³ããã»ãã€ãªå µåšæ³šå°ã®æ°äž»å è°å¡ãèŠããŠããã ãããïŒããªãã¯éããªãã¹ã€ã¹é å ã®ç±³è»è»äºæ³å»·ã§åœŒãåŠåãããã®ãç®æããã
-
æ¥æ¬ã§åã¯ã¯ãéç
- /15 åçåŽåçãè¡é¢æ±ºç®è¡æ¿ç£èŠå§å¡äŒã§æ°ã³ãã¯ã¯çŽ2å4åäžååãçŽ6653ååã®å»æ£ããç¡é§ãšã¯èããŠããªãããšèª¬æïŒDSã«ã«ããæž¡ããŠèšŒæ é æ» ãçµè«ãå ã«ããæ¿çïŒ
- /16 åã©ãããªãã¯ãã³æ ªãXBBã察å¿ã¯ã¯ãã³ãæ¥çš®åŸã«å¿ççã«ãªã£ããšã®å ±åã2äŸãããååŽçã¯éœéåºçãªã©ã«çç¶ãåºãå Žåã¯éããã«å»çæ©é¢ãå蚺ããããæ±ããã
- /17 æ°ã³ãã¯ã¯æ»ã®éºæãªã©13人ãåœã«å¯Ÿããå¯åå¿ãªã©ã®ãã€ãã¹æ å ±ãåºå ±ããã«è¢«å®³ãåºããããšããŠãåãããŠ9100äžåäœãã®è³ åãæ±ãã蚎ããèµ·ãããã
- /18 ã¯ã¯ãã³éå£èšŽèšå ±éã§ããçã«ããã£ãç¿æ¥ãéã³å±å€ªéãšãã®ä»²éã¯ãã瀟é·ãåçªãªè¡šæãè¡ããïŒã€ãã³ã2ã®è©²åœç¯ãåç §ïŒ
- /18 éå£èšŽèšã«ã³ã¡ã³ããããããªãã¯ã»ããŒã©ã³ïŒããã¯ã³ïŒã®éå»ïŒ2021/9/16ïŒã®çºèšãçºæããããã¯ã¯ãã³ã¯ã·ãŒããã«ãããæã€äººã¯ããŒããŒããè¥è ã¯äººãâ¯ãã
- /19 ã³ããã¯ã¯ãã³æ¥çš®åŸæ»äº¡ã§åœãéå£æèšŽã蚎ç¶ã§ã¯æ²³é倪é倧è£ã®ã2ååæã£ãŠæ»ãã§ã人ã¯1人ãããªããçºèšã«çŠç¹ã
- /22 æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãæ¥çš®ããç¿æ¥ã«æ»äº¡ããè±ååžã®å¥³æ§ã®éºæããåœãªã©ã«3100äžåäœãã®æå®³è³ åãæ±ãã蚎ããèµ·ãããã
- /23 ãåŸéºçãæ²³é倪é倧è£ãã³ããã¯ã¯ãã³ã¯å¯©è°äŒã§æ¿èªããããç§ã¯é¢ãã£ãŠãããŸããããåèªæ²»äœã®ããæ¹ã§è¯ããšèšã£ãã
- /26 ã³ãã¯ã¯æ¥çš®ãå§ãŸã£ã2021幎ãã3幎éãåçåŽåçã¯ãæ¥çš®çåäžãç®æããŠãäžè«åœ¢æããå³ããããžã§ã¯ãçŽ3å7åäžåã倧æPRäŒç€Ÿãšå®æœã
ãã®å®æœå 容ã®å ±åæžã®å ¬éãæ±ãããšãããååŽçã¯ãã®ã»ã©ãã»ãŒå šé¢çã«ïŒ2700é è¶ ãïŒäžé瀺ãšããæ±ºå®ãããã詳现ã¯é»å¡ãã§é瀺ããã
-
æµ·å€ã§ãåã¯ã¯ãéç
- /15 ã®ãªã·ã£ã§ã¯ãå¥åº·ãªè¥è ã®éã§å¿äžå šãè³åäžãè¡æ ãæ¥æ¿ãªçã®çºçãã¿ãããæ»äº¡çãæ¥äžæããŠããäžæ¹ãè¥ãç·æ§ãšå¥³æ§ã®åºççã®äœäžã«ããåºççãæ¥èœã
- /17 ç ç©¶è ããæ°åã³ãããŠã€ã«ã¹mRNAã¯ã¯ãã³ã«ã¯å ç«åå¿ãæå¶ããããã®å¢æ®ãåºæ¿ããæåãå«ãŸããŠããããã€ã³ã¿ãŒãã§ãã³ã·ã°ãã«äŒéãæãªãå¯èœæ§ã
- /24 ç±³å»çå éšåçºè ãæ°åã³ãã®ã¯ã¯ã«ãããäœæ¥ãã®éãæ£è ã¯çºäœãèµ·ãããã©ã®è¬ããããæ¢ãããããæçµçã«ã¯...é®éããããåŸãªããªããŸãããã
- /26 ãªãŒã¹ãã©ãªã¢ã¯mRNAæ°ã³ãã¯ã¯ã®æ¥çš®çãæãé«ãåœã®äžã€ãäœå人ãã®äººãè¬å®³è£åã§åããªããæ¢ã«æ°äººã«æ°çŸäžãã«ã®è£åéãæ¯æãããŠããã
- /26 ãã¬ãŒã·ã¢ã®ã¯ã¯ãã³æšé²æŽŸã®æåãªå»åž«ã·ã£ãã£ã¯ã»ãã«ãã£ã³å士ãSNSäžã§å¿ æ»ã®è¬çœªæãçºè¡šããäœå人ãã®æ£è ã«èš±ããŠã»ãããšæé¡ã
- /30 è±åœãšã¹ãŠã§ãŒãã³ã®è£œè¬äŒç€Ÿã¢ã¹ãã©ãŒãã«ãèªç€Ÿã¯ã¯ãã³ãçšã«èŽåœçãªå¯äœçšã®ãè¡æ ããåŒãèµ·ããå¯èœæ§ãèªããã
-
/2 Facebookãã³ããã®ç ç©¶ææŒæŽ©è«ãæ€é²ããããšãèªãããã¶ãã«ãŒããŒã°æ°ã¯WHããæ€é²ã®å§åãåããããšãèªãããã®åŸãå±ããããšãåŸæããŠãããšè¿°ã¹ãã
-
/6 2025幎床 NDAAïŒç±³åœåœé²æš©éæ³ïŒã¯è»ãæåªå ã«ãããâ ã³ãã¯ã¯çŸ©åä»ãã¯éæ³ã§ãããè°äŒãåœé²ç·çãå¥åº·ãšå³å¿æ§ã«æå®³ã§ããããšãèªãããŸã§è»äººãšå®¶æã第äžã«èããŠããªãã
-
/6 ç§åŠè ãã¯æªç¥ã®ãŠã€ã«ã¹ã«ãå¹ãæ°ã¯ã¯ãã³ãéçºäžãããŠã¹ã§è©ŠéšãããŠãããå ç«ç³»ãèšç·ŽããŠãCovidãSARSãMERSãªã©ã®ãŠã€ã«ã¹ã®äž»èŠæåãç¹å®ãããšã®ããšã
-
/8 ãã¥ã·ã§ã³ãåçãžã¹ãããã£ãŒã®éºäŒåæ²»çã®æ²»éšïŒç¬¬2çžèšåºè©ŠéšïŒäžã«å°å¹Žãæ»äº¡ãããšããã¡ã€ã¶ãŒç€Ÿãæ£è æ¯æŽå£äœã«äŒããã
-
/8 ãæã€ããææãã¡ãã£ãããã¡ã ããããå®¶ææã£ã倫ã¯ç¿ææ»äº¡ãïŒæŠé£ããã®æ»äº¡ãšïŒã¯ã¯ãã³ã«é¢ä¿ã¯ãããŸãããã¯ã¯ãã³ææžè«Šããªãã£ã劻
-
/8 å ¬è²»ã«ããçŽ4å3620äžåã®ã¯ã¯ãã³æ¥çš®ã¯21幎2æ-24幎3æã§çµäºãæ¥æ¬ã®ã¯ã¯ãã³è©äŸ¡å¶åºŠã®èª²é¡ã¯ã¯ã¯ãã³æ¥çš®ã®å®å šæ§ãè©äŸ¡ã99%è©äŸ¡äžèœãªã®ã«å®å šïŒ
-
/8 ããŒãã¹ã»ã¬ãŽã£å士ãã¯ã¯ãã³æ¥çš®ãåãã人ã®å°ãªããšã2.8ïŒ ã«å¿èé害ãåŒãèµ·ãããŠããããçŸåšã700äžäººã®ã¢ã¡ãªã«äººãå¿èã«ãã¡ãŒãžãåããŠããã
-
/10 ææ¥ãªã³ã©ã€ã³ãåµå·£ãããçœè¡ç ãåç«è ºããâŠãããè¶ éæ»äº¡çã¯äžæããŠããã京倧åèªææããè«æçºè¡šãã³ããã¯ã¯ãã³ãšã®é¢ä¿ã«èšåã
-
/10 ç¬å ïŒãã¡ã€ã¶ãŒã®å éšåçºè ãåŸæ¥å¡ã«COVID-19ã¯ã¯ãã³ããå¥åã«ãæäŸããäŒç€Ÿã®é»åã¡ãŒã«ããªãŒã¯ãåŸæ¥å¡ã¯ç°ãªãã¯ã¯ãã³ããã©ã»ããæäžãããŠããã
-
/13 朮ç®ãå€ãã£ãïŒãã€ãŠã¯ã¿ããŒèŠãããŠããCOVIDã¯ã¯ãã³ã«ããå·å®³ã«é¢ããç ç©¶ããäžéšã®å»åŠéèªã«æ²èŒãããããã«ãªã£ã
-
/15 ãªãŒã¹ãã©ãªã¢ã®ãã³ãããã¯ã®ããã¯ããŠã³æè°è ã«å¯Ÿããå蚎ãåãäžãããããããéå°ãªæŠåè¡äœ¿ãšåäºéåã§ãã¯ããªã¢å·èŠå¯ã蚎ããéãéãããã
-
/15 ã¢ãã«ã瀟ã®ã¯ã¯ãã³ã®ã®å®å šæ§è©Šé𿷻仿æžã¯æå³çã«ç©ºçœã«ãªã£ãŠããŸããã©ãããã°ã€ã³ãã©ãŒã ãã³ã³ã»ã³ããäžããããšãã§ããã®ã§ããããïŒ
-
/16 ãè¡æ ãã§ãããã§ããWW3ãæ¡å€§ããªãéããããé ããªãå°æ¥ã«ãã¯ã¯ãã³æ¥çš®ãåããäœçŸäžäººãã®æã£ã人ã ãçŸããããšã«ãªãã§ãããã
-
/17 å CDCé·å®ã®ãããŒãã»ã¬ãããã£ãŒã«ãå士ãå€ãã®è¥ããŠå¥åº·ãªäººã ãCOVID mRNA泚å°ã«ãã£ãŠ"é倧ãªå¯äœçš"ã«èŠããã§ãããã
-
/17 æ°ããªé»åã¡ãŒã«ã«ãããç±³åœæ¿åºã¯2021/5ã«ããã¡ã€ã¶ãŒã®å°å èšåºè©Šéšã§ãéåºŠã®æ°åã³ããã¯ã¯ãã³åå¿ããèªèããŠããããšãæããã«ãªã£ãã
-
/17 çŠå³¶é å ž 京éœå€§åŠåèªææã¯mRNAã·ã§ããããæªã®ä»æ¥ããšè¿°ã¹ãWHOãWEFãªã©ã®ã°ããŒããªã¹ãçµç¹ããç§åŠã®ä¹±çšãã«å¯Ÿããåäºè²¬ä»»ãåãããããèŠæ±ã
-
/17 è±åœã®æ¿æ²»å®¶ã¢ã³ããªã¥ãŒã»ããªããžã§ã³æ°ã¯è°äŒã§ãå»åž«ãå¿ççã®500%å¢å ãç®ã®åœããã«ããmRNA泚å°ã®äžæ¢ãæ±ããçµç·¯ã«ã€ããŠèªã£ãã
-
/18 æè¿ã®ãã¬ãå ±éã§ãã¢ã¹ãã©ãŒãã«ã®ã¯ã¯ãã³ã«é¢é£ããè¡æ ã®æœåšçãªãªã¹ã¯ã確èªãããŠããããããã¡ã€ã¶ãŒãªã©ã®ä»£æ¿åãæ€èšããŠã¯ãããïŒã
- ãã¡ã€ã¶ãŒç€Ÿã¯ããããŸã§å ¬è¡šãããŠããªãã£ãçèªçºå€ã§1äžä»¶ä»¥äžã®èšŽèšã«å·»ã蟌ãŸããäŒç€Ÿã§ãçŸåšã¯å®éšçãªmRNAã¯ã¯ãã³ãæäŸããŠããŸãã
- é©ãã¹ãããšã«ããã¡ã€ã¶ãŒç€Ÿèªèº«ããã®ã¯ã¯ãã³ã«ã€ããŠ29ããŒãžã«ãããæ¢ç¥ã®å¯äœçšã75幎éãé ãç¶ããããšãããèªåã§èª¿æ»ãããã
-
/19 ãã¡ãŠãå士ãšããŒã¯ã¹å士ã¯ãäºã€ã®äžç倧æŠãåããããããå€ãã®äººã ãæ®ºå®³ããã
-
/19 å®å šãªäºé²æ¥çš®ãåããŠããCNNã®ã¢ãªã¹ã»ã¹ãã¥ã¯ãŒããçªç¶æ»å»ã圌女ã¯ä»ææ©ãå±å€ã§çºèŠãããŸããã
-
/19 ã³ãã©ã倧åŠã®æ°åã³ããã»ã¯ã¯ãã³ã®æ¥çš®çŸ©åã¯åè¡åœæ²æ³ã«éåãããšé£éŠè£å€æã倿±ºãå€§èŠæš¡èšŽèšã®æéãã
-
/19 å»çæ åœå®ããçŸåœ¹æµ·è»å°æ ¡ã®éã§ã³ããã¯ã¯ãã³é¢é£ã®å¿èçŸæ£ãæ¥å¢ããŠããããšãæããã«ã
å¿ççã151%å¢å ãèºæ§å¿çŸæ£ã62%å¢å ãèè¡æ§å¿çŸæ£ã69%å¢å ãå¿äžå šã¯ãªããš973%å¢å ã -
/19 è±åœåœäŒè°å¡ã¢ã³ããªã¥ãŒã»ããªããžã§ã³ãããã³ãŒã¹ãããã倧ããªãã®ã«ãªãã®ã§ã¯ãªãããšå¿é ããŠããŸããã
ãäžçäžã§å®éšçãªã¯ã¯ãã³ã«ãã£ãŠ1000äžãã2000äžäººãæ»äº¡ããŠããããã®æ°ã¯ä»ãå¢ãç¶ããŠããã -
/20 倧éªåžç«å€§åŠå»åŠéšåèªææã®äºäžæ£åº·ææããã®è¡æçãªã¡ãã»ãŒãž
ããã³ãããã¯ã¯ãWHOãäžçäžã®ãã¹ãŠã®äººã ã«ã¯ã¯ãã³æ¥çš®ãæšé²ããããã®åœã®å£å®ãšããŠå©çšãããŸãã...ãã -
/20 å ±åæžã«ãããšãææè¡æ¶²ã«ããæ²»çãåããŠæ°åäººãæ»äº¡ããæ°å幎ã«ãããè±åœã®ã¹ãã£ã³ãã«ã¯é èœããã倧éšåã¯åé¿ã§ããã¯ãã ãšããã
è±åœã§ã¯1970幎代-1990幎代åé ã«ãããŠã3äžäººä»¥äžãæ±æãããè¡æ¶²ãæäžãããHIVãèçãªã©ã®ãŠã€ã«ã¹ã«ææãããšææè¡æ¶²èª¿æ»ã¯çµè«ã¥ããã -
/20 è±åœã§æ°10å¹Žã«æž¡ãHIVãèçãªã©ã®ãŠã€ã«ã¹ã«ææããè¡æ¶²ãæäžãã3äžäººä»¥äžãææãæ°åäººãæ»äº¡ãããšå ±åæžã§æããã«ãªã£ãã
-
/22 ã¢ã³ããªãªãŒã«åžé·ãèšè äŒèŠäžã«ã©ã€ãã§åããããã¬ãã§äººãåããæ§åãçã§èŠãããšãã§ããªãã£ãæä»£ãèŠããŠãã人ã¯ããã ãããïŒ
-
/25 æ¥æ¬ã§ã¯ä»ããã¬ãã§ã³ããã¯ã¯ãã³ã®æ³šå°ã®å®³ã«ã€ããŠå ¬ç¶ãšèªã£ãŠãããçå®ãæããã«ãªãïŒ5/19ã®ããããŸã§èšã£ãŠå§å¡äŒNPããããïŒã
-
/27 ããŸããŸãªåªäœã§æ¥çš®ãæšå¥šãããã³ãã¯ã¯ãæ¥çš®åŸã«äœå¹ŽãèŠããã§ããå°å¥³ãã¡ããããå¯åå¿ã®çãã®ãã宿 ã«ã€ããŠç޹ä»ïŒå è€æéåïŒ
-
ã¢ã¹ãã©ãŒãã«ã®æ°åã³ããã¯ã¯ãã³
- /3 æ°å¹Žåããé°è¬è«è ããã¡ããã³ããã¯ã¯ãã³ã¯è¡æ¶²ååºãåŒãèµ·ãããšèŠåããŠããã®ãèŠããŠããŸããïŒã¢ã¹ãã©ãŒãã«ã¯æ³å»·ã§ãããèªããã°ããã§ãã
- /5 è¡æ çãåŒãèµ·ããå¯èœæ§ãããããšãåããŠèªããã2021/1/29ã«æ¬§å·å§å¡äŒã«ãã£ãŠèªå¯ããã2021/2/6ã«ã¹ãã€ã³ã«å°çãã3çªç®ã®ã¯ã¯ãã³ã
- /7 ã³ããæ³šå°è¬ã®çç£ãäžæ¢ããåžå Žããæ€éããããšã«ãªã£ããããã¯å€§å€ãªããšã ããã®ä»¶ã«é¢ãããã¥ãŒã¹ã¯ãŸã ã»ãšãã©ãªãã
- /8 Telegraphãçšã§å±éºãªå¯äœçšãåŒãèµ·ããå¯èœæ§ãããããšãèªããŠããæ°ã¶æåŸãäžçäžã§ã³ããã¯ã¯ãã³ãæ€å
- /9 è±äžé¢è°å¡ã¢ã³ããªã¥ãŒã»ããªããžã§ã³æ°ãè°äŒã§æŒèª¬ãç§ã¯æ¿åºã®ä¿èšŒã«åºã¥ããŠæ¥çš®ãå¯äœçšã«èŠãã¿ãŸãããã
- /13 ãããèŠããŠãããïŒ æ±ºããŠå¿ãããª
- ãäžçä¿å¥æ©é¢ã¯ãã¢ã¹ãã©ãŒãã«ã®ã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®äœ¿çšãäžæ¢ããçç±ã¯ãªããšè¿°ã¹ãŠããã
- ãã¯ããã¯ã¯ãã³æ¥çš®åŸã«è¡æ ã¯çºçããŸãããã¯ã¯ãã³æ¥çš®ãåå ã§ããå¯èœæ§ã¯ã»ãšãã©ãããŸããã
- /14 ç±³åœã§ã®èšåºè©Šéšã«åå ããã¢ã¡ãªã«äººããã¯ã¯ãã³æ¥çš®ã«ãããæ°žä¹ çãªé害ããæ®ã£ããšããŠå瀟ã蚎ããŠããã
-
/1 å·æé«è£å€æãCOVID-19ã¯ã¯ãã³èšŽèšã審è°ãããäºäŸã§ã¯ã芪ãåäŸã«ã¯ã¯ãã³æ¥çš®ãæãŸãªãã£ãã«ãããããããæªæå¹Žè ãã¯ã¯ãã³æ¥çš®ãåãããšããã
-
/3 èåãªç§åŠè ã«ããæ°ããªå€§èŠæš¡ç ç©¶ã«ãããæ°ããªå€§èŠæš¡ãªç ç©¶ã«ãããæ°åã³ãããŠã€ã«ã¹ã®mRNAã¯ã¯ãã³ãå°å ã®å¿äžå šçäŸæ¥å¢ã®å¯äžã®åå ã§ããããšã確èªãããã
-
/4 NATIONAL FILEãç¬å å ¥æããè¡æçãªé£éŠæ¿åºã®èšé²ãšãããªã«ãããšãç±³åœé£éŠæ¿åºã¯COVID-19ã¯ã¯ãã³æ¥çš®ãåããªãããšã«ãã人ã ã远跡ããŠããã
-
/4 æ¥æ¬äŒçµ±éŒçžåŠäŒé¡§åã®æŸç°åå ¬ãããæãæããã¹ãã¯ããŠã€ã«ã¹ã§ã¯ãªããå ç«åïŒèªç¶æ²»çåïŒã®äœäžãåç±³åšäœè åãã®ãªã³ã©ã€ã³è¬æŒã§ã
-
/5 Facebook ã¯å€§ããªåé¡ã«çŽé¢ãFacebookã®ã³ããã¯ã¯ãã³ãFact-Checkersããã¯ã¯ãã³äŒç€Ÿããè³éæäŸãåããŠããããšãçºèŠããã
-
/5 ã¢ãŒããã·ã¥ã®äººã ã¯ãã¯ã¯ãã³æ¥çš®ãåããŠããªã人ã ã®å€§èŠæš¡ãªéå£ã®å®ç§ãªäŸã§ããèªéç / èªå·±å ç«çŸæ£ / æ ¢æ§çŸæ£ã¯ãããŸããã
ç±³åœæ¿åºã¯åœŒããå¯Ÿç §çŸ€ã®ããã«ç ç©¶ããŠããããããŒã¿ã¯å ±æããŠããªãã圌ãã¯ããªãã«ãããã€ã³ããè¬ã§ããããšãç¥ãããããªãã®ã§ãã -
欧米ã§ã¯3幎é£ç¶ã§éå°æ»äº¡çã髿¢ãŸã
- /4 COVID-19ã®ãã³ãããã¯éå§ä»¥æ¥ã欧米ã§ã¯3幎é£ç¶ã§éå°æ»äº¡çã髿¢ãŸãããŠããããšããBMJ Public Healthèªã«æ²èŒããã47ã«åœã®ããŒã¿åæã§æããã«ãªã£ãã
- /5 Telegraphããµã©ã»ãããã³ç§åŠç·šéè ãè¶ éæ»äº¡å¢å ã®åå ã¯æ°åã³ãããŠã€ã«ã¹ææçã®åœ±é¿ãããããªãããå¯äœçšãæ»äº¡çãšã®é¢é£æ§ã«ã€ããŠãããªãç ç©¶ãåŒã³ããã
- /5 æ°ããªç ç©¶ã«ãããšããã³ãããã¯ã®æåã®3幎éã§ã西åŽè«žåœã§ã¯300äžäººä»¥äžã®è¶
éæ»äº¡ãèšé²ãããŠããããã®äžå ã«ã¯ã³ããã¯ã¯ãã³ãé¢ä¿ããŠããå¯èœæ§ã瀺åãããŠããã
ä»é±åãã«BMJ Public Healthèªã«çºè¡šãããã¢ã ã¹ãã«ãã èªç±å€§åŠã®ç ç©¶ã«ãããšã2020/1/1-2022/12/31ã®éã«47ãåœã§åèš3,098,456人ïŒ300äžäººïŒã®è¶ éæ»äº¡ãå ±åãããã
-
/7 æžå¿µãæ±ãç±³åœã®å»åž«ãšç§åŠè ã®ã°ã«ãŒãã¯ããã³ãããã¯ä»¥éã«çºçããçšã§èŽåœçãªççäŸã®æ¥å¢ãCOVID-19ã«ãã£ãŠåŒãèµ·ããããŠãããã©ããã調æ»ããŠããã
-
/5 ã¯ã¯ãã³æªæ¥çš®è ã¯ããããå°ããããŸãã ãCOVIDã¯ã¯ãã³ãæåã«ç»å Žãããšãããããå±éºã ãšã©ããã£ãŠããã£ãã®ã§ããïŒããçãã¯ç°¡åã§ããè§£ããŸããã§ãããã
ãããããç§ãã¡ã¯çŽãã«ããã®æ³šå°ãæšé²ããŠãã人ãã¡ãåã€ãã ãšæ°ã¥ããŸããããããããèŠäºã«èª¬æããŠããã®ãã芧ãã ãããã-
ã¿ãã«ãŒã»ã«ãŒã«ãœã³
- ç§ã«ãã®ã¯ã¯ãã³ã売ã£ã人ãã¡ã®æ 床ã¯ããšãŠãäžèª å®ã§ããšãŠãé²éªšã§ãããã¯ã¯ãã³ãå¹ããªããšã¯ç¥ããŸããã§ããã
- ãã¡ãããå¹ããŸããã§ããã害ãåãŒããšãç¥ããŸããã§ãããã§ãã売ã£ã人ãã¡ãåã€ãã ãšããããšã¯ç¥ã£ãŠããŸããã
- ããã«åãããŸãããäœäººãã¯ç¥ã£ãŠããŸããã圌ãã®æ 床ããã圌ããåãã€ããŠããããšã¯ããã«åãããŸãããã
-
ããã§ç§ã¯ããæããŸããã
- ããã¯äœãªã®ãåãããªããç§ã®å®¶æã¯èª°ããããæ£ã£ãŠããªãâŠ
- æåã®æ¥ã«ãããçè§£ãããããªæãã§ããâŠç§ã¯ãäœããããããããšåŒ·ãæãã
- ãã ãèªåã®çŽæãã«åŸããŸããããããŠãããããŸããã£ããšæããŸãã
-
-
ãããŒãã»ã¬ãããã£ãŒã«ãå CDCæé·
-
/6 ãã€ãŠãèª€å ±ããšãããé©ãã¹ãäºå®ã次ã ãšèªãã
- ã¯ã¯ãã³ãå¹ããªãããã«èããããããªããšã¯ããªããšããæ±ºå®ããã£ãã
- ã¡ãªãŒã©ã³ãå·ã§ç§ã蚺å¯ããŠããææè ã®3åã®2ã¯ã¯ã¯ãã³ãæ¥çš®ããŠããã
- COVIDã«ææããŠããªãããéç¯€ãªæ£è ãæ¬¡ããæ¬¡ãžãšèšºå¯ããŠããã
- COVIDã«çœ¹æ£ããŠããªãã«ãããããããéç¯€ãªæ£è ãæ¬¡ããæ¬¡ãžãšèšºãããšã«ãªãã
- ããã¯ãã¹ãŠã¯ã¯ãã³ã®ããã§ããã¹ãã€ã¯èçœè³ªã¯å ç«æ¯æ§ãæã£ãŠããŸããææããã°å ç«æ¯æ§ã«ãªããŸãã
- ã¯ã¯ãã³ãæãŠã°ãã¹ãã€ã¯èçœè³ªãäœãããšãã§ãããã©ããããã¹ãã€ã¯èçœè³ªãã§ãããã¯ããããªãã
- ç§ã¯ãããã€ã³ã»ã¯ã¯ãã³ã䜿ã£ãŠããã®ã§ãã¹ãã€ã¯èçœè³ªã®éã¯æ£ç¢ºã«ææ¡ããŠããŸããäœãã¹ãã€ã¯ã»ãããã€ã³è£œé å·¥å Žã«ãªãããšã¯ãããŸããã
-
/7 2021幎åé ã«ç ç©¶å®€ç±æ¥ã§ããå¯èœæ§ã«ã€ããŠçºèšããããšã¯ç§°è³ã«å€ããã
-
/7 ã¯ã¯ãã³æ¥çš®çŸ©ååã¯ãã²ã©ã決å®ãã§ãããç§åŠã«åºã¥ããŠããªãã£ãããšãèªããã
-
/8 å CDCé·å®ãé©ãã¹ãCOVID-19èªå®ãçºè¡šïŒ
ãã€ãŠã¯ãé°è¬è«ããšã¿ãªãããŠããããããã¹ãŠã®ããšããä»ã§ã¯å æ¿åºé¢ä¿è ã«ãã£ãŠç¢ºèªãããŠããã- æ°ã¯ãã¯ã¯ãã³æ¥çš®çŸ©ååã¯ãã²ã©ã決å®ãã§ãããç§åŠã§ã¯ãªãææ ã«åºã¥ãããã®ã ãšè¿°ã¹ãŠããã
- æ°ã¯ãå šå¡ã«ã¯ã¯ãã³æ¥çš®ã匷å¶ããã®ã¯ãè£œè¬æ¥çã«ãã倧ããªåœ±é¿åãããã£ããšèããŠããã
- ãŸããè¥è ã«ã¯ã¯ãã³æ¥çš®ã匷å¶ããæ ¹æ ã¯å šããªãã£ããšãè¿°ã¹ãŠããã
- è¹ã¯æ²æ²¡ãã€ã€ãããåå£«ã¯æé ãã«ãªãåã«è¹ããè±åºããããšããŠããã
-
-
/8 ãã©ãžã«æ¥å ±ãæ¥æ¬äŒçµ±éŒçžåŠäŒé¡§åã®æŸç°åå ¬æ°ãæ¥æ¬ã¯ã¯ã¯ãã³æ¥çš®çãäžçäžãææçãäžçæå€ãšããæ¬æ¥ãã£ãŠã¯ãªããªãäžæŽåã
-
/8 å¥åº·èªç±é²è¡åºéãšä»ã®ååãšããµã³ãŒã«ã¹çµ±äžåŠåºïŒLAUSDïŒãšã®äºãã®ãã蚎èšã§ãè£å€æã¯ãCOVID-19 mRNAã¯ã¯ãã³ã¯
ãŠã€ã«ã¹ã®æ¡æ£ãé²ãããšã¯ãªãçç¶ãç·©åããã ããªã®ã§ãã¯ã¯ãã³ã®åŸæ¥ã®å®çŸ©ãæºãããŠããªããšããååã®äž»åŒµãèªããã -
/9 ãªã圌ãã¯ç¥ã£ãŠããã®ãããããŠãªãæã ã¯ãã®ããšãèŠéããŠããã®ãïŒååæã«å ¥ãã¹ã人éãããã
- ã¢ããCEOã¯ã2019幎ã«å瀟ã10äžååã®COVID-19ã¯ã¯ãã³ã補é ããããšãåçœããã
- 圌ã¯ããè¿°ã¹ããæ¥å¹Žã¯10åååã補é ããå¿ èŠãããããã³ãããã¯ãèµ·ããã ããã
-
/9 ç°åžžãªè¡æ ã¯ç¶ããŠããŸãã2024/6ã«ã¯3ä»¶ã®çäŸãå ±åãããŠããŸãã
- ãããã®å¥åŠãªè¡æ ã¯ãã¯ã¯ãã³ã®å±éåŸã2021幎åé ã«çŸãå§ããŸããã
- é²è åŠçãå§ã㊠20 幎ã«ãªããŸããããã®ãããªããšã¯äžåºŠãèŠãããšããããŸããã§ããã
- ãªããã®ããšãã·ã§ã¢ããã®ã§ããããïŒããã¯ãçããã«ãèµ·ãã£ãŠããããšãç¥ãæš©å©ãããããã§ãã
- è¡ç®¡ã®åé¡ãå¿èã®åé¡ãè³åäžãé²è¡æ§ã®çã«èŠãã人ãããã»ã©å€ãã®ã¯ããããçç±ãããããŸããã
-
/10 ãä»ããåæ°ãåºããªããã°ãªããŸãããããã¡ã€ã¶ãŒç€Ÿã®å å¯ç€Ÿé·ããã€ã¯ã»ã€ã§ãŒãã³åå£«ã¯æ¬¡ã®ããã«èªã£ãã
- æã ã¯æŽå²äžæå€§ã®ç¯çœªã®çã£ãã äžã«ãããããã¯äžçèŠæš¡ã®ãã®ã ã
- æ¯é ã®æå³ãããããã¹ãŠã®äººã®èªç±ã奪ããããã«æ°çŸäžäººãããæ°åå人ã®åœã奪ãããšã«ãªããããã¯é·ãéèšç»ãããŠããããšã ã
- ãã®æŽæ¿ã«åŸãã°ãèªç±ã倱ããããããåœã倱ãããšã«ãªãã§ããããããªããä»ã®èª°ããäœãããªãããšãéžãã å Žåããããªãã§ãããã
-
/10 ãã¡ãŠãå士ãäœçŸäžãã«ã皌ãã ãã³ããã»ã¯ã¯ãã³ããæåŠãã人ã ã®ç掻ã
ããã«å°çã®ãã®ã«ãããããã®èª¬æãèããŠæ¬²ããããã®çµæãäžçäžã§2åäžäººä»¥äžã殺ãããã -
/11 WEFå ±åèšç«è ããžã£ãã£ã®æ¯åãWEFã¡ã³ããŒã®é®æãèŠæ±ãèªåãšæ¯èŠªããæ¯ããšåŒã°ããã¯ã¯ãã³ã§æ»ã«ã€ã€ãããšèšãã
-
/11 æµåºããé³å£°ã«ãããã¡ãŠãã¯æ°ééšéãææ®ããŠãå®éšçãªCOVIDã¯ã¯ãã³ã®æš©åšçæ¥çš®çŸ©åã宿œããŠããããšãæããã«ãªã£ãã
-
/11 ã€ã³ããã€ãã«ã¡ã¯ãã³ãããã£ãŠèª€è§£ãæãã€ã³ãäººãæ®ºå®³ãããšããŠWHO䞻任ç§åŠè ã«æ»å倿±ºã®å¯èœæ§
- ã€ã³ãåŒè·å£«äŒã¯5/25ãWHO䞻任ç§åŠè ã®ã¹ã¯ãããµã³å士ãæèšŽãã71é ç®ã«åã¶èšŽç¶ã§ãã€ãã«ã¡ã¯ãã³ã«ã€ããŠã€ã³ãåœæ°ã誀解ãããŠæ»ã«è³ãããããšéé£ã
- ããã¯å»åž«ãçè·åž«ãªã©ãæ£ããããšãããããã®èŠéãšãªãã¯ãã§ããçããã¯è²¬ä»»ãåãããã§ããããæ£çŸ©ã¯èšªããŸãã人éã«å¯Ÿãã眪ã®èšŒæ ã¯åŠå®ã§ããŸããã
-
/12 ããµã³ãŒã«ã¹åžè°äŒãéåžžäºæ 宣èšãè§£é€ããŠãã1幎以äžãçµã¡ãè·å¡ãžã®ã³ããã¯ã¯ãã³æ¥çš®çŸ©åãçµäº
-
/12 Project Veritas ã«ãããã®èª¿æ»ã«ãããšã補è¬äŒç€Ÿã¯èªç€Ÿè£œåã®æ¿èªãåŸãããã«FDAã«ééãæ¯æã£ãŠããã
-
/12 COVID-19ãã¯ã¯ãã³ãã¯çµå±ã¯ã¯ãã³ã§ã¯ãªãããšã倿ãããªã³ããã¯ãšã¢ãã«ãã¯ãã€ãŠãmRNA泚å°ãéºäŒåæ²»çãšåŒãã§ããã
-
/12 æ¿åºã¯ãããèãããããªãã補è¬äŒç€Ÿãçç©å µåšè²©å£²æ¥è ã«ãã£ãŠæ®ºå®³ãããäžçã®äººã ã®æ°ã¯ãç±³åœãåå ãããã¹ãŠã®æŠäºã®åèšãããå€ããã
-
/12 ãªãã¯ã¹ãã©ãŒã倧åŠã®ç ç©¶è ãã«ãããåã©ãã®å¥åº·ç¶æ ãæ¯èŒããæè¿ã®ãã¬ããªã³ãã§ãå¿ççãšå¿èçã¯ã¯ã¯ãã³æ¥çš®åŸã«ã®ã¿çºçããCOVID-19ææåŸã«ã¯çºçããªãã
-
/12 ã¹ãŠã§ãŒãã³ã®æ€å¯åœå±ã¯ãæ»äº¡ãã13æ³ã®å°å¹Žã«ã¢ãã«ãç€Ÿã®æ°åã³ããã¯ã¯ãã³ãæäžããå»åž«ããéå€±èŽæ»ã®çãã§ææ»ããŠããã
-
/12 å¥åŠãªç¹ç¶ç¶ã®è¡æ ã§èŠã€ãã£ãäžäœ 21 ã®ã¿ã³ãã¯è³ªã®ãªã¹ãã以äžã«ç€ºããŸããèŠã€ãã£ãã¿ã³ãã¯è³ªã¯ 500 çš®é¡ä»¥äžãããŸããã
ç§ã¯å»è ã§ãç§åŠè ã§ããªãã®ã§å®å šã«ã¯çè§£ããŠããŸãããããã®æ å ±ãè§£éã§ãã人ãããããäœããåŠã¹ãããšãé¡ã£ãŠããŸãã -
/13 ã¿ã¬ã³ããäœæã®ãå ãããã®äœè€åŒéããïŒ55ïŒãè髿¢å¡ãçºçãäžå身ãŸã²ãšæå±äºåæãéããŠçºè¡šã仿2æ¥ã«äœèª¿ã厩ããŠå ¥é¢ã掻åãäŒæ¢ãçé€ã«å°å¿µã
-
/13 ãããã¯ã¡ãã£ã¢ã«ãã£ãŠç¡èŠãããŠããé倧ãªãã¥ãŒã¹ã§ãã
- ç±³åœã®è£å€æã¯ãmRNA 泚å°ã¯åŸæ¥ã®æå³ã§ã®ã¯ã¯ãã³ã§ã¯ãªããšã®å€æ±ºãäžããŸããã
- 1989幎ã®çç©å µåšããã³ããå¯Ÿçæ³ãèµ·èãã人ç©ã¯ãCOVID-19ã®mRNA泚å°ã¯ãçç©å µåšïŒéºäŒåæ²»çïŒããšè¿°ã¹ãŠããã
- ïžã¹ãŠã§ãŒãã³ã®æ€å¯åœå±ã¯ãæ»äº¡ããå°å¹Žã«ã¢ãã«ãã®æ³šå°ãæœããå»åž«ããéå€±èŽæ»ã®çãã§ææ»ããŠããã
-
/17 ãã©ã³ã·ã¹ã»ãã€ã«å士ïŒãCOVID-19ããç²å泚å°ããŸãã¯ãmRNAããç²å泚å°ããŸãã¯ãCOVID-19泚å°ãã¯ã
ç±³åœæ³å žãçç©å µåšã«é¢ããçŠæ¢äºé ããããªãå·æ³å žã倧éç Žå£å µåšãŸãã¯åœé 倧éç Žå£å µåšã®è£œé ãã®åºæºãæºãããŠããã -
/18 ãã¡ã€ã¶ãŒã«å¯Ÿããã«ã³ã¶ã¹å·ã®æ°ããªèšŽèšã§æããã«ãªããããããªã36ã®èšŒæ
- ãã¡ã€ã¶ãŒã®åæèšåºè©ŠéšããŒã¿ã§ã¯1223äººã®æ»äº¡ãå ±åããã
- ãžã§ã€ã³ãã£ã»ã¯ãããµã³å士ã«ãããšããæ²»éšäžãä»å ¥ã«ãã£ãŠåœãæãããããšã¯äžåºŠããªãã£ãã
- åãDRã¯ããã¡ã€ã¶ãŒã®èšåºè©Šéšã®ã¯ã¯ãã³æ¥çš®çŸ€ã§å ¬è¡šãããŠããªãæ»äº¡è æ°ãæããã«ããã
- RFKã¯ããã¡ã€ã¶ãŒèªèº«ã®ããŒã¿ã«ããã°ã6ãæéã®æéã®çµããã«ã¯ã¯ãã³æ¥çš®çŸ€ã§å šæ»äº¡çã§äº¡ããªã£ãäººã®æ°ãå€ãã£ããšè¿°ã¹ãã
- ã¯ã¯ãã³æ¥çš®çŸ€ã§ã¯å¿èçºäœã5åçºçãããã©ã»ã矀ã§ã¯ãã®æéã®çµããã«1åã®ã¿çºçããŸããã500%ã®å¢å ã§ãã
- ã¬ãŒã³ãžãŒå³¶ã§ã¯ãå°å ¥ã®å¹Žã«å¿ççã500%å¢å ããããã¯ãã¡ã€ã¶ãŒã®å®éã®è©ŠéšããŒã¿ãšäžèŽããŠããã
- ãã¡ã€ã¶ãŒã¯ãè»æ€ åã«ä¹ã£ãŠããããã£ã»ãã»ã¬ã¬ã€ããããèçãã蚎ããŠãããšFDAã«å ±åããã
- ãã¡ã€ã¶ãŒã¯ãEUAæ¿èªãšè³ å責任ä¿è·ã«é¢ããäžé¢ã®èšŒèšã§å ±åãããããã£ã®æå®³äºè±¡ãšäžèŽããªãããŒã¿ãFDAæ¿èªã«äœ¿çšã
- ããã£ã®æ¯èŠªã«ãããšãFDAã¯ãããã£ãèšåºè©Šéšã§æçšããmRNAã³ãã補åã«é¢é£ããADEã§å ¥é¢ããŠãããšãã«ããã¡ã€ã¶ãŒã®mRNAã³ããã¯ã¯ãã³ãåäŸã«æ¿èªããã
- ãã¡ã€ã¶ãŒã¯ã補åã®æå¹æ§ãšããŒã±ãã£ã³ã°ã«ãããŠçµ¶å¯Ÿãªã¹ã¯ã§ã¯ãªãçžå¯Ÿãªã¹ã¯ãéèŠããã
- ãã¡ã€ã¶ãŒã«ãšã£ãŠã絶察ãªã¹ã¯ã®èгç¹ããèŠããšãmRNAã¯ã¯ãã³æ¥çš®çŸ€ã§ã¯ãCOVID-19ææäºé²ã«çµ±èšçã«ææãªå¹æã¯èŠãããªãã£ãã
- ãã¡ã€ã¶ãŒã¯ãã¯ã¯ãã³ãææãäºé²ã§ãããã©ãããã¹ãããããšã¯äžåºŠããªãããšãèªããã
- ã€ã¹ã©ãšã«ã®ç ç©¶ã§ãã¯ã¯ãã³æ¥çš®ãåããç·æ§ã®ç²Ÿåæ°ãæžå°ããããšãããã£ã
- RFKã«ãããšããã¡ã€ã¶ãŒã¯åã補åã«2ã€ã®ã©ãã«ãä»ããŠãããEUA補åã¯å ¥æå¯èœã ã£ãããåã補åã®èªå¯çã¯ãå ¥æäžå¯èœãã ã£ãã
- ãã¡ã€ã¶ãŒãšFDAã¯èšåºè©Šéšã®èšŒæ ã75幎éé ãããšãã
- DrAseemMalhotraã¯ããã¡ã€ã¶ãŒã®ããŒã¿ã®ååæã§ã¯æå®³äºè±¡çºççã1/800ã§ããããšã瀺ãããŠãããšè¿°ã¹ãã
- ãªãŒã¹ãã©ãªã¢ã®FOIã¯ãmRNAè質ããç²åãäœå šäœã«ååžããŠããããšã瀺ãTGAçäœèç©ç ç©¶ãæããã«ããã
- åæ§ã®ããŒã¿ã§ã¯ã詊éšããããŠã¹ã®çåºæå€±ã¯mRNA矀ã§2å以äžã«ãªã£ãã
- å¿ççã¯äžçååœã®æ¿åºããèªããããå¯äœçšã§ããã
- ããã€ãã®ç ç©¶ïŒã€ã¹ã©ãšã«ã§è¡ããããã®ïŒã§ã¯ãå¿ççã¯ã¯ã¯ãã³æ¥çš®ãåãã人ã«ã®ã¿çºçããããšã瀺ãããŠããã
- ã¢ã«ããŒãã»ããŒã©æ°ã¯ãmRNAã¯ãããŸã§äžåºŠã補åãåºè·ããããšããªãããã¡ã€ã¶ãŒã¯çµéšãå°ãªãããšè¿°ã¹ã
ãã¡ã€ã¶ãŒãšããªã³ããã¯ã¯2018幎ããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®mRNAã«åãçµãã§ããã - ã¢ã«ããŒãã»ããŒã©æ°ã¯ã2åã«ããã£ãŠèªèº«ã®ã¯ã¯ãã³è£œåãæ¥çš®ãããã©ããå°ãããããšãããããããšçããåã«å²ã蟌ããããšã¯æãã§ããªãã£ãã
- ã¢ã·ãŒã ã»ãã«ããã©å士ã«ãããšããã¡ã€ã¶ãŒã¯ã¯ã¯ãã³æ¥çš®çŸ©ååãæšé²ããããã«ããã³ãã°ã«ãŒãã«ééãæ¯æã£ãã
- ãªãŒã¹ãã©ãªã¢äžé¢ã§ã®èšŒèšã§ãã¡ã€ã¶ãŒã®åºå ±æ åœè ãè¿°ã¹ããšããã«ãããšããã¡ã€ã¶ãŒã¯åŸæ¥å¡åãã«ç¹å¥ãªmRNAã¯ã¯ãã³ããããçšæããŠããã
- åã¢ããªã«ã®è£å€æãææžãå ¬éããã¡ã€ã¶ãŒãæ¿åºã«å¯äœçšã«å¯Ÿããä¿éºå¶åºŠã®èšç«ãèŠè«ããããšãæããã«
- ãã¡ã€ã¶ãŒã¯åã¢ããªã«ã®è£å€æææžã§ãã¯ã¯ãã³ã®é·æçãªåœ±é¿ãšæå¹æ§ã¯çŸæç¹ã§ã¯äžæã§ããããšèªããã
- åŠåš äžã®å®å šæ§ãè©äŸ¡ããããã«äœ¿çšããã詊éšããŒã¿ã¯ãè©äŸ¡å¯Ÿè±¡ã®è£œåã補é ããäŒç€Ÿã®æ ªãææããç ç©¶è ã«ãã£ãŠåæãããã
- RFKã«ããã°ããã¡ã€ã¶ãŒã¯è²¬ä»»ä¿è·ã®ããã«åäŸãã¡ã«æšå¥šããå¿ èŠããã£ãã
- @Kevin_McKernan ãã¡ã€ã¶ãŒã§DNAæ±æãçºèŠãããã@P_J_Buckhaults DNAæ±æãçºèŠãããã
- ãªãŒã¹ãã©ãªã¢ã®ãã¡ã€ã¶ãŒãšã¢ãã«ãã®ãã€ã¢ã«ã§DNAæ±æã確èªãããããã¡ã€ã¶ãŒã®DNAæ±æã¯TGAãèšå®ããæäžéãããã®å¶éã®350å以äžã§ãã£ãã
- @DrDMartinWorld ãã¡ã€ã¶ãŒã¯ãæåºæžé¡ã®äžã§èªç€Ÿã®è£œåãå®éšçãªéºäŒåæ²»çã§ããããšãèªãããšè¿°ã¹ãã
- ãã¡ã€ã¶ãŒã¯ãªãŒã¹ãã©ãªã¢ã®éºäŒåæ²»çèŠå¶ã«ããæ¿èªãæ±ããªãã£ã (ã®ã¬ã¹ããŒ)
- @naomirwolf æ°çå ã®ãã¡ã€ã¶ãŒè£œåãžã®ãèç€çµç±ã®æé²ãã«ã€ããŠèšåããã¡ã€ã¶ãŒã®æ²»éšã§ã¯æµç£çã80%ã ã£ãã
- ãã¡ã€ã¶ãŒã®mRNAã¯ã¯ãã³ã¯ã¹ãã€ã¯ã¿ã³ãã¯è³ªãããŒã¹ã«ããŠããã匷åãªèšŒæ ãã人工ãŠã€ã«ã¹ã§ããããšã瀺åãããŠãããGOFã®ç ç©¶ã«ãã£ãŠäœãããå¯èœæ§ãããã
- ãžã§ãŒã ãºã»ãªããŒãã»ããªã¿ã¹ã®å éšåçºè ã«ãããšããã¡ã€ã¶ãŒã®åç· åœ¹ã¯ããã¡ã€ã¶ãŒããå€ç°ããã³ãããŠã€ã«ã¹ãã«ã€ããŠè©±ããŠãããšè¿°ã¹ãã
- æãå€ãã®è«æãçºè¡šããŠããå¿èå°éå»ã®äžäººã§ããããŒã¿ãŒã»ãã«ããŒå士ã¯ããã¹ãŠã®ããŒã¿ãåæãããã¡ã€ã¶ãŒã¯ã決ããŠæ¿èªãããã¹ãã§ã¯ãªãã£ãããšè¿°ã¹ãã
- ãã®èšŒæ ãªã¹ãã«ä»ã«äœãå ããå¿ èŠãããã ãããïŒãã¡ã€ã¶ãŒã«å¯Ÿããã«ã³ã¶ã¹å·ã®æ°ããªèšŽèšã®èšŒæ é瀺æç¶ãã¯ééããªã壮倧ãªãã®ã«ãªãã ããã
-
/18 é£ç ãè髿¢å¡ãã®äœè€åŒéãçŽçã§ç€ºãã埩掻ãžã®èŠæãä»ã¯å šãæ©ããŸãããïŒæåïŒæåäžå¯§ã«âŠãªãããªã§å埩ããäŸãã
è髿¢å¡ã¯ãè³ã®æä»€ãäŒéããéèŠãªéšäœã®èé«ã«ããè¡ç®¡ãè©°ãŸãããšã§èé«ã®äžéšã壿»ããç¶æ ã®ããšãããã -
/19 æ¥æ¬åœå ã§48æé以å ã«äººãæ»ã«è³ããããã人é£ããã¯ããªã¢ããšãåŒã°ããææçïŒSTSSïŒãåºãã£ãŠããã
ãåžžåšèãã®AçŸ€æº¶è¡æ§ã¬ã³ãµçèïŒæº¶é£èïŒïŒGASïŒãåå ã§ããããæ£è ã®æ·±éšçµç¹ãè¡æµã«åºãããšãçç¶ã¯æ¥éã«æªåããã -
/22 2022/2ã«æ°åã³ããã®ã¯ã¯ãã³ãæ¥çš®ããåŸã2幎以äžãå šèº«ã®åŠæ æãªã©ã«èŠããã§ãã女æ§ããåœã補è¬äŒç€Ÿãçžæåããæå®³è³ åãæ±ããŠæèšŽã
-
/23 äžè¬ç€Ÿå£æ³äººæ± ç°åµäŸ¡åŠäŒãå ¬åŒçºè¡šãæ¬ä»¶ã¯å ¬çéå ±ã«ããäºå®ãšç¢ºèªãããŸããã
å ¬æå å è°å¡ãçéãããïŒ2022幎è°å¡10æè°å¡èŸè·ïŒã2021幎è°å¡äºåæããæžé¢ã§åçãã¯ã¯ãã³ã¯äººå£åæžãç®çã -
/23 COVIDãã¯ã¯ãã³ããèªç¥æ©èœãæãªããšãã蚌æ ã倿
- æ°ãåããªãã»ã©ã®äººã ããã¯ã¯ãã³æ¥çš®åŸã«æãã人ãã¡ããå£ããŠãããã®ãç®æããã
- ããã¯ãé°è¬è«ããšã¿ãªãããŠããŸããããä»ã§ã¯ãããè£ä»ããããŒã¿ãããã
- éåœã®æ°ããç ç©¶ã§ã¯ããœãŠã«ã«äœã220äžäººãåŸã«430äžäººã®é»åã«ã«ããåæãé©ãã¹ãçºèŠã
-
/23 ã©ã³ã»ããèªã24æé以å ã«åé€ããè¡æçãªç ç©¶ãæ»èªãçµãŠå ¬éïŒæ»äº¡è ã®74ïŒ ãCOVID-19ã¯ã¯ãã³æ¥çš®ã«çŽæ¥é¢é£ããŠããããšãæããã«
- ãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã®æ»äº¡äŸã«ããã忀æèŠã®ç³»çµ±çã¬ãã¥ãŒããšé¡ããããã®ç ç©¶ã§ã¯325ä»¶ã®åæ€äŸãåæ
- é©ãã¹ãããšã«æ»äº¡äŸã®73.9%ãCOVID-19ã¯ã¯ãã³æ¥çš®ãçŽæ¥ã®åå ã§ããããã¯ã¯ãã³æ¥çš®ã«å€§ããå¯äžããŠããããšãè§£ã£ãã
-
/25 ãã£ã³ã©ã³ããé³¥ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã人éã«æäŸãå§ããæåã®åœã«ãªãïŒç¬ïŒ
-
/25 çŸåšãç±³åœã®5å·ããCOVID-19ã¯ã¯ãã³ã®å®å šæ§ãšæå¹æ§ã«ã€ããŠåãã€ãããšããŠãã¡ã€ã¶ãŒãæèšŽããŠããŸãã
- ãã¡ã€ã¶ãŒã¯ãèªç€Ÿãå®å šã§å¹æçãªã¯ã¯ãã³ãæã£ãŠãããšåœæ°ã誀解ãããã
- ãã¡ã€ã¶ãŒã¯ãèªç€Ÿã®ã¯ã¯ãã³ãéç¯€ãªæå®³äºè±¡ã«é¢é£ããŠããããšãç¥ã£ãŠããã«ãããããããèªç€Ÿã®COVID-19ã¯ã¯ãã³ã¯å®å šã ãšäž»åŒµããã
- ãã¡ã€ã¶ãŒã¯ãèªç€Ÿã®ã¯ã¯ãã³ãæéã®çµéãšãšãã«å¹æãèããCOVID-19ã®å€ç°æ ªã«å¯Ÿããé²åŸ¡åããªãããšãç¥ããªããæå¹ã§ãããšäž»åŒµããã
- ãã¡ã€ã¶ãŒã¯ãèªç€Ÿã®ã¯ã¯ãã³ãæææ¡å€§ã«åãŒã圱é¿ãç ç©¶ããããšããªãã£ãããšãç¥ããªãããæææ¡å€§ãé²ããšè¿°ã¹ãã
-
/26 ãã¡ã€ã¶ãŒãšã¢ãã«ãã®COVID-19 mRNAã¯ã¯ãã³ã¯é床ãã€æ°žç¶çãªè³æå·ãåŒãèµ·ãããå€§èŠæš¡ãªç ç©¶ã«ãããå€ããçã£ãŠããããšã確èªãããŠããŸãã
-
/26 ããã·ãŒäžé¢è°å¡ããã€ãã³æ¿æš©ã®åäŸãšè¥è ã«å¯Ÿããã¯ã¯ãã³æ¥çš®ã®çŸ©ååã§ãå¯äœçšç ç©¶éãèŠæ±ããFDAã®å°éå®¶3人ãè§£éãããããšãæããã«ããã
-
/27 ããã·ãŒäžé¢è°å¡ãã¯ã©ãŠã¹å士ïŒã³ãããã®æã®å FDA2å·ã¯ã¯ãã³å¯©æ»å®ïŒã¯ããŒã¹ã¿ãŒãåããŸãããïŒãã¯ã©ãŠã¹å士 ããããã
-
/27 ã¢ã¹ãã©ãŒãã«ããã¥ãŒãžã§ã³ãè²·åãã¿ãŒãã¬ã³ãåŒãèµ·ããå®éšçãªmRNA泚å°ã®åŸãã¬ã³ãæ²»çããäŒç€Ÿãè²·å - çŽ æŽãããããžãã¹ã¢ãã«âïž
- /4 5å·ãCOVID-19ã¯ã¯ãã³ã®å¹å䞻匵ãããããã¡ã€ã¶ãŒãæèšŽãžããã¡ã€ã¶ãŒç€Ÿã¯èšŽèšããæ ¹æ ããªãããšããŠå®¹çãåŠå®ããŠããã
- ã«ã³ã¶ã¹å·ãã¢ã€ããå·ããã®ä»3å·ã¯ãCOVID-19ã¯ã¯ãã³ã®å®å šæ§ãšæå¹æ§ã«ã€ããŠèª€è§£ãæã䞻匵ããããšããŠãã¡ã€ã¶ãŒã蚎ããŠããã
- ã«ã³ã¶ã¹å·åžæ³é·å®ããã¡ã€ã¶ãŒç€Ÿã¯ãã¯ã¯ãã³ãåŠå©Šã«ãšã£ãŠå®å šã ãšå®£äŒããŠããããåŠå©Šã®åæ°ä»¥äžãæå®³äºè±¡ãå ±åãã10ïŒ ä»¥äžãæµç£ãå ±åãããã
- /5 ãã€ãã®ç ç©¶ãã¯ã¯ãã³ã¯ã³ãã¥ããã£ã¬ãã«ã§ã¯æçãªå¹æããªãããå·å ã§ã¯ã¯ãã³æ¥çš®ãå€ããã°å€ãã»ã©ãè¶ éæ»äº¡çã®å¢å ã倧ããã
- /5 ç²ç°æ æ± ç°åµäŸ¡åŠäŒ 代衚çäºãã¯ãã倧æŽé²äŒè°ã補è¬äŒç€Ÿããè³è³ãåãã人ãè°æ±ºã«åå ã§ããªã ãæµãã¯å®å šã«å€ãããŸãã
- /5 ãªãŒã¯ããããããªã®äžã§ããã©ã³ããRFKã«é»è©±ããããå°å çšã¯ã¯ãã³ã«é¢ãã圌ã®å瞟ãç§°è³ããŠããã圌ã¯COVIDã¯ã¯ãã³ã®äŸ¡å€ã«ã€ããŠã®æžå¿µãèªããŠããã
- /17 EUã®è£å€æã¯ãæ°åã³ãã»ãã³ãããã¯äžã«ã¯ã¯ãã³ã確ä¿ããããã«æ¬§å·å§å¡äŒãç· çµããæ°ååãŠãŒãèŠæš¡ã®å¥çŽã®è©³çްãé èœããã®ã¯èª€ãã ã£ããšã®å€æ±ºãäžããã
- /18 ããŒã©ã³ãã®æ¬§å·è°äŒè°å¡ã欧å·è°äŒã§ç¯çœªè ã§ããEUéŠè³ãŠã«ãºã©ã»ãã©ã³ã»ãã¢ã»ã©ã€ãšã³ãç Žæ» ããããæ¬§å·å§å¡äŒã§ã¯ãªããããªããååæã«è¡ãã¹ãã§ããã
- /19 æ¥æ¬ã®ç§åŠè ã°ã«ãŒãã¯ç¹æ®ãªçæ€æè¡ãçšããŠãæ°åã³ãããŠã€ã«ã¹ã®mRNAã¯ã¯ãã³æ¥çš®ãäžçäžã§èŽåœçãªå¿äžå šã®çäŸã®æ¥å¢ãåŒãèµ·ãããŠããããšãã€ãã«èšŒæããã
- /26 ç±³åœãã·ãããã¯ïŒäžåœè£œã³ãã¯ã¯ïŒã«é¢ããåœæ å ±ãæµããããšãèªãããç±³åœé²ç·çã¯æ°çŸã®åœã®SNSã¢ã«ãŠã³ããäœæãã¢ãžã¢ãäžæ±å šåã§æ³šå°ã¯åœç©ãšä¿¡ã蟌ãŸããã
- /29 åã¢ããã¡ã€ã¶ãŒãšç· çµããç§å¯ã®ã¯ã¯ãã³è³Œå ¥å¥çŽãå ¬éãå¹èœã¯äžæãæªç¥ã®æå®³äºè±¡ãé·æçãªåœ±é¿ã¯äžæãäžçäžã®æå°è ãã¡ã¯ãèªåœæ°ãç¡è¬ã«ãå®éšå°ã«ããã
-
/2 ä¿¡ããããªãïŒãªãã¯ã¹ãã©ãŒãã¯ã¯ãã³ã®è²¬ä»»è ããžã§ã³ã»ãã«ææãçæŸéã§è¡æã®äºå®ãæŽé²ïŒãäžçã®äººå£ã®60ïœ70ïŒ ãäžåŠåããã
-
/2 米補è¬ã¢ãã«ããçºè¡šãã2024幎4-6æææ±ºç®ã§12å7900äžãã«ïŒçŽ1900ååïŒã®èµ€åãå幎åæã¯13å8000äžãã«ã®èµ€åãåŒãç¶ãæ°åã³ãã¯ã¯ãã³è²©å£²äžèª¿ãæ¥çžŸäžæ¯ã§æ ªäŸ¡ã20%å®ã
-
/2 RFKãCDCãåã©ããžã®å®æçãªæ³šå°ãæšå¥šããŠããã¯ã¯ãã³ã®ãã¡ãé·æéã®ãã©ã»ãå¯Ÿç §è©Šéšã«åºã¥ããŠFDAãèªå¯ãããã®ã¯ãªãã
ç§ã¯ã芪ãå»åž«ãåã©ãã®å¥åº·ã«ã€ããŠååãªæ å ±ãåŸãäžã§éžæã§ããããããããã詊éšã宿œãããããåªããŸãã -
/3 圌ãã¯ç¥ã£ãŠãããå šå¡ãç¥ã£ãŠããã圌ãã¯èªåãã¡ã«å察ããè å šå¡ãæ¹æ®ºããã
ãç§ã¯ææ¥å»ãšããŠ31幎éå€åããŸãããããã®éæ£è ããèŠæ ã1ä»¶ããªãã£ãã®ã«è§£éãããŸãããã- ç§ã¯ãèªç¶å ç«ãæã€äººã¯æ¢ã«å ç«ãæã£ãŠããç æ°ã«å¯ŸããŠã¯ã¯ãã³æ¥çš®ãåããå¿ èŠã¯ãªããšèšã£ãããã«è§£éãããŸããã
- 幞ããªããšã«ãåå ¥ã®å°ãªããšã50ïŒ ã倱ããææ¥å»ãšããŠåããªããªã£ãã«ãããããããå»åž«å èš±ã¯ãŸã ãããå人蚺çãç¶ããŸããã
-
/7 ãªãŒã¹ãã©ãªã¢ã®ã¯ã¯ä¿¡ãžã§ãŒã³ã»ãã³ã»ã³ãæ»äº¡
- ãªãŒã¹ãã©ãªã¢ã§æã声é«ã«ã¯ã¯ãã³æ¯æã蚎ããMSMã®ãžã£ãŒããªã¹ãã®äžäººã§ãCurrent Affair ã®ããã¥ã¡ã³ã¿ãªãŒãAnti-vaxxers Exposedãã®èè
- 声é«ã«èªãããã«ãã¡ã€ã¶ãŒã®ã¯ã¯ãã³ãæ°åæ¥çš®ããŠããããã 3 幎åŸã«ãæ¬æ¥ãŽãŒã«ãã³ãŒã¹ãã§è³è «çã«ãã亡ããªã£ãã
-
/9 å°çäžã§æãã¯ã¯ãã³æ¥çš®ãé²ãã§ããåœãä»ã人å£å±æ©ã«çŽé¢ããŠããããã®åå ã¯ãæªåé«ãCOVID-19ãã¯ã¯ãã³ãã«ããããã ã
ã·ã³ã¬ããŒã«åœå±ã¯åœæ°ãéšãããšããããæ°åã¯åãã€ããªããéå°æ»äº¡æ°ãæ¥å¢ããŠããã ãã§ãªããåºççãæ¥èœããŠããã -
/9 COVID-19ã®ææã«ããååãæ»äº¡ããåŸãæµ·è»ç¹æ®éšéã®èšç·Žçã72æé以å ã«100人ãèŸè·ã
- æµ·è»å€§å°ã§å æµ·è»ç¹æ®éšéSEALsç¹æ®æŠèšç·Žåžä»€å®ãã©ããã»ã®ã¢ãªãŒããè»ã®æ°åã³ããã¯ã¯ãã³æ¥çš®çŸ©åãæç²Ÿééšéã«äžãã壿» çãªåœ±é¿ã«ã€ããŠå éšåçºã
- 倧å°ã¯ã¯ã¯ãã³æ¥çš®ãã2022幎2æã®ãå°çã®é±ãäžã«ã¯ã¯ãã³æ¥çš®ã匷å¶ãããåŸã«åãã24æ³ã®SEALåè£è ã«ã€ã«ã»ãã¬ã³ã®æªåé«ãæ»ãåŒãèµ·ãããå¯èœæ§ã確èªã
- æ»å ã¯å ¬åŒã«ã¯ãçŽ°èæ§èºçããšãããã®ã¢ãªãŒå€§å°ãšä»ã®å£«å®ã¯çã®åå ãé èœããããã«ã¹ã±ãŒããŽãŒãã«ãããã
- æãåœã®æãåªç§ãªè»éã壿» ãããããèåŸã«ããæå³ã¯äœã ã£ãã®ãããããŠä»ã«äœãé èœãããŠããã®ãïŒ
-
/16 ææ¡ææ°èã倪平æŽå ¬è¡è¡çåžä»€éšãæ²çžçåæçŽåºå°ã®ç¬¬18èªç©ºå£ã¯ã2024/5-6ã«ãããŠåºå°ã®èšºçæãMMRã¯ã¯ãã³ãšæ°Žçã¯ã¯ãã³ã广ã®ãªãéã§æäžããçµç·¯ã調æ»ã
-
/19 ãã¬ãæ±äº¬ãæ°åã³ããã¯ã¯ãã³ã®æ¥çš®åŸã«æ»äº¡ãã人ã®éºæãªã©ãåœã«å¯ŸããŠãåãããŠ9,100äžåäœãã®è³ åãæ±ããè£å€ã®ç¬¬äžåå£é åŒè«ã19æ¥æ±äº¬å°è£ã§éãããã
-
/22 ææ¡ææ°èã ç±³åœã§åããŠCOVID-19ã®ææè ã確èªãããŠãã4å¹Žãæµ·è»ã®ç ç©¶æã¯ã¯ã¯ãã³ã«é¢ãã远跡調æ»ã®ãããæ¥æ¬ã®2ã€ã®åºå°ã§çŸåœ¹ã®ãã©ã³ãã£ã¢ãåéããŠããã
-
ç²ç°æ æ± ç°åµäŸ¡åŠäŒ 代衚çäº
-
/7 ç§ã®åšã¯2021幎é床ã®ç ã§2åææ¥æ¬éãèŠè«ããŸããã
- äžåã¯æ¬éèªäœãæãããäºåç®ã¯èšºæãæãããŸããããã®äºæ ãå ¬æå è°å¡ã«èª¬æããŸããã2幎以äžãåçããããŸããã
- åäŸã®åœã«é¢ããäºæ ãæŸçœ®ãæ¢åŸæš©çç¶æã«æãæ®ããè°å¡ãåµäŸ¡åŠäŒå¡ãšããŠåç¶ãããäºã¯ã§ããªãã
-
/8 第äžåå£é åŒè«éãæ°åã³ããã®ã¯ã¯ãã³æ¥çš®åŸæ»äº¡ç·å¥³ã®éºæãªã©ã蚎ãã
ã³ã¬ã¯åãªãè¢«å®³è ææžã§ã¯ãªããå 害è ãå 害è ãšæå®ããäºã§ãããšæããŸãã
ãã®è£å€ã¯ç§ã泚èŠããŠããã¯ã¯ãã³ãæšé²ããå ¬æå ã®æçœªã«åã倧ããªåé²ãšãªããšæããŸãã -
/22 æ¬æ¥ç¥æžå°è£å°è£ã«ãŠã¯ã¯ãã³è¢«å®³è ã®åœè³ 蚎èšç¬¬äžåå£é åŒè«ããããŸãããåŒè«ãçµãããšåœ¹äººã¯éããããã«åž°ã£ãŠè¡ããŸããã
-
/22 åµäŸ¡åŠäŒã®çæ§ãæ¬æ¥ã¯ç¥æžå°è£ã§ã¯ã¯ãã³ã®åœè³ 蚎èšããããŸãããå ¬æå ã¯ã¯ã¯ãã³è¢«å®³ãèªç¥ããŠããã«ãé¢ãããæšé²ããŠãŸãã
-
/22 ä¿¡ããããªãäºã§ããå ¬æå åºå ±ã¯ããŸã ã«ã¯ã¯ãã³ã®æšé²ãããŠãŸããåœæ°ã®çæ§ãå ¬æå è§£äœã«ãååé ãããã§ãã
-
/27 Facebookãã³ããã®æ å ±çµ±å¶ãééãã ã£ããšèªããŸãããå ¬æå ã¯ãã®äºã«ã€ããŠã³ã¡ã³ããåºãã¹ãã§ããå ¬æå è°å¡ãåæ§ã§ãã
-
/30 å ¬æå ããã¯ã¯ãã³ã®æšé²ã¯ããŠãªããããšã·ã©ãåãå§ããŸãããåœæ°ã®çæ§ããã¯æããŠèš±ããããã®ã§ã¯ãããŸãããæã£ãŠäžããïŒïŒ
-
/31 ãåºå³¶ã¯ã¯ãã³å察ãã¢æ±ºèµ·éäŒãæ± ç°åµäŸ¡åŠäŒä»£è¡šçäºã»ç²ç°ææ°ã®æŒèª¬ãå°é¢šã®äžãæ²¢å±±ã®æ¹ãéãŸããŸãããããç§ã¯å£°ãäžããäºã«ããŸããïŒã
-
-
忥NHKãçæ ã²ããå§ããã
-
NHKã¯ã2021/8/10ã«ããã§ã€ã¯ã»ãã¹ã¿ãŒãºããšããçªçµã§ãã¯ã¯ãã³ãå±éºãšããã®ã¯ããããšæŸéã
-
NHKã¯ã2023/12/18ã«ãé°è¬è«ã«ããã£ãæ¯èŠªãšããŠé·æéæŸéãã¯ã¯ãã³ã«å¯Ÿããèãæ¹ãé°è¬è«ã«èªå°ããååå ±éã
-
NHKã¯ã2023/6/19ã«ãNHKãã¯ããæ¥æ¬ã§å°å ç§åŠäŒãä»åœã§ã¯æ¢ã«å€§äººãæããªããªã£ãã³ãã¯ã¯ãããã¹ãŠã®å°å ã«æšå¥šããšå ±é
-
/21 ã€ãã«NHKããã³ããã¯ã¯ãã³æ»äº¡ãã®å€§ã çãªå ±éãå¥åº·è¢«å®³ãæ»äº¡èªå®ãã€ã³ãã«ã¯ã¯ã¯50幎ã§25ä»¶ãã³ãã¯ã¯ã¯3幎ã§762ä»¶ã
-
/21 NHKçŠå²¡ããã³ãã¯ã¯æ¥çš®åŸã®æ·±å»ãªåŸéºç被害ã«ã€ããŠ14åéã«ãããæžŸèº«ã®ã¬ããŒããæŸéã
-
/22 73æ³ç·æ§ãã¯ã¯ãã³æ¥çš®15æéåŸãæ¥æ§å¿äžå šã§æ»äº¡ãæ°åã³ãã¯ã¯è¢«å®³è ããåœã補è¬äŒç€Ÿã蚎ããã®ã¯å šåœã§5ä»¶ç®
-
/26 éºæã®èŠæã§ãçŽ3幎åã®13æ³å°å¹Žã®æ»äº¡ïŒã¯ã¯ãã³æ¥çš®4æéåŸã颚åã§æ°Žæ²¡ãæ»äº¡ïŒãéååžãå ¬è¡š
-
/27 åçåŽå倧è£èšè äŒèŠã§æŠèŠå€§è£ãæ°åã³ããã¯ã¯ãã³ã«ã€ããŠãè¬å®³ããšããèšèãå£ã«ããŸãããHPäžã§ã¯ã«ããã
-
/28 NHKãããã€ããã§1æé以äžãæ°åã³ãã¯ã¯ãã³ãšææžå¶åºŠããæŸéã空åçµ¶åŸã®å¥åº·è¢«å®³èªå®æ°ãèŠèŽè ããã®ã¡ãã»ãŒãžãå ±ããããã
-
/29 NHKãæ°åã³ããã¯ã¯ãã³è¢«å®³ãå ±ããé端ã«ãã¯ã¯ä¿¡ãæã®ã²ããè¿ããããã«ãå®ã¯ç§ãå±éºã ãšèšãåºããªãã§ãããšèšãå§ããŠããã
-
/29 絶倧ãªä¿¡é ŒãããŠããNHKããã€ãã§ã€ãã«ãã¯ã¯ãã³åŸéºçãèªå®æ»äº¡777人ããå ±éãããååŽçžã¯ãè¬å®³ããèªããŠåé€ããŠçäž
-
/30 åçåŽå倧è£èšè äŒèŠãæ°åã³ããã¯ã¯ãã³ã«ããå¥åº·è¢«å®³ããè¬å®³ã«è©²åœãããã«ã€ããŠã®ãçãã¯ããŸã ãã®æç¹ã§ã¯å·®ãæ§ãããã
-
-
/27 Metaã®CEOãã¶ãã«ãŒããŒã°ãçæ ã²ããå§ãããïŒã€ãã³ã2.6ã®è©²åœç¯ãåç §ïŒ
-
/1 å»çæ åœå®ããçŸåœ¹æµ·è»å°æ ¡ã®éã§ã³ãã¯ã¯é¢é£ã®å¿èçŸæ£æ¥å¢ãæããã«ãããå¿ççã151%ãèºæ§å¿çŸæ£ã62%ãèè¡æ§å¿çŸæ£ã69%ãå¿äžå šã¯ãªããš973%
-
/6 Bloombergãäžåœã®èŠå¯åœå±ã¯ãè±è£œè¬å€§æã¢ã¹ãã©ãŒãã«ã®çŸã»å åŸæ¥å¡5人ãéæ³æŽ»åã®çãã§åã調ã¹ãããææïŒé¢ä¿è ïŒ
-
/12 米補è¬ã¢ãã«ãã2027幎ãŸã§ã«11åãã«ïŒçŽ1560ååïŒã®éçºç ç©¶ïŒR&DïŒã³ã¹ãåæžã宿œããå幎æ«ãŸã§ã«10çš®é¡ã®æ°è£œåãæ¿èªãããèŠéãã ãšçºè¡šã
-
/13 ãããªãå·å ¬è¡è¡çå±é·å®ãå·æ°ã«å¯ŸããmRNAã®COVID-19ã¯ã¯ãã³æ¥çš®ãé¿ããããä¿ãã代ããã«å¥åº·çãªé£çæŽ»ãæ¥å æµŽã®æéãåãããšãæšå¥šããã
-
/19 åå£äžåïŒèïŒããã©ã³ãããã¯æŠäºãäœããããã³ãããã¯ïŒæªæ§ãªã³ãè «ãšã®éããè¶ ããŠïŒ åè¡æ¬
-
/19 ããŒã Kãç§ãã¡ã¯å£²ããããªãïŒãâå±ãªãã¯ã¯ãã³â販売ãåœãããã補è¬äŒç€ŸçŸåœ¹ç€Ÿå¡ã®æ å
-
/20 æ¥éã®ç§åŠè ã«ããæè¿ã®æ»èªä»ãåŠè¡èªã¯ãã³ãã¯ã¯ãé倧ãªç·ç¶æ§ååºãåŒãèµ·ãããããšã蚌æãæ»åŸã®è¡æ ã§èŠãããããç°åžžãªéã®ã¿ã³ãã¯è³ªãæ¡åã
-
/20 æ¥æ¬ãã³ãã¯ã¯æ¥çš®è ã«å³ããèŠåãã¯ã¯ãã³ãæ¥çš®ããŠããªãäººã«æ¯ã¹ãŠãã¯ã¯ãã³ã2åæ¥çš®ããå Žåã®æ»äº¡çã¯5åé«ããªããŸããã- å°å³¶èª åžææ
-
/24 CDCã¯ãæ°åã³ãããŠã€ã«ã¹ã®mRNAã¯ã¯ãã³ãæ¥çš®ãåãã人ã®å¯¿åœããªããš24幎ãçž®ãããšããè¡æçãªäºå®ãèªããã
- ããã¯ãæ°åã³ãããŠã€ã«ã¹ææçã¯ã¯ãã³æ¥çš®ã®é·æçãªåœ±é¿ãä»ãèªèããã€ã€ããäžã§ã®åºæ¥äºã§ããã
- æè¿ãã¢ãã«ã瀟ãèªç€Ÿã®ã¯ã¯ãã³ããããåŒãèµ·ããããšãèªããããšãæããã«ãªã£ãã
- mRNAæè¡ã®çºæè ã§ãããããŒãã»ãããŒã³å士ã¯ãè¡æçãªè°äŒèšŒèšã®äžã§ãé©ãã¹ãäºå®ãæããã«ããã
-
/26 ãã¡ã€ã¶ãŒç€Ÿã®å å¯ç€Ÿé·ããã€ã¯ã»ã€ã§ãŒãã³å士ããïŒmRNAããŒã¹ã®æ°åã³ãããã¯ã¯ãã³ãã¯ïŒæå³çã«ã人ãå·ã€ããå·ã€ããæ®ºããçæ®èœåãäœäžãããããã«èšèšããããã
-
/29 17,000人ã®ç§åŠè ãšå»åž«ããäžçäžã®æ¿åºãšäŒæ¥ããã³ãã¯ã¯ã«é¢ããŠäººé¡ã«æ æã«æå³çã«åãã€ããããšã確èªãè©æ¬ºãäžåœåºåãéå£é倱殺人ã®çœªã§èµ·èšŽãããªããã°ãªããªãã
-
/30 çŸåšããã¡ãŠãæ°ã¯ãCOVIDã¯ã¯ãã³ãç¹ã«è¥ãç·æ§ã«å¿çæ¢å¡ãåŒãèµ·ããããšãèªããŠããã圌ã¯åœæ°ã«åãã€ãããšããŠèµ·èšŽãããã¹ãã§ããããïŒ
-
/30 ããã¯ã亡ããªã£ãã³ãã¯ã¯æ¥çš®è ã®è¡ç®¡ããåºãŠãããã®ã§ãã誰ãããã®åé¡ã«å¯ŸåŠããã®ã§ããããïŒ
ç§ãã¡ã¯ãäœå ã§ãã®ç æ°ãæé·ããŠããŠãããã«æ°ä»ããŠããªãäœçŸäžäººãã®äººã ãæãããšãã§ãããããããŸããã -
ç²ç°æ æ± ç°åµäŸ¡åŠäŒ 代衚çäº
- /4 å ¬æå ã¯ã¯ã¯ãã³æšé²ããŠãŸãã蚌æ ãšããŠæ®ããŸããå ¬æå ã®å±±å£é£æŽ¥ç·ããGaviã¯ã¯ãã³ã¢ã©ã€ã¢ã³ã¹ãã®è³é調ééšé·ã®è¡šæ¬ãåãæè«ã
- /5 å±±å£é£æŽ¥ç·ãé亡ãå ¬æå ãä¿¡ããŠæ¥çš®ããæ¯æè ãèŠæ®ºãã§ãã代衚ãå€ãã£ãŠãå ãåç¶ããäºãåœæ°ã¯æãŸãªããå ¬æå ãè§£äœããŠããéä»»ããŠé ãããã
- /6 ã¯ã¯ãã³åé¡ãåŒçšãªããããåè«ç¡ãã§ãããã¯ã§ãããããä»ã®å ¬æå åœäŒè°å¡ã§ãã
- /6 ãã®åç»ã芳ãŠé ãããã§ããå ¬æå ã¯ãããªå±éºãªç©ãæšé²ããŠãã®ã§ãã被害è ãšåãåããéããäºãåœæ°ã¯èš±ããªãã
- /17 å ¬æå è°å¡ã¯å šå¡ãã®ä»¶ã«å¯Ÿããã³ã¡ã³ããåºããŠäžãããå ¬æå è°å¡ã«ããã°ïœ¢ã¬ããªã³ã³ã¯ã¯ãã³ã¯ãã¡ããã³ãã¯ã¯ãïŒããïŒæšå¥šã»æšé²ããŠããªãã
- /22 ã¬ããªã³ã³ã®æ²»éšã§æ»äº¡è ãåºãŠããäºãååŽçãèªããŸãã
- /28 ååŽçãæ»è ã®æžå¿µãææããŠããzoomäŒè°
- /28 ææãã¢ããã®æ°äž»å¢åã«ã¯åãŠãªãã§ããããåµäŸ¡åŠäŒã®åãæã£ãŠãããçšã®äººãéçµãããäºã¯ã§ããªãããã®æ°äž»å¢åã¯ä»åŸåºããã§ãããã
-
/19 ãã¬ããªã³ã³ã¯ã¯ãã³ãå¿é¿ïŒèº«å ã«åºããããææ²»HDãã§å ä¹±åçºïŒ
- ãã¬ããªã³ã³ã¯ã¯ãã³ãæ¥çš®ãããã客æ§ã¯å®å šæ§ã確èªã§ãããŸã§å ¥åºããæ§ãããã ããŸããããé¡ãç³ãäžããŸãã
- å··ã«ãã¬ããªã³ã³æ¥çš®è ãæããã®åç¥ãç¶ã ç»å Žã瀟å¡ããå±ãªãã¯ã¯ãã³ãã®åçºæ¬ãçºå£²ãå æå€æ£ã
-
/24 æ°å€ãã®å®éšå®€ç ç©¶ã«ããããã¡ã€ã¶ãŒã®COVID-19ã¯ã¯ãã³ã«ãã©ã¹ããDNAãå«ãŸããŠããããšã確èªãããŠããã
- å®éãæè¿ã®åæã§ã¯ããã¡ã€ã¶ãŒã®ã¯ã¯ãã³1ååã«2000åå以äžã®DNAæçãå«ãŸããŠããå¯èœæ§ãããããšãæããã«ãªã£ãã
- ãããã¯ãããåŒãèµ·ããå¯èœæ§ãããããã人éã®ãµãã©ã€ãã§ãŒã³ã«æ±ºããŠå ¥ã£ãŠã¯ãªããªããã¯ã¬ãªããã§ããã
-
/23 åäžé·è ã®ãã«ã»ã²ã€ãæ°ã¯ããªã©ã³ãã®è£å€æãããCOVID-19ã¯ã¯ãã³ã®å®å šæ§ã«ã€ããŠåœæ°ã誀解ãããããšããŠãªã©ã³ãã§è£å€ãåããããåœããããã
-
/23 ãã«ã»ã²ã€ããmRNAã¯ã¯ãã³ã«é¢é£ããŠãæ°çŸäžäººã殺害ãã眪ãã§è£å€ãåããããåœããããã
- ã²ã€ããé廿°å幎ã«ããããã¢ããªã«ãã€ã³ãã§å®éšãè¡ããã¯ã¯ãã³ã®å±éãäž»å°ããå€ãã®äººåœã倱ãããã
- ã²ã€ããWHOãMSMãã°ããŒããªã¹ãå£äœãšã®é¢ä¿ãå©çšããŠãèªåã®è¡åãé ããŠããã
- ãããä»ããªã©ã³ãã®è£å€å®ããã«ã»ã²ã€ãã«è£å€ãåããããåœããã²ã€ãã¯ææã«éããŠããã
-
/31 æ¥æ¬ã®å»åŠå°éå®¶ãã¡ã¯ãã³ããã¯ã¯ãã³æ¥çš®åŸã«æ»äº¡è æ°ãå¢å ãç¶ããŠããããšã«æžå¿µã瀺ããŠããã
- åœç«ããç ç©¶ã»ã³ã¿ãŒãæ ¶æå€§ãæ±å€§ã®ç ç©¶è ãã¡ã¯ã1995-2022幎ãŸã§ã®å šæ»å ããã³å¹Žéœ¢æšæºåæ»äº¡çãåæãã2021幎åé ã®ã¯ã¯ãã³å±éåŸã«æ»äº¡çãæ¥å¢ããããšãææã
- 2023幎以éãæ»äº¡çã®äžæåŸåãç¶ããŠãããšå ±åãããç¹ã«å¿è¡ç®¡çŸæ£ãããã«ããæ»äº¡ãå¢å ããŠãããé·æçãªåœ±é¿ã®èª¿æ»ãå¿ èŠã ãšãããŠããã
- æ¥æ¬ã¯2021幎ã«ã¯ã¯ãã³æ¥çš®ãéå§ããé«ãæ¥çš®çãéæããããæ»äº¡è æ°ã®å¢å ãå ¬è¡è¡çãžã®åœ±é¿ãæžå¿µãããŠããã
-
ç²ç°æ æ± ç°åµäŸ¡åŠäŒ 代衚çäº
-
/3 応é£ç¿å¿ããXããã蚎ãããããâãã€ãã«æšé²æŽŸã®åãç· ãŸããå§ãŸã£ãããã§ãããã
応é£ç¿å¿ã¯ãXã§ã¯ã¯ãã³æ¥çš®ã§æ»ãã ããåŸéºçã¯ãªããšèåœæšå¥šã«éšãããæçš¿è ã§ãã被害è ãéºæã«ã¹ã©ããèšŽèšæèµ·ããŠæå®³è³ åéãåããŠããã -
/7 尟身èã®2021/8/10ã®çºèšãæ¥çš®70ïŒ ã§ãéå£å ç«ã¯å°é£ãšã®èŠéãïŒã¯ã¯ãã³ã§éå£å ç«ç²åŸã¯å¹»æ³ïŒç¬ïŒïŒ
-
/7 ã²ã€ã財å£CEOãšæŠèŠæ¬äžãåœé£ç·äŒéå¬äžã®NYã«ãŠé¢äŒãççãšã¯ãã®äºã ãå€ãã®åŠäŒå¡ãçºä¿¡å ïŒã®æåçŸä¿åïŒãåŠäŒå¡ã§ããäºãç¥ããªãã
-
/10 ææ²»HDç³»ãåèªæ¯æã§åã¯ã¯ãã³å£äœãæèšŽãž\
- é£ãã§ç«ã«ããå€ã®è«ãšã¯ãã®äºã§ããåœæ°é£åã¯èŠäºã«æµãçãåºãæ³å»·ã©ã€ã³ã«ä¹ããŸããã
- ããã§æšé²æŽŸã¯åŒãè¿ãäºãã§ããªãå°çè¡ãã®ç¹æ¥ã«èªãã®ææã§ä¹ã£ããšèšãèš³ã§ããæ¥œãã¿ãäžã€å¢ããŸãããã
-
ã¢ã¡ãªã«äººãžã£ãŒããªã¹ããã¬ããªã³ã³ã¯ã¯ãã³ãã倧éèæ®ºããšçºä¿¡
-
人é¡å²äžæãå é²çã§ææåãããæåã®äžã€ã§ããæ¥æ¬ãã倧éèæ®ºãããããšããŠãããæ¥æ¬ã¯åæããªããã°ãªããªããäœãããªãå人ã¯ããªãã
-
-
/2 åå£äžåè°å¡ããã€ãŠæ°æ¥æ¬çªçŽ ç€Ÿé·ãææ°Žæåã¯å®å šã§ãããšãå±éºæ§ãææãã人éã蚎ãããã糟匟ããäºããã£ãã
- ã®ã¡ã«ãªã£ãŠå æé¢ä¿ãæããã«ãªããåççã¯ãæ°Žä¿£ç ã®åå ç©è³ªããããœæ°Žä¿£å·¥å Žã®å»æ¶²ã«å«ãŸããã¡ãã«æ°Žéååç©ã§ãããšèªå®
- æ°æ¥æ¬çªçŽ ã¯ãåç£ãããããããªãçšã®å€é¡ã®æå®³è³ åãæ¯æãçµæãšãªã£ãã倱ãããåœãæãªãããå¥åº·ã¯æ»ã£ãŠæ¥ãªãã£ãã
-
/3 æµ·å€ãããNHKã8/28ã«COVID-19 mRNAã®ã¯ã¯ãã³ã«é¢ãã1æéã«ãããã¬ããŒããæŸéãããšããæ¥æ¬åœæ°ã¯è¡æãåããã
çªçµã«ã¯2,000人以äžã®èŠèŽè ããã¡ãã»ãŒãžãå¯ãããã被害ã®èŠæš¡ããããŸã§èããããŠããããã倧ããããšãæããã«ãªã£ãã -
/4 ãã©ã³ãæ°ã¯æè¿ã®é»è©±ã€ã³ã¿ãã¥ãŒã§ãç±³åœã§ã¯ã¯ãã³ãçŠæ¢ããæ¡ã«ååãã§ããããšã確èª
- ãã®åé¡ã«ã€ããŠã¯RFKãžã¥ãã¢æ°ãä»ã®å°éå®¶ã«å©èšãæ±ãããšä»ãå ããã
- èšè ïŒç¹å®ã®ã¯ã¯ãã³ã®çŠæ¢ãæ€èšãããå¯èœæ§ã¯ãããšæããŸããïŒ
- ãã©ã³ãïŒç§ã¯åœŒãšããããŠä»ã®äººã ãšè©±ãåã£ãŠæ±ºæããã€ããã§ããã圌ã¯éåžžã«æèœã®ãã人ç©ã§ããã匷ãæèŠãæã£ãŠããŸãã
-
/4 ãã€ãªãŒæ°æœ®ãèªæ®ºè¡çºã«çãããã¬ããªã³ã³ã¯ã¯ãã³æ¹å€ã®ç ç©¶è ãå察éåã®çæãæãããåœæ°ã®å¥åº·ããã補è¬äŒç€Ÿã®å©çããšããå§¿å¢ã
- ãmRNAã¯ã¯ãã³ãããçµæãã¿ã³ãã¯ã¯ã¯ãã³ãã«æ°ãã«ãã¬ããªã³ã³ããå ãã£ãæ°åã³ããã®ã¯ã¯ãã³å®ææ¥çš®ã
- ç®äžããã®æ°ã¯ã¯ãã³ãå·¡ãçŸçïŒããã€ïŒãªè«äºãç¹°ãåºããããŠãããåãªãâé°è¬è«âããã¯ããŸã身åœããªããã£ãèŠéãã
-
/4 åå£äžåè°å¡ãmRNAã¯ã¯ãã³ãåçãšãããšãã¬ããªã³ã³ã¯ãã£ãšåãäžæ§åç匟ãšããããšã§ãããã
- ãããã§ããå šãŠã®äžã§æãæåŒ·ã®ç匟ã§ãããïŒãã©ã³ã¹åœç«ç§åŠç ç©¶æç 究䞻任ããžã£ã³ã»ãã«ã¯ã»ãµãããšå士ïŒã
- 圌ãã®è«çã«ããã°ãããããéç§åŠçãšèšãã¹ãã§ã¯ãªãã®ãïŒãã©ã³ã¹ã«èšã£ãŠãããã©ããïŒ
-
ãã©ã³ãåå©åŸ
-
/7 補è¬äŒç€Ÿã®ããã5人ã®CEOãååŸ1æã«ç·æ¥é»è©±äŒè°ãéå¬ããäºå®ãåŒè·å£«ã¯å šå¡ããããã¯ç¶æ ã«ããããšã確èªïŒæ å ±çïŒ
-
/7 ããã«ãã»ãã©ã³ããéžæã«åå©ããããšã¯ãä»é±ãæå€§ã®è©±é¡ã§ã¯ãªãã
- å ±åæžã¯ãã«ãããäžåœã®æ©èœç²åŸç ç©¶ã«é¢äžããŠããããšããããŠãã«ããŒéŠçžããããé èœããŠããããšã確èªããã
- ã«ããã¯COVID-19ãã³ãããã¯ãåŒãèµ·ããäžå ãšãªã£ãå¯èœæ§ãããã説æè²¬ä»»ãšã¯ã©ã®ãããªãã®ã§ããïŒ
-
/8 ãäžæåºå»åž«ãšèªãâã¬ããªã³ã³ã¯ã¯ãã³ããããéâããä»®å èš±é転ãã«èšå€§ãªåœè²»ãïŒïŒãé·åä¿¡éã®ãæ¥æ¬ã®æš©åãæ¬ãïŒã
-
/9 ãäŒæ¥å¯¡é å¶ã2006-2019幎ã®éã«ãFDAã®å§å¡10人ã®ãã¡9人ããèŠå¶ãæ åœããŠãã補è¬äŒç€Ÿã«å€åãFDA ã®å»è¬å審æ»äºç®ã®çŽ 65% ã¯è£œè¬æ¥çããçŽæ¥æäŸã
-
/16 ECã¯EUã®ãŠã«ãºã©ã»ãã©ã³ãã¢ã©ã€ãšã³å§å¡é·ãšãã¡ã€ã¶ãŒç€Ÿã®ããããšã®éã§äº€ããããè¬ã®ããã¹ãã¡ãã»ãŒãžã¯æ°ã³ãã¯ã¯å¥çŽãšã¯ç¡é¢ä¿ãšäž»åŒµãæ³å»·ã§å®å¢ã«ç«ããããã
-
/18 COVID-19ã¯ã¯ãã³æ¥çš®åŸã®çªç¶æ»ã«é¢ããç ç©¶è«æãæ»èªãçµãŠæ°ãã«åºç
- ãã®è«æã¯ãéå»ã«ã©ã³ã»ãããä»ã®ãšã«ãŒãã¢ç³»ãžã£ãŒãã«ã§ã®æ€åãæ€é²ã«çŽé¢ããçºè¡šãé ãããã®ã§ãã
- ç ç©¶ã®èæ¯ïŒæè¿COVID-19ã¯ã¯ãã³æ¥çš®ãåããåŸã«çªç¶æ»äº¡ãã325äººã®æ€æ»çµæãåæããäžçæå€§èŠæš¡ã®ç ç©¶ã
- äž»ãªçµæïŒã¯ã¯ãã³æ¥çš®ããæ»äº¡ãŸã§ã®å¹³åæéã¯14.3æ¥ãæ»äº¡è ã®73.9%ããCOVID-19ã¯ã¯ãã³æ¥çš®ãçŽæ¥çãŸãã¯å€§ããå¯äžãããšå€æãããã
- æçŸ©ïŒCOVID-19 mRNAã¯ã¯ãã³ãæ¥çš®åŸæ©æã«çªç¶æ»ãåŒãèµ·ããå¯èœæ§ãããããšã瀺ãåŸæ¥ã®ãæªæ¥çš®ããšã©ãã«ä»ããããã±ãŒã¹ã®èæ¯ãæããã«ããã
- æ€é²ãžã®æ¹å€ïŒä»¥åã®åºçéçšã§åäŸã®ãªãç§åŠçæ€é²ãšããŠæ¹å€ãããèè ãé¢ä¿è ã®åªåã«ããä»åã®åºçãç§°è³ãããã
-
/22 ã·ã¢ãã«ã®ã¯ã·ã³ãã³å·ãã³ã°é¡ã§ã¯ãäœæ°ã®98%ãCOVIDã¯ã¯ãã³ãå°ãªããšã1åæ¥çš®ããŠããã«ããããããã2020-2023幎ã«ãããŠå¿èçºäœã«ããæ»äº¡è æ°ã1,236%å¢å
åææã«å¿åæ¢ã«ããæ»äº¡è ãçŽ25%å¢å ããé¡ã®äººå£ã¯æžå°ããã®çŸè±¡ã«ã€ããŠãããŒã¿ãŒã»ãã«ããŒå士ã¯ã¯ã¯ãã³ã®åœ±é¿ãèãããããšææãããããªã調æ»ãå¿ èŠãšè¿°ã¹ãŠããã -
/23 ææ²»HDã¯ããããªéè¡ã»äžè±UFJä¿¡èšéè¡ã»èŸ²æäžå€®é庫ãªã©éèæ©é¢ã®æ ªäž»9ç€Ÿãææ²»HDæ ªã売ãåºããšçºè¡šãçºè¡æžã¿æ ªåŒç·æ°ã®çŽ4.7%ã420ååèŠæš¡ã
-
/25 Judy Mikovitsãã€ã¿ãªã¢ä¿å¥å€§è£ãã¯ã¯ãã³æ¥çš®ã«ããæ»äº¡è ãé èœããããåœä»€ãçŸåšæ®ºäººå®¹çã§ææ»äžãåœç¶ã®ããšã ã
-
/26 ãã©ã³ã倧統é ãCOVID-19ã¯ã¯ãã³ãæåŠããããã«ãã€ãã³å€§çµ±é ãè§£éããè»äººãåéçšãã圌ãã«è¬çœªããå šé¡ã®æªæã絊äžãæ¯æãèšç»
-
/26 NIHã®é¢ä¿è ãCOVID-19ã®å¥åº·å¯Ÿçã«ã€ããŠããå®å šã«ã§ã£ã¡ããããšè¿°ã¹ãã¯ã¯ãã³ã®ææé²æ¢å¹æãäžæã§ãããå®å šæ§ã«ã€ããŠãååã«æ€èšŒãããŠããªãããšãèªããã
- åæ°ã¯ããã¡ã€ã¶ãŒãã¢ãã«ãã倧ããªå©çãåŸãŠããã ãã ãšæ¹å€ããã¯ã¯ãã³æ¿èªãè¿ éåãããããšã«ãæžå¿µã瀺ããã
- ãŸããç£èŠã®äžè¶³ãææãã€ã€ããããŸãå¿é ããªãããšçºèšãããã«ããã©ã³ãæ°ã®åå©ã¯NIHã«ãšã£ãŠäžå©ã§ãããæ°äž»å ã®æ¿æš©ç¶ç¶ãæãŸãããšè¿°ã¹ãã
-
/27 æ¥æ¬ã®æ€å¯åœå±ããã³ãããã¯äžã«äººéã«å¯Ÿãã眪ã§ãã«ã»ã²ã€ãã鮿ãž
- çŸä»£ã®åžæ³ãåå®çŸ©ããå¯èœæ§ã®ãããã®äºä»¶ã§ãæ¥æ¬ã®æ€å¯ã¯èŠæã匷ããŠããããã«ã»ã²ã€ããåã³æ¥æ¬ã«è¶³ãèžã¿å ¥ããã°äººéã«å¯Ÿãã眪ã§é®æãããšèªã£ãŠããã
- æ¥æ¬ã®åœå±ã¯ããªã©ã³ãã§é²è¡äžã®èšŽèšïŒã²ã€ãæ°ãšãã¡ã€ã¶ãŒã®ã¢ã«ããŒãã»ããŒã©CEOãCOVID-19ã¯ã¯ãã³ã«ã€ããŠåœæ°ã欺ããïŒãšé¡äŒŒç¹ãæããŠããã
- æ€å¯ã¯ããã³ãããã¯äžã«å€§éæ®ºäººãšæ°ååäººãæ®ºå®³ãè² å·ãããçµç¹çãªäœæŠã«å ±è¬ãããšããŠã²ã€ãæ°ã®è²¬ä»»è¿œåã«åãçµãã§ããã
-
/27 ãã¬ãŒã·ã¢åœæ°ããCOVID-19ã¯ã¯ãã³æ¥çš®ã«ããæ»äº¡ãæ·±å»ãªå¥åº·è¢«å®³ãçç±ã«ãæ¿åºããã¡ã€ã¶ãŒãWHOãããã³ãããã¹äºåå±é·ãçžæåãéå£èšŽèšãèµ·ãããã
- 蚎èšã§ã¯ãWHOã2020幎ã«ãã³ãããã¯ã宣èšããéãäžæ£ã§éç§åŠçãªå€æãè¡ããäžçäžã§æŽ»åå¶éåœä»€ãã¯ã¯ãã³æ¥çš®ãæšå¥šãããšäž»åŒµã
- ååãã¯ãCOVID-19ã人工çã«äœãããçç©å µåšã§ããå¯èœæ§ãææãããã³ãããã¯å¯Ÿå¿ã®ããã«ãæ¯æ§ã®ããå®éšã¯ã¯ãã³ãã䜿çšããããšãæšå¥šãããšéé£ã
- 被ååŽã¯ãå ·äœçãªäºäŸãæããã¯ã¯ãã³ã®å®å šæ§ãæå¹æ§ã«ã€ããŠé©åãªèšåºè©Šéšãè¡ãããé倧ãªé倱ããã£ããšããã¯ã¯ãã³æšå¥šããã³ãããã¯å¯Ÿå¿ã®è²¬ä»»ã远åã
-
/28 ãã©ã³ãæ¿æš©1æç®ã«è»äºéšéã§åå ãããã«ããŒãã€ãºå士ãèªèº«ã®ãã£ã³ãã«ã«ã¢ããããåç»æ¥æ¬ã®æ€å¯åœå±ããã³ãããã¯æã®äººéã«å¯Ÿãã眪ã§ãã«ã»ã²ã€ãæ°ã鮿ãž
-
/30 ã€ã®ãªã¹äººããã«ã»ã²ã€ãã远ããããããã«ã»ã²ã€ãã鮿ããïŒããšå«ã³ãªããæ®ºäººè ãšåŒãã ãããª
-
ç²ç°æ æ± ç°åµäŸ¡åŠäŒ 代衚çäº
- /28 æ¬æ¥ãååŽçã被害統èšãæŽæ°ãèªå®ä»¶æ°ïŒ8,470ä»¶ïŒïŒ38ä»¶ïŒæ»äº¡èªå®æ°ïŒ909ä»¶ïŒïŒ6ä»¶ïŒ
ç ç²è ã¯å¢ããäžæ¹ã§æ¥çš®ã®æšé²ã¯æ¢ããªããããã¯ã殺çã仿³ã§ã®çœªãç¥ããªããæŸçœ®ããŠãäºã«ãªããŸãã
- /28 æ¬æ¥ãååŽçã被害統èšãæŽæ°ãèªå®ä»¶æ°ïŒ8,470ä»¶ïŒïŒ38ä»¶ïŒæ»äº¡èªå®æ°ïŒ909ä»¶ïŒïŒ6ä»¶ïŒ
-
RFK
-
/6 ç§ãã¡ã¯æåéããRFKãžã¥ãã¢ã«å€§æè£œè¬äŒç€Ÿãææ»ã起蚎ããæš©éãäžããã
-
/7 CNNããã©ã³ãæ¬¡ææ¿æš©ã§å ¬è¡è¡çãçµ±æ¬ããRFKæ°ãã¯ã¯ãã³ã®å®å šæ§ãšæå¹æ§ãå·¡ã調æ»ãçŽã¡ã«å§ããæ¹éã
-
/7 ã¯ã¯ãã³ã人ã ãã奪ãããããã§ã¯ãªããã¢ã¡ãªã«åœæ°ã«éžæã®èªç±ãäžãããã
ã»ã¯ã¯ãã³ã®å¹æãä¿¡ãããªãæ¥çš®ãã¹ãã ããååãªæ å ±ã«åºã¥ããŠéžæããããšãéèŠã ã
ã»å¹Žé7,600äžäººã®å¥åº·ãªåäŸãã¡ã«ã¯ã¯ãã³æ¥çš®ã矩åä»ããããŠããããšã«è§Šãããªã¹ã¯ããªãããã«ç¹ã«æ éã§ããã¹ãã ã
ã»ããã«ãã¯ã¯ãã³ã¯å ¬è¡è¡çå±ã«ãã£ãŠåœå®¶å®å šä¿éã®äžç°ãšããŠå°å ¥ããããã®ã§ãããéåžžã®å»è¬åãšç°ãªããé·æçãªå®å šæ§è©ŠéšãçµãŠããªãã
ã»ã¯ã¯ãã³ã®ãªã¹ã¯ãããã¡ã€ã«ãäžæã§ããããšã¯åé¡ã§ãããèªåãWHã§è·åãéè¡ãããªãã°ãå©ççžåã®ãªãå§å¡äŒã«ãã峿 Œãªç ç©¶ãšè©äŸ¡ãè¡ãã -
/8 RFKã¯ã¯ã¯ãã³ã®è©±é¡ã§è°è«å¥œããªãžã£ãŒããªã¹ãã«æ£ããèŠè§£ãè¿°ã¹ãã
ã»ãã¯ã¯ãã³ã«é¢ããç§ã®ç«å Žã¯ãã¯ã¯ãã³ã¯ä»ã®å»è¬åãšåæ§ã«ãã¹ããããã¹ãã ãšããããšã§ããã
ã»ãçŸåšã¢ã¡ãªã«ã®åäŸãã¡ã«çŸ©åä»ããããŠãã72åã®ã¯ã¯ãã³æ¥çš®ã®ãã¡ãèªå¯åã®ãã©ã»ãå¯Ÿç §è©Šéšãåãããã®ã¯1åããããŸãããã
ã»ãä»ã®å»è¬åã«ã¯ããããããšãæ±ããããŠãããã¯ã¯ãã³ã«ããããã¹ãã§ããããç§ãééã£ãŠãããªãããã¹ãçµæã»ç ç©¶çµæãèŠããŠãã ããã
ã»ããã¯ã§ããªãã§ããããäœæ ãªãããã®ãããªãã®ã¯ååšããªãããã§ããã€ãŸããé·æçãªãªã¹ã¯ãäœãªã®ãåãããªããšããããšã§ãã -
/11 ãã¡ã€ã¶ãŒãã°ã©ã¯ãœãã¡ã«ã¯ããµããã£ã®4ã€ã®è£œè¬äŒç€Ÿã¯éå»ã«ç§åŠã®åœé ãè©æ¬ºãç¯ããæ°åäžäººã®æ»ã«å¯Ÿãã責任ãåãããŠãããšéé£
ã»ã¡ã«ã¯ã®ããã€ãªãã¯ã¹ãã¯ãå¿èçºäœãåŒãèµ·ããå±éºãç¥ããªãã販売ãããçµæçã«50äžäººãã®åœã奪ãããŸããããå瀟ã¯70åãã«ã®çœ°éãæãã®ã¿ã§å眰ã¯å ããŸããã
ã»ãŸãã1986幎ã«ã¢ã¡ãªã«ã§ã¯ã¯ãã³è£œé äŒæ¥ã蚎远ãå é€ãããæ³åŸã坿±ºãããããšã«ãããã¯ã¯ãã³åéã¯è£œè¬äŒç€Ÿã責任ãåãããªãå¯äžã®é åãšãªã£ãŠããã -
/12 RFKæ°ãåäŸã«çŸ©åä»ãããã72çš®ã®ã¯ã¯ãã³ã®ãã¡ãå®å šæ§è©Šéšãè¡ããããã®ã¯1ã€ããªãããã§ã€ã¯ã ãšäž»åŒµãããã¡ãŠãå士ã«å¯Ÿã蚎èšã
ã»1幎éã®åŠšå®³ã®åŸããã¡ãŠãæ°ã®åŒè·å£«ã¯RFKæ°ãæ£ããã£ãããšãèªããã
ã»é£éŠæ¿åºãåäŸãã¡ã«ã¯ã¯ãã³æ¥çš®ã矩åä»ããäŒæ¥ã¯å·šé¡ã®å©çãåŸãŠããã
ã»1989幎以éã®åäŸã®æ ¢æ§çŸæ£ïŒADHDãèªéçãç¡ç é害ãªã©ïŒã®å¢å ãšã¯ã¯ãã³æ¥çš®ãšã®é¢é£æ§ã瀺åã -
/15 ããŒã¿ãŒã»ãã«ããŒå士ããCOVIDã¯ã¯ãã³ããªããå µåšããªã®ãã60ç§ä»¥å ã«èª¬æã
ã»è³ãå¿èã«äŸµå ¥ããŸããè³ãšå¿èã«æå·ãåŒãèµ·ãããŸãã
ã»éªšé«ã«äŸµå ¥ããŸããæäœãåºæ¿ããŠçްèãè¡å°æ¿ãæ»æããŸãã
ã»ãããŸã§ã«èŠãããšã®ãªããããªè¡æ¶²ååºãè¡ç®¡ã®æå·ãåŒãèµ·ãããŸãã
ã»ãããããŒã°å€§åŠã®ããŒã¿ã«ãããšããããåŒãèµ·ããå¯èœæ§ãããããšã瀺åãããŠããŸãã -
/16 RFKæ°ãä¿å¥çŠç¥é·å®ã«ä»»åœãããã°COVIDã®è£å€ã宿œãããšçºèšããã©ã³ãæ¿æš©ã¯RICOæ³ãå©çšããŠå€§æè£œè¬ã«ã«ãã«ãè§£äœããæ±è·ãå³ããæ³ç眰åã§åŠçœ°ããã
-
/28 RFKãã€ã³ãã«ãšã³ã¶ã®äºé²æ¥çš®ãåãã人ã¯ãèæ ªããå®ãããŸãããå ç«ç³»ãæå·ãããããããã以å€ã®ææçã«ãããå¯èœæ§ã4.4åé«ããªããŸãããCDCãäŒããŠããªãããšã
-
-
-
/3 æ¯æ¥æ°èãåå®®é žãããäºé²ããHPVã¯ã¯ãã³ã«ã€ããŠãå šåœã®å°ãªããšã12åžåºãæ¥çš®æžã¿ã®å¥³æ§ã«äžèŠãªæ¥ç𮿡å ãéµéãããã®å¥³æ§ãèŠå®åæ°ïŒ3åïŒãè¶ ããŠã¯ã¯ãã³ãæã€ãéå°æ¥çš®ãã
-
/3 2019幎9æãå¿åæ²ç€ºæ¿4chanã®æçš¿è ããæ°åã³ãããŠã€ã«ã¹ææçã®ãã³ãããã¯ãšèŽæ»æ§ã®ã¯ã¯ãã³ã«ã€ããŠäžæ°å³ã«æ£ç¢ºãªäºæž¬ãè¡ã£ãã
- ãã®æçš¿è ã¯ã2020幎ãã2021幎ã«ãããŠã¢ã¡ãªã«ã§900ïœ1000äžäººãæ»äº¡ãããšè¿°ã¹ã2020幎å¬ã«çºå£²ãããã¯ã¯ãã³ãçµ¶å¯Ÿã«æ¥çš®ããªãããèŠåããã
- ã¯ã¯ãã³ãé«éœ¢è ãä¹³å ã«èŽåœçãªåœ±é¿ãäžããå¯èœæ§ãããäžæ¹ãã¡ãã£ã¢ã¯ãŠã€ã«ã¹èªäœãé床ã«å±éºèŠããå ±éããããšäž»åŒµãæçš¿è ã¯ã¯ã¯ãã³ãå®éã®å±éºèŠå ã«ãªããšæèšããŠããã
-
/4 RFKæ°ã蚎èšã®è è¿«ãåãããã¡ãŠãå士ããçŸåšç±³åœã§åäŸã«çŸ©åä»ããããŠãã72çš®é¡ã®ã¯ã¯ãã³ã®ããããå®å šæ§è©ŠéšãåããŠããªãããšãèªããããåŸãªãã£ãçµç·¯ãèªãã
-
/6 ãã©ã³ã倧統é ã¯ãã®ç¹ã§ã¯æ®å¿ã ã
- ãã¡ã€ã¶ãŒãä»ã®å€§æè£œè¬äŒç€Ÿã®å¹¹éšãã¯ãèªåãã¡ã®æªåŸ³ãªå©çã®ããã«æé¡ããããŒæŽ»åããããã«ããŒã«ã»ã¢ã»ã©ãŽã«ãã£ãŠæ¥ãã
- ãããŠãã©ã³ãã¯ã圌ããåãåºããåãäºå®ç¢ºèªããããã«RFKãäŒè°ã«é£ããŠããã 倧æè£œè¬äŒç€Ÿã®å°æšªã®æä»£ã¯çµãããè¿ãã€ã€ããã
-
/7 NYPãé£éŠå€äºã¯ãå ¬éèšé²èšŽèšãçµããããããè£å€æã説åŸã§ããªãã£ããããç±³åœé£åå»è¬åå±ã«COVID-19ã¯ã¯ãã³ã®æ¿èªã®æ ¹æ ãšãªããããªãæ å ±ãå ¬éããããåœããã
-
/7 è£å€æã¯ãFDA ã«å¯Ÿãããã¡ã€ã¶ãŒ C19 泚å°å€ã®è©Šéšææžãããã«ã100 äžããŒãžãæåºããããåœãããã統治è ã®ååŒãé èœãããŠããéã人æ°ã®èªç±ã¯å®å šã§ã¯ãããŸãããã
-
/8 RFKãžã¥ãã¢ã¯ããã©ã³ã倧統é ã®2æç®ã®åæ¥ã«ã倧æè£œè¬äŒç€Ÿãšã®æŠããéå§ããããã«åœå®¶éåžžäºæ 宣èšã«çœ²åãããšçºè¡šããã
-
/9 ããªãã§ãã®åãæ¥ã«æ»ããããã®ïŒããã¹ãã»ã©ãŒãç§ãã¡ã¯å£²ããããªãïŒãã®èµ·ç¹ãšãªã£ãã³ããã¯ã¯ãã³è¢«å®³è ã®ç¶ãåçœ
-
/9 å éšåçºè ãããã¡ã€ã¶ãŒã®ã³ãã¯ã¯çºå£²ãã2ãæä»¥å ã®158,000ä»¶ãè¶ ããæ·±å»ãªå¯äœçšã®å ±åã瀺ãå éšææžãå ¬éãFDAã¯ããã75幎éé èœããããšããŠããã
-
/9 ãã©ã³ãã¯2012幎以æ¥ã倧æè£œè¬äŒç€ŸãšæŠäºãããŠãããã¯ã¯ãã³ãåäŸã®èªéçãå©é·ããŠãããšå ¬ç¶ãšéé£ãFox Newsã§ã¯ãããäŒæç ãšããåŒãã ã
ãããã12幎ãçµã¡ã倧統é ã¯ããã«äžæ©é²ãã§ãRFKæ°ããå°å çšã¯ã¯ãã³ãšèªéçãšã®æœåšçãªé¢é£æ§ã«é¢ãã調æ»ã®è²¬ä»»è ã«ä»»åœããã -
/11 ãã€ãã³ã¯åœæ°ãå®ãã®ã§ã¯ãªãã¯ã¯ãã³è£œé æ¥è ãå®ãããšã«èºèµ·ã«ãªã£ãŠããã
ãã©ã³ãæ°ã¯RFKæ°ãã¯ã¯ãã³ã«ã€ããŠèª¿æ»ããã ãããšè¿°ã¹ããã§ã¯ããã€ãã³ã¯ããã«å¯ŸããŠäœãããã®ãïŒ- ãã€ãã³ã¯æ¿æš©ã«è¿ éã«è¡åãèµ·ããããCOVID-19 ã®ãç·æ¥äºæ 宣èšããå»¶é·ãããã
- ãã®PREP ACTã¯ãèŽæ»çãªmRNA COVIDã¯ã¯ãã³ã«å¯Ÿããè³ å責任ä¿è·ã2029幎ãŸã§å»¶é·ã
- ããã«ããã倧æè£œè¬äŒç€Ÿã¯ã¯ã¯ãã³ã«ããããããå¯äœçšã«å¯Ÿãã責任ãå ããããšã«ã
-
/12 TIMEããã©ã³ãæ°ãå°å ã¯ã¯ãã³æ¥çš®ãå±éºãŸãã¯æçã§ãªããšå€æããå Žåãäžéšã®ã¯ã¯ãã³æ¥çš®ã廿¢ããããšãæ€èšãããã
-
/13 ãã©ã³ã次æç±³å€§çµ±é ãåçé·å®ãšããŠæåããRFKæ°ã®åŽè¿ã®åŒè·å£«ãFDAã«å¯ŸããŠããªãªïŒå°å ãŸã²ïŒã¯ã¯ãã³ã®æ¿èªåãæ¶ãã®ç³ãç«ãŠãããŠããããšãæããã«ãªã£ãã
-
/13 æ°ããªå ±éã«ãããšã倧æè£œè¬äŒç€Ÿã¯è²æ©ããHHSé·å®åè£ã®RFKãžã¥ãã¢æ°ã«å察ãããããŒæŽ»åã¯è¡ããªããšããã
-
/13 ã¹ã€ã¹ã®å»åž«ããã®æ¹å€RNAã«ãã倧éèæ®ºã¯äººé¡å²äžæå€§ã®å»çç¯çœªã§ãããèŠåïŒãã¹ãŠã®ã¯ã¯ãã³ã¯ä»ãmRNAãã¹ã¯ã¯ãã³ã§ãã...
-
/13 ãã¡ã€ã¶ãŒç€Ÿã®é ãããå ±åæžã«ãããšãã¯ã¯ãã³æ¥çš®è ã¯æªæ¥çš®è ã«æ¯ã¹ãå¿èé¢é£ã®å¥åº·ãªã¹ã¯ãå¢å ããŠããããšã倿
- æ¥æ§å¿è¡ç®¡é害ïŒãªã¹ã¯23%å¢ïŒæéãšãšãã«æ¡å€§ïŒãäžæŽèïŒãªã¹ã¯27%å¢ãå¿äžå šïŒãªã¹ã¯2%å¢ïŒçµ±èšçæææ§ã¯äžæïŒã
- ã¹ãã¬ã¹æ§å¿ççïŒãªã¹ã¯30%å¢ãå åèçŸæ£ïŒãªã¹ã¯40%å¢ïŒæéãšãšãã«å¢å ïŒãå¿ççïŒ21æ¥ä»¥å ã«ãªã¹ã¯130%å¢ã
-
/16 æ°åã³ããã¯ã¯ãã³è¢«å®³è éºæãååŽçåã§è¡å®£ãããïŒåºŠãšãã®ãããªæ²ãã¿ãèµ·ããããªãã§ã
-
/22 ãã¡ã€ã¶ãŒãšã¢ãã«ãã®COVID-19 mRNAã¯ã¯ãã³ãã¿ãŒãã¬ã³ãåŒãèµ·ãããããã5: ãªã³ãè «ãè³ãä¹³æ¿ãçµè žãèº
ç§ã¯2幎éãã®ããšã«ã€ããŠèŠåããŠããŸãããCOVID-19 mRNAã¯ã¯ãã³ã¯åžå Žããæ€å»ãããmRNA/LNPæè¡ã¯çŠæ¢ãããªããã°ãªããŸããã -
/22 RFKãCIAãšãã«ã»ã²ã€ãã¯ã©ããã£ãŠ"ã³ãã"ã«ã€ããŠäºåã«ç¥ã£ãã®ãïŒã
- ããã«ã»ã²ã€ãã¯NYåžã§ã³ãããŠã€ã«ã¹ã®ãã³ãããã¯ã»ã·ãã¥ã¬ãŒã·ã§ã³ãäž»å¬ããŠããã
- 圌ã®å ±åäž»å¬è ã¯CIAå¯é·å®ã®ãã€ã³ãºã§ããCIAã¯å ¬è¡è¡çãã©ãŒã©ã ã§äœãããŠããã®ã§ããããâŠïŒã
-
/22 ãããã»ãã ããŒã¯é³¥ã€ã³ãã«ãšã³ã¶ãã³ããã®ãã³ãããã¯ããèµ·ããããšãã©ããã£ãŠç¥ã£ãã®ãïŒãŠã¯ã©ã€ããã€ãªã©ãã«æè³ããããïŒ
-
/23 ãã©ã³ãæ°ãRFKã«ã€ããŠã25幎åãèªéçã¯1/1äžäººã®å²åã§ãããçŸåšã§ã¯ã1/36ã§ãããããŒããšç§ã¯ããã®è§£æ±ºçãèŠã€ãåºãã€ããã§ããã
-
/23 DNAãæ¹å€ïŒ - ã³ããã¯ã¯ãã³ã§äœãããããªããšãèµ·ãã£ãŠãããç§åŠè ãã¡ã¯ã¯ã¯ãã³æ¥çš®ããäœå¹Žãçµã£ãŠãããè¡æ¶²äžã«ã¹ãã€ã¯ã¿ã³ãã¯è³ªãçºèŠããã
-
/24 ã©ã³ãã»ããŒã«äžé¢è°å¡ããã¡ãŠãå士ãååæã«éãããèŠæ±ãç§ãã¡ã®äžéšãæã€åã¯ããã¡ãŠãå士ãååæã«å ¥ãããªã©ãè¯ãããšã«äœ¿ãããªããã°ãªããŸãããã
-
/25 ã¬ããªã³ã³ã¯ã¯ãã³ãçç©å µåšãŸãããææ²»ç³»è£œè¬äŒç€Ÿãç«æ°ã»å壿°ã25æ¥æèšŽãž
-
/25 Meiji Seikaãã¡ã«ãããåå£äžåè°å¡ããåèªæ£æã«åºã¥ãæå®³è³ åè«æ±ãã§æèšŽã
-
/26 MeijiSeikaãã¡ã«ãã®èšè äŒèŠããã£ã12/25ã«ææ²»ããŒã«ãã£ã³ã°ã¹ã®æ ªäŸ¡ãå¹Žåæ¥ã®æå®å€ 3,108åãèšé²ã
-
/27 ä»ãããã¡ãŠãå士ã鮿ãããCDCã¯çŸåšãã¯ã¯ãã³ãæ¥çš®ããâŠã¯ã¯ãã³ãæ¥çš®ããâŠåŸã«è³åäžãèµ·ããã人ã ã®çäŸãååã«ãããšèšã£ãŠããâŠã
-
/29 æ°ããªç ç©¶ã«ãããmRNAã³ããã¯ã¯ãã³ãæ¥çš®ããã¢ã¡ãªã«ã®åäŸãã¡ã®æ»äº¡çãé©ãã»ã©æ¥å¢ããŠããããšãæããã«ãªã£ãã
ã¯ã¯ãã³æ¥çš®ãåããåäŸãå代ã®è¥è ã¯ãã¯ã¯ãã³æ¥çš®ãåããŠããªãå幎代ã®è¥è ã«æ¯ã¹ãŠæ»äº¡ããå¯èœæ§ã500%ãé«ãã -
ç²ç°æ æ± ç°åµäŸ¡åŠäŒ 代衚çäº
- /14 åœäŒã¯mNRAã¯ã¯ãã³ã®äžæ¢ãåã³ãWHOæ©ææ€éãæèšããããŸããåœæ°ã®çæ§ãæ¯æã®çšãããããé¡ãç³ãäžããŸããð
- /23 å»åŠãšå«çã¯ã»ããã§åŠã¶ã¹ãã§ããã人ãå¥åº·çãªç掻ãéããèš³ãç¡ãïŒè§£åç ä¿®ã®ç®äœåçã®ä»¶ã§ïŒã
- /25 æªå ã¯ãã®ããã«èªãå¢ç©Žãæãã®ã§ããåå£äžåè°å¡ã«åãŠãèš³ãç¡ããåå£å çãå ã ãšåã£ãŠäžããïŒ
-
以åããã«ã¶ãã¹ã¿ã³ãªã©ã§ã
ãç±³åœãšææºããŠæ°èšããBSL-2 BSL-3ã®åœå®¶ãã€ãªã»ã©ãã®æšé²ã
ã«äžé²ããçåèŠãã声ãäžãã£ãŠããã -
2022/3ïŒéæŠçŽåŸïŒ
- ãŠã¯ã©ã€ãã§ããã·ã¢ã«ãããã€ãªã»ã©ããçºèŠããã
- äžé²ã足䞊ã¿ãæããŠãã€ãªã»ã©ãåé¡ã®è¿œæ±ãå§ããã
- ãã¯ããªã¢ã»ããŒã©ã³ãããã€ãªã»ã©ãã®ååšãèªãããïŒããŒã¿åæäŸ - å®é²æŠäºã®è©²åœç¯ãåç §ïŒ
-
ãã®åŸããã³ã¿ãŽã³ã®é¢äžããã¢ããªã«ãŸã§ã®åºããã倿ããã
- /24 ç±³åœã®ãã€ãªç ç©¶æã§ã¯ãç åäœã®æ©èœåŒ·åã«é¢ããäœæ¥ãæç¢ºãªç®¡çãªãã«è¡ãããŠããã
- /24 ãã·ã¢åœé²çããã€ãªç ç©¶ã®ç¬¬äžåœãžã®ç§»è»¢ã«ãããç±³åœã¯ãã®è²¬ä»»ãåãããã«æžãã
- /24 ç±³åœé²ç·çã¯ãã€ãªãããžã§ã¯ãããŠã¯ã©ã€ãããäžå€®ã¢ãžã¢ã»æ±æ¬§ã«ã·ãã
- /31 2019幎以æ¥ãã¢ã¡ãªã«ã®å°éå®¶ã¯HIVææã«é¢é£ãããŠã¯ã©ã€ãã®é åã§å®éšãæšçã°ã«ãŒãã®1ã€ã¯è»éã
- /1 ãã·ã¢å€§äœ¿ãç±³åœã¯ãŠã¯ã©ã€ãã®ãã€ãªç ç©¶æã«é¢ããçºèšã§ççŸ
- /11 ãã·ã¢åœé²çãç±³åœã®çç©åŠçããã°ã©ã ã«é¢äžãããŠã¯ã©ã€ã人ã®ååãæããã
- /14 ãã·ã¢é£éŠè°äŒãååœè°äŒã«ç±³åœã®è»äºçç©æŽ»åãæ¿æ²»çè©äŸ¡ããèæ¡ãäžé¢ã«æåº
- /26 ç±³ãšãã«ã®ãŒçãæ°åã³ããã¯å®éšå®€ã®æŒæŽ©ããçºçããå¯èœæ§ãé«ããšçµè«ïŒWSJ
- /26 é»éºå€¢ïŒLi-Meng YanïŒãæ°åã³ããã¯æŠæŒ¢ããã®æŒæŽ©ãšã®äž»åŒµãå§ããã
-
/4 ããŒãã³ãCSTOã®ãã€ãªã»ãã¥ãªãã£ååã«é¢ããè°å®æžãäžé¢ã«æåºãæ¹åãæ±ãã
-
/10 ç±³åœäžé¢ã¯æ°ã³ãã®ãã³ãããã¯ãšãŠã€ã«ã¹æŒæŽ©çæã®ããäžåœã®ç ç©¶æã«é¢ããæ å ±ã®æ©å¯è§£é€ãå šäŒäžèŽã§å¯æ±º
-
/10 ãã·ã¢åœé²çãã¢ã¡ãªã«ã®çç©åŠçããã°ã©ã ã«é¢äžãããŠã¯ã©ã€ã人ã®ååãæããã
-
/15 ãããŒã F. ã±ãã㣠Jr.ããã¡ãŠãã¯2002幎ãããã³ã¿ãŽã³ã®ããã«çç©å µåšã®éçºãæ åœããŠããã
-
/15 ãã¡ãŠãå士ãäžåœã®COVIDã®ç ç©¶éçºãšãããã¬ã³ãã«çŽæ¥ãã€å€å€§ãªè²¢ç®ãããããšã瀺ãè¡æçãªèšŒæ
-
/20 ãã€ãã³ãã³ããäžåœèµ·æºèª¬ã«é¢ããææžã®æ©å¯å ¬éæ³æ¡ã«çœ²å
-
/20 ãã·ã¢å€åçã¯ãã¢ããªã«ã«ããç±³åœã®çç©ç ç©¶æã倧éžã«è åšãäžããŠãããšçºè¡š
-
/22 ç±³åœè°äŒå§å¡äŒã¯ãŠã¯ã©ã€ãã®çç©ç ç©¶æã«é¢ããæçµäŒè°ãéå¬
-
/29 ãã¥ãŒããªãŒãæ§ãœé£å ±ååœãããã³å€ãã® SCO å çåœãçç©å µåšã®å®éšå Žã®èŠéã«å ¥ã£ãŠãã - TASS
- /7 ãã·ã¢åœé²çããŠã¯ã©ã€ãã«ãããç±³è»ã®çç©åŠçããã°ã©ã ã®åå è ã®æ°ããååãçºè¡š
- /7 ãã·ã¢åœé²çãç±³åœããŠã¯ã©ã€ãã§ãã€ãªã©ãã®å»ºèšãåé
- /11 ãŠã¯ã©ã€ãã«ããç±³åœã®ãã€ãªã©ãã©ããªãŒã«é¢ããå§å¡äŒã®æçµå ±åæžãäžé¢ãæ¿èª
- /11 ãŽã©ããã£ã³äžé¢è°é·ãããŒã©ã³ãããã®å¿çããªãã®ã§ç±³åœå€§äœ¿ãæåŸ ããŠã¯ã©ã€ãã®çç©åŠç ç©¶æã«ã€ããŠè©±ãããã«æç€º
- /11 ç ç©¶æã§ã®é³¥ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹äºæ
ã¯ãå±éºãªæ©èœç²åŸç ç©¶ã®æ æ°ãªç£èŠã瀺ã
https://www.usatoday.com/story/opinion/2023/04/11/lab-leak-accident-h-5-n-1-virus-avian-flu-experiment/11354399002/ - /11 ç±³åœåœå€ã®åœé²ç·çã®ãã€ãªã©ãã«ã€ããŠè§£ã£ãŠããããš https://tass.ru/info/17495041
- /17 ç±³åœã®ãã€ãªã©ãã«é¢ãããã·ã¢ã®èª¿æ»ãçµäº - BRICSæ å ±ããŒã¿ã« http://infobrics.org/post/38196/
- /19 å CDCé·å®ããã¡ãŠãã¯æŠæŒ¢ç ç©¶æã®æ©èœç²åŸç ç©¶ãžã®è³éæäŸã§åãã€ãããå åœå®¶æ å ±é·å®ã¯åæã
- /25 åœé²ç·çã¯ããŠã¯ã©ã€ãã® 46 ã®ãå¹³åãªçç©åŠç ç©¶æãã«è³éãæäŸããããšãèªããŠããã
https://www.defense.gov/News/Releases/Release/Article/3057517/fact-sheet-on-wmd-threat-reduction-efforts-with-ukraine-russia-and-other-former/ - /27 ãã«ãšåŒãæãã«ç«ç
ãç±³åœã®ãçç©å
µåšã®éçºã»å®éšãžã®ååããšãé·æããŒã³ã§ééçã«äŸåã
https://anna-news.info/epidemii-v-obmen-na-dollary/ - /30 ã©ã³ãã»ããŒã«ãç±³åœã¯å®éã«äžåœæŠæŒ¢ã®ã³ãããŠã€ã«ã¹ç ç©¶ã«è³éãæäŸããã®ã§ããããïŒ
ãµãã³ãµã»ãã¯ãŒãºç±³åœééçºåºïŒUSAIDïŒé·å®ãæã ã¯æ©èœæ¡åŒµå®éšã«ã¯è³éãæäŸããŸããã§ããã
- /7 åœé²ç·çã2018幎ãççœèãšãšãã©åºè¡ç±ãç±³éžè»ææçå»åŠç ç©¶æïŒã¡ãªãŒã©ã³ãå·ãã©ãŒãã»ãããªãã¯ïŒããæŒæŽ©ããäºãèªããã
- /31 å äžåœCDCãããã®é«çŠæ°ãBBCã€ã³ã¿ãã¥ãŒã§ç ç©¶ææŒãã説åŠå®ãããå šãŠãçãã®ãç§åŠã ãäœäºãæé€ãã¹ãã§ã¯ãªãã
-
/6 ãããŒã F. ã±ãã㣠Jr.ããŠã¯ã©ã€ãã«ç±³åœã®çç©ç ç©¶æãååšããããšãèªãã
-
/7 The DisInformation Chronicleãã¢ãã©ã³ãã£ãã¯ãCNNãã人皮差å¥ããçç±ã«æŠæŒ¢ç ç©¶æäºæ ã®å¯èœæ§å ±éçŠæ¢ãæŽé²
-
/14 ãããã»ã¿ã€ãããã€ã±ã«ã»ã·ã§ã¬ã³ããŒã¬ãŒã®PublicããCOVID-19ã§æåã«ç æ°ã«ãªã£ãã®ã¯ã
ãŠã€ã«ã¹ãäœã£ã "æ©èœç²åŸ "ç ç©¶ãç£ç£ããŠããäžåœäººç§åŠè ã ã£ãããšãã倧äœãçºè¡š -
/14 ãã€ã±ã«ã»ã·ã§ã¬ã³ããŒã¬ãŒãæåã«æ°åã³ãããŠã€ã«ã¹ææçã«çœ¹æ£ããã®ã¯æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã®äžåœäººç§åŠè ã ã£ããš
ç±³åœæ¿åºé¢ä¿è ãçºè¡šã3人ã®ç§åŠè ã¯ãç æ°ã«ãªã£ããšããSARSã®ãããªã³ãããŠã€ã«ã¹ã®ãæ©èœç²åŸãç ç©¶ã«åŸäºããŠãã -
/16 ç±³åœå®¶æ å ±é·å®ãæ³çã«çŸ©åã§ãæ¥ææ¥ãŸã§ã«ãã¹ãŠã®æ°åã³ãããŠã€ã«ã¹ææçã®èµ·æºã«é¢ããæ å ±ãæ©å¯è§£é€ãå ¬è¡šããã
-
/20 ãŠã€ã«ã¹å°éå®¶ãWHOã¯æ°åã³ãããŠã€ã«ã¹ã®å·åé£åèµ·æºèª¬ãèåŸã«çœ®ããç ç©¶ææŒæŽ©èª¬ãåŽäžãã¹ãã§ã¯ãªãã£ããšèªããã
-
/25 ç±³åœã¯ãæ°åã³ãããŠã€ã«ã¹ã®èµ·æºã«é¢ããæ©å¯è§£é€ãããå ±åæžãçºè¡šãhttps://t.co/sOfsHtR9ty
-
/28 ANIãæŠæŒ¢ãŠã€ã«ã¹åŠç ç©¶æã®ç ç©¶è ã¯ãäžåœãæå³çã«COVIDã "çç©å µåš "ãšããŠè£œé ã瀺å - Insider Paper
-
/28 ããŒã¿ãŒã»ããŽã¡ããããªã³ã±ã³ã¯ç±³äžé¢ä¿ã®åæ»åãšåŒãæãã«æŠæŒ¢ç ç©¶æã®åœ¹å²ãé èœããå¯çŽã亀ãããã®ã ãããïŒ
-
/11 ç±³åœåœé²ç·çã2019幎ã«ãŠã¯ã©ã€ãã§ãæ°åã³ãããŠã€ã«ã¹ç ç©¶ãã®å¥çŽãç· çµ
-
/11 è¯åæ°ææå°æ¹Ÿçãç±³åœã¯å°æ¹Ÿã«å¯ŸãæŠéãŠã€ã«ã¹ãäœæããããã®BSL-4ã®çç©åŠç ç©¶æã®å»ºèšãèŠæ±
- 2022/6/23-2023/1/9ãã³ãŒãããŒã ãåã·ãæµ·äŒè°ããšåŒã°ãã2åã®ç§å¯äŒè°ã§
- ã¢ã¡ãªã«åŽã¯ããããã¹ãããããã«å°éå®¶ãæŽŸé£ãããšçŽæãããšèšãã
- å°æ¹Ÿæ¿åºé£åã¯è¡è±ææ°ã¯ãã®ãããžã§ã¯ããç¹å¥ã«éèŠããŠãããšä»ãå ããã
-
/11 ãããŒã F. ã±ãã㣠Jr.ãæŠæŒ¢æ°åã³ãããŠã€ã«ã¹æŒæŽ©ç ç©¶æãžCIAãUSAIDãéããŠè³éæäŸããŠããã
-
/11 ç±³äžé¢ç£èŠå§å¡äŒã»ã³ããç¹å¥å°å§å¡äŒããã©ããã»ãŠã§ã³ã¹ãã©ããå§å¡é·ïŒå ±åå ããªãã€ãªå·éžåºïŒ
- æªåé«ããThe proximal origin of SARS-CoV-2ãåºçç©ã®èµ·èãåºçãæ¹å€çãªåãæ¢ããéããŠã\
- ç±³åœã®äž»èŠãªå ¬è¡è¡çåœå±è ãå®éšå®€ãªãŒã¯ä»®èª¬ãæå§ããå æ¬ç調æ»ã®è©³çްãèšããäžéã¹ã¿ããå ±åæžãçºè¡š
- ç±³åœä¿å¥ç€ŸäŒçŠç¥çããã·ã§ã«ã»ãŠã©ã¬ã³ã¹ããŒCDCæé·ã2023/6/13ã®å ¬ç蚌èšã«æçµçã«åæããããšã確èª
-
/12 äžé¢å ±åå ã誀ã£ãŠæ°åã³ãããŠã€ã«ã¹é¢é£ææžãå ¬é
- æ°ããææžã§ã¯
- ãThe proximal origin of SARS-CoV-2ãè«æãèµ·èããäžã§ã
- ç 究宀ããã®æŒæŽ©ã®å¯èœæ§ãéåžžã«é«ãããšè«æãšå察ã®äž»åŒµãè¿°ã¹ãŠããã
- è«æã¯ç§åŠçåæã®ããšã§ãŠã€ã«ã¹ãäžåœçé®®åžå Žã§èªç¶çºçãããšèšãäžè¬å°è±¡ãäœãåºãäž»å°çãªåœ¹å²ãæãããã
- æ°ãã«å ¬éãããææžã«ã¯ãã¬ããŒãçšã«åãåãããå®å šãªé»åã¡ãŒã«ãšSlackãã£ããã®ããŒãžãå«ãŸããŠããã
- æ°ããææžã§ã¯
-
/16 ã±ãã㣠Jr.ããŠã¯ã©ã€ãã®ãã€ãªã©ãããæ°æãæšçãšããçç©å µåšãã補é ããããã«ããã·ã¢ã®DNAãåéãããŠããã
-
/18 ãã·ã¢åœé²çããŠã¯ã©ã€ããšäžçã«ãããç±³è»ã®ç ç©¶ã¯ã人工çã«å¶åŸ¡ãããäŒæç ã®çºçãç®çãšããŠããã
-
/18 ãã·ã¢åœé²çãç±³åœã®ãã€ãªã©ãããžãããã¬ãŒãããšãžããã§ç¹ã«å±éºãªææçã«ã€ããŠç ç©¶ãè¡ã£ãŠããã
-
/19 äžçã¯ç±³åœã®ãã€ãªã©ãã«ããæ°ããªãã³ãããã¯ã«çŽé¢ããŠãã
- 10幎åã«æªç¥ã®ãŠã€ã«ã¹ãããŒãã«ãã倿°ã®æ ç»ããã¬ã ã·ãªãŒãºã®èæ¬ãçŸå®ã«ãªã£ãå ¬éãããã
- ææçã®ç åäœãåéããçŸå°äœæ°ã®çºççãç¹å®ãããããžã§ã¯ãã¯1950幎代åŸåã«ç±³æµ·è»ãäž»å°ããŠå§ãŸã£ãã
- ãã®æ ç¹ã¯2019幎ã«ã€ã¿ãªã¢ã«ç§»è»¢ãããã°ããã ãããã®æ¯åºã¯ä»ã§ããšãžãããã¬ãŒãããžããããã®ä»ã«æ®ã£ãŠããã
-
/19 ãã·ã¢ããã«ã»ã²ã€ããšãã³ã¿ãŒãçããã¡ã¿ãã€ãªãŒã¿ãéå¶ãã
ç±³åœãã€ãªã©ãã®æ å ±ãåœåçãšå€§è¥¿æŽçäºäŒãæ€é²ããŠãããšäž»åŒµ- çç©å µåšçŠæ¢æ¡çŽã«ãã£ãŠç®¡çãããŠããªã人çºçã«ç®¡çãããäŒæç ã®åœ¢æãç®çãšããŠããã
- 倧æè£œè¬äŒç€Ÿã®å©çã®ããç±³è»ãå©çšããŠå°å äœæ°ã§æªç»é²ã®å»è¬åã詊éšãåŸã«èŠå¶åœå±ã«æ¿èªãããŠããã
-
/19 Bloombergãç±³WHãæŠæŒ¢ç ç©¶æã®é£éŠè³éãžã®ã¢ã¯ã»ã¹åæ¢ïŒæ°åã³ãã調æ»ã«å¿ãã
-
/19 Zerohedgeããã€ãã³æ¿æš©ãå®å šæ§ãšã»ãã¥ãªãã£å¯Ÿçã«é¢ããææžãæåºããªãã£ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æãžã®é£éŠè³éãžã®ã¢ã¯ã»ã¹ã忢ã
-
/20 ã©ã³ãã»ããŒã«ãé£éŠè°äŒãžã®åœèšŒçœªã§ãã¡ãŠãæ°ãåžæ³çã«éæ€ã
-
/21 Matt TaibbiããCOVIDã®èµ·æºããšãä¿¡é Œã®æ»ããproximal originææžãäœã瀺ãããªãæŽå²çãªã®ãïŒ
-
/22 ãã¡ãŠãå士ã宣èªèåœã®çœªã§èµ·èšŽå§åããç¿æ¥ãã©ã³ãã»ããŒã«äžé¢è°å¡ã®ã±ã³ã¿ãããŒå·äºåæãçäž
-
/27 ããªã¢ã³ãã»ããã·å士ãå»åŠéèªã¯æ»ãã ã®ãïŒãäœå幎ãå»åŠéèªãæ©ãŸããŠããåé¡ã«ã¯ã
æ»èªã®å€±æã è€è£œã®å±æ©ããŽãŒã¹ãã©ã€ ãã£ã³ã°ã 倧æè£œè¬äŒç€Ÿã®åœ±é¿ãªã©ãå«ãŸããŸãã -
/30 ã¢ã³ãœããŒã»ãã¡ãŠãã®å äžåžãšã¯ãŒãã»ã¹ããŒãäœæŠã®è²¬ä»»è ãCOVID-19ã®èµ·æºãšé èœãæŽé²ãããšã®å ±é
-
/30 ã©ã³ãã»ããŒã«ãåžæ³çã«æ£åŒãªåäºåçºç¶ãéã£ãçç±ã¯ããã¡ãŠããNIHãæŠæŒ¢ã«è³éæäŸããããšãåŠå®ããããã
- /9 DailyMailãäžåœãæ¯æŽããã«ãªãã©ã«ãã¢ã®ãã€ãªã©ãããéæ³ãªæ°åã³ãããŠã€ã«ã¹æ€æ»ãè¡ãããã«ç±³åœæ¿åºãã15äžãã«è¿ããåãåã£ã
- /15 ã±ãã㣠Jr.ããŠã¯ã©ã€ãã®ç±³åœãã€ãªã©ãã«ã€ããŠã³ã¡ã³ããåœé²ç·çã¯çç©å µåšã®ç ç©¶ã«ä»åœãå©çšãããšã¿ãã«ãŒã»ã«ãŒã«ãœã³ã«èªã£ã
- /18 åœç«ææçç ç©¶æãããã¹èãæ±ãè·å¡ãè žããã¹ãçºçãããšçºè¡šãç ç©¶ã§ææãããã©ããäžæã§ä¿å¥æãçµè·¯ã調æ»äžã
- /25 LPRã®Farmbiotestç ç©¶æã§èŠã€ãã£ãææžãããŠã¯ã©ã€ããäŒæ¥ã«ãã³ãã¹ã®è²§ããäœæ°ãå©çšãæ°ã³ãæ²»éšã宿œãããŠããäºãæããã«ã
- /1 ã¡ãããŒãžã§ãããäžçã§ã¯èªç¶ç±æ¥ã§ãªã人工起æºã®æ°ããªãŠã€ã«ã¹ãåºçŸããå¯èœæ§ããããïŒ31æ¥ã®å€§çµ±é ç§åŠæè²è©è°äŒå¹¹éšäŒè°ã®åé ã§ïŒ
- /5 ãã¡ãŠãæ°ã¯2020幎1æãŸã§ã«æŠæŒ¢ç ç©¶æã®æ°åã³ãããŠã€ã«ã¹ãšNIHã®é¢ä¿ãç¥ããããŠãã
- /6 ãã·ã¢åœé²çããŠã¯ã©ã€ãã¯ç±³åœã®ãã€ãªã»ãã¥ãªãã£èšç»ã«ãããŠç¹å¥ãªäœçœ®ãå ããŠããã
- /12 å éšåçºè ãCIAãæ°åã³ãããŠã€ã«ã¹èµ·æºç ç©¶æã®æŒæŽ©èª¬ã人ç£å ±éææçã«å€ããããã¢ããªã¹ãã«è³è³ãèŽã£ãçãã§åçº
- /27 ç¹å¥å°å§å¡äŒãåéããæ å ±ã«ããã°ãCIAã¯COVIDã®èµ·æºèª¿æ»ã«"圱é¿ãäžãã"ããã«ãã¡ãŠãå士ãCIAæ¬éšã«å¯ãã«ä»ãæ·»ãããã
- /27 ãã¡ãŠãæ°ãšCIAïŒæ°ããªèª¬ãæµ®äžããã¡ãŠãã¯ãã£ãšCIAäž»å°ã®æ å ±ã³ãã¥ããã£ã«ããããã£ãšæ·±ãé¢å¿ãšåªå äºé ã®ããã³ããã³ãšããŠåœ¹å²ãæŒããŠããã
- /29 åœç«ææçç ç©¶æã7æã«è·å¡ãè žããã¹ãçºçããåé¡ãå·¡ããå®éšå®€å ã§ããã¹èã«ææãšçµè«ã¥ããå ±åæžãå ¬è¡šãè·å¡ã¯ããã©ã³ã§æ¥µããŠæ·±å»ãšææã
-
/2 åœé£çç©å µåšå§å¡äŒã®å ã¡ã³ããŒã§ããã€ãŒãŽãªã»ãã¯ãªã³æ°,ãæçç©è³ªèæ§ãæã€ãŠã¯ã©ã€ãè»ã®ææçã¯ããŠã¯ã©ã€ãã®ç±³è»çç©åŠå®éšã®å¯èœæ§ã
-
/2 ãã·ã¢åœé²çã¯ãç±³åœãšãŠã¯ã©ã€ãã®è»äºçç©æŽ»åã®äž»å¬è ã®ãªã¹ãã«è¿œå ãããããã·ã¢åœé²çã®ä»£è¡šè ã«ãããšããã®ãªã¹ãã«ã¯ç¹ã«ä»¥äžã®äººç©ãå«ãŸããŠããã
- ããŒãã¹ã»ãŽã©ãŒã«æ°ããŠã¯ã©ã€ãã®ãã©ãã¯&ãŽã£ããã®å¯ç€Ÿé·å Œå ¬åŒä»£è¡šè ãçç©å€ãšç©è³ªã®ç®¡çãšç£èŠã
- ã±ãã³ã»ãªãªãã«æ°ãå¥çŽå£äœãšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã®ç ç©¶æ åœå¯ç€Ÿé·ãã³ãŠã¢ãªãåªä»ãã人ç£å ±éææçã«é¢ããç±³è»ãããžã§ã¯ãã«çŽæ¥é¢äžã
- ããã€ã«ã»ãŠãµãã£æ°ããŠã¯ã©ã€ãå ¬è¡è¡çæ¿çç ç©¶æãšã°ãŒã¯ãã£ãã»ãã£ã¬ã¯ã¿ãŒããªãããµã®ã¡ããã³ãã»ãŠã¯ã©ã€ãç«ç 察çç ç©¶æã§ç±³åœãšã®ç åäœå ±åç ç©¶ãç£ç£ã
- ã¿ãã¢ãã»ããªã€ãŸã¯æ°ããŠã¯ã©ã€ãå ¬è¡è¡çæ¿çç ç©¶ææé·ããªãããµã®ã¡ããã³ãã»ãŠã¯ã©ã€ãç«ç 察çç ç©¶æã§ç±³åœãšã®ç åäœå ±åç ç©¶ãç£ç£ã
-
/18 ãã·ã¢å€åçã®äžæ¡æ£ã»è»å管çå±ã®å¯å±é·ã
- ãã³ã¿ãŽã³ã®æ¯æŽã§ãŠã¯ã©ã€ãã¯ãã·ã¢é è¿ãã§çç©å µåšãéçºã
- ãçç±ã®ãã質åãã¯ãã¹ãŠé©åãªåçãåŸãŠããããæªè§£æ±ºã®ãŸãŸãã
- /15 ãã ã»ã¬ã³ãåŒè·å£«ãCIAãšåœé²ç·çãæ°åã³ãããŠã€ã«ã¹ææçã«æ·±ãé¢äžããŠããããããªã³å°è»ããã ã»ã¬ã³ãåŒè·å£«ã¯æ£ããã
- /16 äžåœææã®ç§å¯ã®éæ³ãã€ãªã©ããã«ãªãã©ã«ãã¢ã§ãHIVãããšãã©ããšã©ãã«ä»ããããç åäœãä¿ç®¡ããŠããã®ãçºèŠ â å ±é
- /21 æŠæŒ¢ç ç©¶ã«é¢ããç§å¯ã®èŠåã¯ãã³ãããã¯ä»¥åããååšããŠãã
- ç±³åœãè³éæäŸããäžåœã§ã®ç ç©¶ããããããããŸã§å ±éãããããšã®ãªãã£ãäžé£ã®èŠåãšè¡çªã¯ãé·å¹Žã®æ©æŠãæããã«ããŠããã
- æ¿åºç§åŠè ã®2ã€ã®ã°ã«ãŒããããªãã¡åœéååãåªå ããã°ã«ãŒããšãæå 端æè¡ãæªäººã®æã«æž¡ããããããªããšèããã°ã«ãŒã
- DOEåœå±è
ã¯ããã³ãããã¯ãå§ãŸããããæ°ã«æåã®2019幎åã°ã«ãæãå
·äœçãªèŠåãçºãããšãŽã¡ããã£ã»ãã§ã¢èªãæããã«ããã
- ãã³ã»ãã«ã€ã¬ãããšãã«ã®ãŒå¯é·å®ã¯ãç±³åœãWIVã§è³éæäŸãæ¯æŽããŠããã³ãããŠã€ã«ã¹ç ç©¶ãè»äºç®çã«æµçšãããå±éºæ§ããããšãã¡ãŠãæ°ã®äžçŽé¡§åã«èŠåããã
- ãã«ã€ãšããæ°ã¯ãæ©å¯æ±ãã®è åšè©äŸ¡ãšDOEã®ç§åŠè ãæèµ·ããæžå¿µã«åºã¥ããŠãNIAIDã«å¯Ÿãäžåœæ¿åºã®ç§åŠè ãšã®ååã«ã¯æ éã«ãªãããæ±ããã
- /28 NYPãå ãã©ã³ãæ¿æš©åœå±è ãäžåœãç§å¯è£ã«ã¯ã¯ãã³éçºã«åãçµã¿ãã³ãããã¯ãåŒãèµ·ãããå¯èœæ§ãããæŠæŒ¢ã®ç§åŠè ãæ®ºå®³ããå¯èœæ§ã¯ç¢ºãã«ãããã
- /11 ãã·ã¢è»ããžã¥ããŒãã®çç©æ¯çŽ å µåšçŠæ¢æ¡çŽïŒBTWCïŒ2023å¹Žç· çŽåœäŒè°ã«ãŠã¯ã©ã€ãã®ç±³åœãã€ãªã©ãã®æ°ããªè³ªåãæåºã
- /26 ä¿å®çãªããªããŒãžè²¡å£ã®Oversight ProjectããCOVID-19ã®åºèªã«é¢ãã調æ»èšé²ãæ±ããŠCIAãæèšŽããŠããããšãDaily Callerã®åæã§åãã£ãã
- /28 RFKãæ°ã³ããäžåœã®æŠæŒ¢ã®ç ç©¶æããæµåºããçç©å µåšã§ããããšã瀺ãå§åçãªèšŒæ ããããç§ã®æ°èãæŠæŒ¢é èœå·¥äœãã§è©³è¿°ããŠããŸãã
-
/1 æŠæŒ¢ã®é èœå·¥äœ: ãããŠæãããçç©å µåšã®è»æ¡ç«¶äº
-
ãããŒã»ã±ããã£ã®éèŠãªæ¬ã®æžè©ã
- æ°å¹Žåã«ãããŒã»ã±ããã£ããã®æ¬ã®å·çã«ã€ããŠè©±ãããšããç§ã¯åœŒã«ããªãã§ããïŒããšå°ããŸããã
- 圌ã¯ãçå®ãèšæ¶ã®ç©Žã«åããã€ã€ãããå°æ¥ã®ããã«äœãèµ·ãã£ãã®ãã«ã€ããŠã®æ£ç¢ºãªæŽå²çèšé²ãäœæããããšè¿°ã¹ãã
-
RFKã®ãæŠæŒ¢é èœå·¥äœããç¬¬äºæ¬¡å€§æŠåããã®æ¥æ¬ã®731éšéãéã玹ä»ã
- å®ã¯ä»åã®ãŠã€ã«ã¹çç©å µåšäºä»¶ã®ååã¯731éšéã«ããããšãæŽå²ããã©ã£ãŠè§£èª¬ã
- å»è ãã¢ã©ã«ãæšãŠãŠäººäœå®éšãšç£æ¥ã¬ãã«ã®çç©å µåšç ç©¶éçºã«å€§ã çã«åãçµãã ã®ãæ¥æ¬ã®731éšé
- æŠåŸç±³åœã¯é¢ä¿è ãå 責ããŠå€é¡ã®ã«ããæ¯æã£ãŠå®éšææãæã«ãããã®åŸã®ç±³åœã®çç©å µåšç ç©¶ç«ã¡äžãã®åºç€ã«ããŠãã£ãã
- ä»ã®ãã¡ãŠããæã®ç³äºåéã§ãããåŠäŒãããå°æ¬ãããŠãããè峿·±ãããšã«ãã€ãè»ã¯çç©å µåšã¯æ¡çšããªãã£ãã
-
-
/7 ãšãã¹ã¿ã€ã³ãšæ©èœç²åŸç ç©¶
- ãšãã¹ã¿ã€ã³ã¯ã人ç£å ±éææçã®ãŠã€ã«ã¹åŠè ã§ã¡ã¿ãã€ãªãŒã¿ã®åµèšè ã§ãããã€ãµã³ã»ãŠã«ãã®ç®¡çäžã«ãããŠãSARS-CoV-2ã®äœæãšå ¬è¡šã«é¢äžããŠããã
- ãã·ã¢ããŠã¯ã©ã€ãã§çç©å µåšã補é ãããšããŠåçºãã人ç©ã¯ããšãã¹ã¿ã€ã³ / ããã¯ã¹ãŠã§ã«ãã¯ãªã³ãã³ããã€ãã³ãã²ã€ããšééçã«çµã³ã€ããŠããã
-
/9 ãã¡ãŠãæ°ã¯è°äŒè¿œåäžã«æ°åã³ãããŠã€ã«ã¹ã«é¢ãã100以äžã®è³ªåãåé¿ããå±éºãªæŠæŒ¢ã³ãããŠã€ã«ã¹ç ç©¶ææ¡æžãèªãŸãã«æ¿èªããããšãèªããã
-
/10 RFKãããã¡ãŠãå士ã¯"æãåºããªã"ãããç§ã壿» çãªçç©å µåšããã°ã©ã ãšãã³ãããã¯å¯Ÿå¿ãææ®ããŠããããããããç§ãå¿ãããã ãããã
-
/15 ãã·ã¢åœé²çãç±³åœã¯ãµã«çãŠã€ã«ã¹ãçç©å µåšãšããŠäœ¿çšããå¯èœæ§ãæ¢ã£ãŠãããç±³é²ã®2æ©é¢ã ãããŠã€ã«ã¹ãæ±ãããšãèš±å¯ãããŠããã
-
/17 DailyMailãäžåœã®ç§åŠè ãè³ãæ»æãããŠã¹ã®èŽæ»ç100ïŒ ã®å€ç°ã³ãããŠã€ã«ã¹æ ªãäœæã
-
/18 ã¡ãã£ã¢å ±éã«ãããšãäžåœã®ç ç©¶è ãã¯ãæ°ã³ãã»ãŠã€ã«ã¹ãäžåœãå ¬åŒã«äžçã«éç¥ããå°ãªããšã2é±éåã«ç¹å®ããå°å³ãäœæããã
- è°äŒèª¿æ»å®ãã¯ã2019/12ã«å京ã®äžåœäººç ç©¶è ããŠã€ã«ã¹ã®æ§é ã®äžå®å šãªé åãç±³åœæ¿åºéå¶ã®ããŒã¿ããŒã¹ã«ã¢ããããŒã
- ãã®åœæäžåœåœå±ã¯æŠæŒ¢ã§ã®ææçã®æµè¡ã¯åå äžæã®ãŠã€ã«ã¹æ§èºçã«ãããã®ã§ãããšå ¬çã«èããŠããã
-
/19 ã³ããçºè¡š2é±éåã«è§£æçµäºãïŒãäžåœã®ç ç©¶å¡ãç±³æ¿åºãšå ±æã
- äžåœã®ç ç©¶è ãäžåœæ¿åºã«ããæ°åã³ããçºè¡šã®2é±éåã«ãã§ã«ãŠã€ã«ã¹ã®è§£æãçµããŠããã
- äžåœã®æ¿åºç³»ç ç©¶æã«æå±ããç ç©¶å¡ãã2019/12/28ã«æ°åã³ãããŠã€ã«ã¹ã®ã»ãŒå®å šãªé åãã¢ã¡ãªã«æ¿åºã®DBã«äžããŠããã
-
/24 2020幎åé ãFBIãä¿¡é Œããäžåœã®æ å ±çãæŠæŒ¢ã®ç ç©¶æããCovidãæµåºãããšèªã£ãããããFBIã®25人ã®äžåœæ å ±éšéå šå¡ãç¥ã£ãŠããã
- 2/1 ã©ã³ãã»ããŒã«äžé¢è°å¡ãRFKã®ãThe Wuhan Cover-Upãã¯ã2020 幎㚠Covid-19 ã®éã«äœãèµ·ãã£ããã«ã€ããŠã®çå®ã®ç©èªã§ãã
- 2/12 ããªãŠããªåžã§ãæ°é人ã«å¯Ÿããçãããå®éšã®ãããªã蚌æ ãçºèŠããããRTããŠã¯ã©ã€ãã®æ§æ¥µç§å»çç ç©¶æãèŠå¯ïŒåç»ïŒ
- 2/21 DailyMailãç±³åœæ¿åºã¯äžåœã®ç§åŠè ãšååããŠå±éºãªé³¥ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ã®å®éšãæ¯æŽããããã«ç±³åœã®çŽçšè ãã100äžãã«ã䜿ã£ãŠããã
- 2/27 2018 幎ã®ç匟ããã¥ã¡ã³ã¿ãªãŒã¯ããŠã¯ã©ã€ããšãžã§ãŒãžã¢ã«ããç±³åœ (ãã£ãŒãã¹ããŒã) ã®ãã€ãªã©ããæŽé²ããŸã...
-
3/1 ã©ãã¬ãŒã¹å€§åŠã®ååçç©åŠè ãªãã£ãŒãã»Hã»ãšãã©ã€ãããCOVID-19ãäžåœã®ç 究宀ã®ç ç©¶è ã«ãã£ãŠæå³çã«äœæããããæ±ºå®ç蚌æ ãããããšäž»åŒµ
-
3/1 ç§å¯ææžã«ããããã«ããŒæ¿åºã®ãŠã€ã«ã¹åŠè ãã¡ãäžåœã®è«å ±å¡ãšãç§å¯ã®é¢ä¿ãã«ãã£ãããšãæããã«ãªã£ãã
ãã«ããŒæ¿åºã¯ãã®æ å ±ã®å ¬éã黿¢ããããã«äžé¢è°é·ã蚎ãããããã®çæã¯æ³å»·ã§ã¯æ€èšŒãããŠããªãã -
3/7 DailyMailããšãã©åºè¡ç±ãäžåœã«éµéããã«ããã®ç 究宀ãã远æŸãããäžåœäººç§åŠè ãæŠæŒ¢æµåºäºä»¶ã®äžå¿äººç©ã§ãããŠã€ã«ã¹åŠè ãšäžç·ã«åããŠããã
-
3/20 ãžã§ããªãŒã»ãµãã¯ã¹ã®èŠæžïŒCOVID-19ã¯ç±³åœã®GOFãããžã§ã¯ãã®çºæ¡ã ã£ããCOVID-19ãç±³åœã«ãã£ãŠäœãããããšã瀺ã15ã®èšŒæ ãããã
-
3/25 ååŠå µåšçŠæ¢æ©é¢(OPCW)ã®åžžä»»ä»£è¡šã§ãããŠã©ãžããŒã«ã»ã¿ã©ããªã³é§ããŒã°ãã·ã¢å€§äœ¿ã
- ç±³åœã¯éæ³ãªè»äºçç©åŠèšç»ã®äžç°ãšããŠãŠã¯ã©ã€ãé åå ã§30ã®ãã€ãªã©ããéå¶ãç¶ããŠãããšäž»åŒµããã
- ãŠã¯ã©ã€ãé åå ã«ç±³åœã®ç ç©¶æã倿°ããããšã¯é·ãéããç¥ãããŠããïŒããªããå°å°ã¯2022/3ã«30ãæååšãããšäž»åŒµããŠãããïŒ
-
3/31 åœç«ææçç ç©¶æãæ±äº¬éœå ã®ç ç©¶æœèšã§ããšãã©åºè¡ç±ã®åå ãšãªããšãã©ãŠã€ã«ã¹ãªã©ãããŠã¹ã«ææãããåç©å®éšãéå§ããããšãåãããŸããã
-
4/10 ã¢ã³ãœããŒã»ãã¡ãŠãïŒã¢ã«ããã¢äººïŒã¯ã21äžçŽã®ãšãŒãŒãã»ã¡ã³ã²ã¬ã«äŸããããã圌ã¯ãšãã§ããªãè©æ¬ºåž«ã§ãããéªæªãªé°è¬å£ã®ä»£åŒè ã§ããã
-
4/16 ã¢ã³ãããé§ç±³ãã·ã¢å€§äœ¿ãç±³åœã¯ãè»å管çã»è»çž®ã»äžæ¡æ£ïŒACRNïŒã®æ çµã¿ãç Žå£ãããŠã¯ã©ã€ããè»äºçç©åŠçããã°ã©ã ã®éæ³å®æœã®å®éšå Žã«å€ããããšãæ¥ããŠããªãã
-
ã©ã³ãã»ããŒã«ãç匟çºèš
- 4/10 æŠæŒ¢ãšãã¡ãŠãã®NIHç ç©¶æã¯2018幎ã«é«äŒææ§ã³ãããŠã€ã«ã¹ã®å ±åç ç©¶ãããã15ã®æ¿åºæ©é¢ãç¥ã£ãŠãããæ²é»ãå®ã£ãŠããã
-
4/11 DailyMailããã¡ãŠãå士ã®ç±³åœã®ãããä¿å¥è£äœå®ãå人ã¡ãŒã«ã䜿çšããŠæå³çã«æ°åã³ãææçã®èµ·æºã«é¢ããè°è«ãé ãããšããããšãæ°ææžã§æããã«ãªã£ãã
- 4/11 æ°ã³ãåã®ãã¡ãŠãã®CIAïŒæŠæŒ¢ç ç©¶æãªãŒã¯èª¬ã«çåãåããïŒãžã®ç°¿å€èšªåã調æ»ãããšçºèšããã©ã³ãæ¿æš©ã¯ããŒã«ã®èª¿æ»ã«å奜çã§ããå¯èœæ§ãããã
- 4/18 å°ãªããšã15ã®é£éŠæ©é¢ã代衚ããæ¿åºé¢ä¿è ã¯ãããŒã¿ãŒã»ãã¶ãã¯æ°ã®ãšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ãšæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æãææ¡ãããããžã§ã¯ãã«ã€ããŠèª¬æãåããã
- 4/18 DEFUSEãããžã§ã¯ãã¯DRASTIC Researchã«ãã£ãŠçºèŠãããããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ããåœé²é«çç ç©¶èšç»å±ïŒDARPAïŒãžã®æ©èœç²åŸç ç©¶ã®ææ¡ææžãããæããã«ãªã£ãã
- 4/18 2020/4/26ãç 究宀ãªãŒã¯ä»®èª¬ãæ¯æãéããŠããäžã§ã®çµç¹çãªåŠå®ãšåŒ·å¶çãªèªç¶èµ·æºèª¬ã«å¯ŸãããŒã«ã¯ãã¹ã¶ãã¯ãšãã¡ãŠãã®åãè ã®ãã€ãããã»ã¢ãŒã³ãºé»åã¡ãŒã«ãææ
-
/6 Daily MailçŽãäžåœã®ç§åŠè ãããã€ãªã»ãŒããã£èŠåãåé¿ããããã«ãšãã©ãŠã€ã«ã¹ã®å€ç°äœãäœæããæãããçç¶ãåŒãèµ·ãããŠãã ã¹ã¿ãŒã®çŸ€ããæ»æ» ãããã
-
/10 60幎代åŸåãã³ããã«ããå·ã®çç©å µåšæœèšã§3ã€ã®è¬ã®ããç ãçºçãã©ã€ã ç ã¯70幎代åã°ãŸã§ç®ç«ã£ãåé¡ã§ã¯ãããŸããã§ãããCDC ã¯äœãããã®ã§ããããïŒ
-
/17 å NIHæé·ã¯ã瀟äŒçè·é¢æ¿çãæ¯æããç§åŠçæ ¹æ ã蚌æ ã¯ãªãã£ãããšãèªããŸããã圌ã¯ãŸããã³ãããŠã€ã«ã¹ãç 究宀ããæŒãããšããèãã¯é°è¬è«ã§ã¯ãªããšèšŒèšã
-
æŠæŒ¢ç ç©¶æãªãŒã¯èª¬
-
/9 ã³ããã»ãã³ãããã¯ã«é¢ããäžé¢ç¹å¥å°å§å¡äŒã
- åœåçã«æ°åã³ãææçãæŠæŒ¢ç ç©¶æèµ·æºã§ããæšã®æ©å¯ææžããçå®ãç±³åœæ°ãšå ±æãããããè§£é€ããããæ±ããã
- åœåçã®æ©å¯ææžãæŠæŒ¢ç ç©¶æãªãŒã¯èª¬ã"ä¿¡ææ§ããã£ãŠç€ºåããŠãã"ããšãäžåœå ±ç£å ã"é èœããããšãã"ããšãæããã«ããã
-
/17 NIHã¯ããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ãéããŠæŠæŒ¢ã§ã®æ©èœç²åŸç ç©¶ã«è³éæäŸããŠããããšãèªããŸãããããã¯å€§ãã¥ãŒã¹ã§ãã
-
/18 ãç çãªåãNYPçŽã¯ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã§ã®å±éºãªãŠã€ã«ã¹ç ç©¶ã«é¢ãããã¡ãŠãå士ã®åã远åããŠããã
- ãããã®åã€ããã¡ã«ãšã£ãŠãäºæ ã¯ãŸããŸãæªåããã°ããã ïŒå人ãNYã®ããã¬ãããã®åçãéã£ãŠãããïŒã
- ç©èªã¯ãã 厩ããŠããã®ã§ã¯ãªãã倧ããªå¡ãšãªã£ãŠãã©ãã©ã«ãªã£ãŠãããããããé°è¬è«ãã ã£ãé ãèŠããŠããŸãã
-
/23 ã³ããã»ãã³ãããã¯ã«é¢ããäžé¢ç¹å¥å°å§å¡äŒã
- ãã¡ãŠãã®äžçŽé¡§åã§ããããããã»ã¢ã¬ã³ãºå士ã®äžæ£è¡çºãšéæ³è¡çºã®çæãæŽé²ãæŽé²ã
- ã¹ã¿ããã¬ãã«ã®ã¡ã¢ã«å«ãŸããæ°ããé»åã¡ãŒã«ã¯ãã¢ã¬ã³ãºå士ã以äžã®ç¹ã§æçœªãšããŠããã
ã»ç±³åœæ¿åºã®æŽ»åã匱äœåããããé£éŠæ¿åºã®COVID-19èšé²ãéæ³ã«åé€ã
ã»æ å ±å ¬éæ³ãåé¿ããããã«å人ã¡ãŒã«ã䜿çšãé£éŠæ¿åºè·å¡ãšããŠãµãããããªãè¡çºãè°äŒã«åãã€ããå¯èœæ§ã
-
/24 倧éã®é»åã¡ãŒã«ãããæ©èœç²åŸã«é¢äžããäžæµç ç©¶è ããã蚌æ ãšãªãé»åã¡ãŒã«ãåé€ããããã«å ±è¬ããŠããããšãæããã«ãªã£ãã
çŠç¹ãšãªãŠããã¢ã¬ã³ãºå士ã¯èšé²éç€ºè«æ±ãåé¿ããããã«NIHã®æ å ±èªç±æ³ïŒFOIAïŒäºåå±ã«ååãæ±ãããã¢ã¬ã³ãºå士ã¯çŸåšäŒè·äžã§ããã -
/24 ç±³å ±åå ã®ã©ã³ãã»ããŒã«äžé¢è°å¡ã¯ãã¢ã³ãœããŒã»ãã¡ãŠããšå ±ã«åããŠããCOVIDæä»£ã®ä¿å¥åœå±è
ã®éã§äº€ãããããã³ãããã¯åœæã®é»åã¡ãŒã«ãæ°ãã«å ¬éããã"å€§èŠæš¡ãªé èœå·¥äœ"ã®èšŒæ ã«ãªããšåçºã
-
-
/4 æ°ããªå ±åæžã«ãããšãCOVID-19ãŠã€ã«ã¹ã¯äžåœã®ç ç©¶æããæŒããå¯èœæ§ãé«ãããšã倿ã
- å®å šå¯Ÿçãäžååãªæœèšã§ã極ããŠææåã®é«ããŠã€ã«ã¹ã«é¢ããé«ãªã¹ã¯ã®ç ç©¶ã«æ°åäžãã«ãã€ã蟌ãã 責任ã¯ç±³åœã«ããã
- ããŒããŒã倧åŠãšMITã®ååçç©åŠè ã¢ãªãã»ãã£ã³ã«ããåæã¯ãNYTã®ã²ã¹ããšãã»ã€ãšããŠçºè¡šããããšNYPãå ±ããŠããã
-
/12 DailyMailãè°äŒã®è¡æçãªå ±åæžããã¡ãŠãã®éšéã¯"ãã³ãããã¯ãåŒãèµ·ããå¯èœæ§ããã£ã"å€ç°ãµã«çãŠã€ã«ã¹ãäœæããèšç»ãé ããŠããã
-
/25 RFKãå é±ãäžé¢ã®åœåå®å šä¿éå§å¡äŒã¯ã€ãã«æ°åã³ãããŠã€ã«ã¹ã®èµ·æºã«é¢ããå ¬èŽäŒãéå¬ããã
- äžé¢è°å¡ãã¯ãå¿ èŠãªæ å ±ã«ãŸã ã¢ã¯ã»ã¹ã§ããŠããªããNIHã¯è°äŒã«50ããŒãžã®å 容ãæäŸããããšãæåŠããã
- ç§ã倧統é ã«éžãã§ãããã°ãããã«ä¿å¥çŠç¥çã®ç§å¯ã®ççžãè§£æã§ããã§ãããããããŠããã£ãšããããã®ããšã
-
/26 ãã·ã¢è»äºæ å ±å±ïŒMILïŒããã®æ°ããªå ±åæžã«ãããšããã·ã¢ããŠã¯ã©ã€ãã®ç ç©¶æãè§£æŸãããããåœé²ç·çã¯çç©å µåšäœæŠãã¢ããªã«ã«ç§»è»¢ãããšããã
- ãã€ãã³æ°ãææããã¡ã¿ããªã¿ããã®ä»ã®ä»²ä»NGOãã人éçæŽ»åãè£ ã£ãŠç±³åœåœåçãšåœé²ç·çã®é ãèãšãªãã倧æè£œè¬äŒç€Ÿã®ããã®ç åäœçç£ãšããçã®ç®çãé èœããŠããã
- ã¡ã¿ããªã¿ç€Ÿãããã®æªè³ªãªçç©åŠç掻åãšèšç»ãç¥ãããããã«ãã¢ããªã«ã®å€ãã®åœã§ã®äºæ¥ã忢ããããåŸãªããªã£ããšææããŠããã
- ã¡ã¿ããªã¿ã®åµèšè ã¯ã®ã¬ãŒãã»ãã¯ã¹ãŠã§ã«æ°ãšã¯ãªã³ãã³æ°ã®é¢ä¿è ã§ãããŠã€ã«ã¹åŠè ãã€ãµã³ã»ãŠã«ãæ°ã§ããããšãèŠããŠãããŠã»ããã
- 以åã®äž»åŒµã2024幎ã®éžæã«åããŠæ°ããªãã³ãããã¯ãèµ·ããããšããŠããããåããç±³åœãæž¡ãé³¥ãä»ããŠç æ°ãåºããèšç»ãââããŠãããšã䞻匵ããŠããã
-
/26 ãã·ã¢è»ã¯ããŠã¯ã©ã€ãã®ãã€ãªç ç©¶æããã¹ãŠç Žå£ãããšäž»åŒµããåŸãç±³åœæ¿åºããã€ãªç ç©¶æãã¢ããªã«ã«ç§»è»¢ããããšéé£ããŠããã
- ãã€ãªã©ãã®èšç«ã詊ã¿ãããåœã ã«ã€ããŠèšåãã1. ã³ã³ãŽã2. ã·ãšã©ã¬ãªãã3. ã«ã¡ã«ãŒã³ã4. ãŠã¬ã³ãã5. åã¢ããªã«
- 人éçåªåãè£ ããªãããç±³åœã¯å®éã«ã¯2020幎ãšåæ§ã®ãã³ãããã¯ã2024幎ã®éžæã«åããŠèšç»ããŠãããšäž»åŒµããŠããã
-
/26 ãã«ã»ã²ã€ãã¯ã³ããæµè¡ã®ããã1幎åã«æŠæŒ¢å€§åŠã«499.944ãã«ãå¯ä»ããŠããããšã倿
- ã³ããã»ãŠã€ã«ã¹ã®æ©èœç²åŸç ç©¶ã宿œãããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã«150äžãã«ãå¯ä»ããã
- ãã«ã»ã²ã€ããã3å1900äžãã«ãåãåã£ãäž»æµã¡ãã£ã¢ã¯ããã®ããšãå ±éããã ãããïŒ
-
/27 ãã·ã¢è°å¡ã¢ã¬ã¯ãµã³ãã«ã»ããã³ããã¢ããªã«å€§éžãã¯ã·ã³ãã³ã®çç©å µåšç ç©¶æã®å®éšå ŽãšããŠå©çšãã¹ãã§ã¯ãªããšåœé£ã«æèšŽã
-
/2 ã©ã³ãã»ããŒã«ãCOVIDã®èµ·æºãæ©èœç²åŸç ç©¶ããã¡ãŠãå士ã®é èœå·¥äœã«ã€ããŠè¶ å æŽŸã®èª¿æ»ãéå§ããŸãããææ°æ å ±ãåãåãã«ã¯ãµã€ã³ã¢ããããŠãã ããã
-
/3 ç±³åœã¯ã¯ã¯ãã³ã¡ãŒã«ãŒã®ã¢ãã«ã瀟ã«ãé³¥ã€ã³ãã«ãšã³ã¶ã®æ²»çã«äœ¿çšã§ãããã³ãããã¯ã¯ã¯ãã³ã®éçºã®ãã1å7600äžãã«ãæ¯æãäºå®
-
/29 RFKããã¥ã«ã³ãã«ã¯ç¶±é ã¯ãäžçäžã§äººéã察象ã«ããå»åŠç ç©¶ã宿œããããã®å«ççããã³æ³çåºæºãšããŠãç¬¬äºæ¬¡äžç倧æŠåŸã«å¶å®ãããŸããã
- ãããç±³åœã§ã¯ã人äœã察象ãšããç ç©¶ãè¡ã補è¬äŒç€Ÿã«å¯Ÿããæ³çå¶çŽãšçµæžçã³ã¹ããç·©åããããã«ãFDAãšè°äŒã«ãã£ãŠèŠå¶ãçž®å°ãããŠããã
- 1æã«FDAã¯ã補è¬äŒç€Ÿãéçšããæ©é¢å¯©æ»å§å¡äŒãã被éšè ã®ã€ã³ãã©ãŒã ãã³ã³ã»ã³ãã¯äžèŠã§ãããšå€æã§ããããã«ããæçµèŠåãçºè¡ããã
- ããã¯åãå ¥ããããŸããããã¥ã«ã³ãã«ã¯åºæºã«æ»ãå¿ èŠããããŸãããããªããªã¹ã¯ã䌎ãèšåºè©Šéšã§ã¯ã被éšè ã®ã€ã³ãã©ãŒã ãã³ã³ã»ã³ããå¿ èŠã§ãã
- ç§ã®æ¿æš©ã¯ãå«ççãªå»çãšå«ççãªå»çç ç©¶ãæãåœã«æ»ãããã®ç¬¬äžæ©ãšããŠãåæ¥ã«æ¢åã®æ³åŸãš FDA èŠåãæ¹æ£ããããåãçµã¿ãŸãã
-
/15 WHOã¯ãµã«çã®ææãã¢ããªã«äžéšã®ã³ã³ãŽæ°äž»å ±ååœã§æ¡å€§ããã¢ããªã«ä»¥å€ã«ãåºãããããããããšããŠãåœéçã«æžå¿µãããå ¬è¡è¡çäžã®ç·æ¥äºæ ãã宣èšã
-
/15 ã¢ã³ãœããŒã»ãã¡ãŠãå士ã®å ç ç©¶æã¯ããã³ãããã¯ãåŒãèµ·ããå¯èœæ§ã®ãããã©ã³ã±ã³ã·ã¥ã¿ã€ã³ã®ç¿çãŠã€ã«ã¹ãäœæããèšç»ã«ã€ããŠè°äŒã欺ããã
- åœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æïŒNIAIDïŒã¯ããã¡ãŠãå士ããŸã åç ç©¶æã®è²¬ä»»è ã ã£ã2015幎ã«ãããäŒæåãšèŽæ»æ§ã®é«ãMpoxæ ªãéçºããèšç»ãæåºããã
- ç ç©¶è ãã¯ãããã¯æ©èœç²åŸç ç©¶ã ãããšè¿°ã¹ããèŽæ»æ§ãäŒææ§ã®é«ããŠã€ã«ã¹ãäœãåºãããšãå«ã¿ãCOVID-19ã®èªçã®èåŸã«ããã®ã§ã¯ãªãããšæžå¿µãããŠããã
- 倩ç¶çãšåããŠã€ã«ã¹ç§ã«å±ãããµã«çã¯çºç¹ãã€ã³ãã«ãšã³ã¶ã®ãããªçç¶ãåŒãèµ·ãããåœéçã«æžå¿µãããå ¬è¡è¡çäžã®ç·æ¥äºæ ãšå®£èšãããŠããã
-
9/17 ãªãŒã¹ãã©ãªã¢ã®äžé¢è°å¡ãã«ã³ã ã»ãããŒãã¯ãäžççãªCOVIDèšç»ãéé£ããç±çãªæŒèª¬ãè¡ããåœæ°ã¯ç®èŠãã€ã€ããã責任ãããšãªãŒããã¡ã远åããã ãããšèŠåããã
-
10/29 RFKã2014幎ã300人ã®ç§åŠè ãã¢ã³ãœããŒã»ãã¡ãŠãå士ãäžççãªãã³ãããã¯ãåŒãèµ·ããã ãããšèŠåããã
- ç±³åœã®ç ç©¶æãã3ã€ã®çްèãéãåºãããšããäºä»¶ãåã300人ã®ç§åŠè ã¯ãªãã倧統é ã«æçŽãéãããã¡ãŠãã®æ©èœç²åŸç ç©¶ãäžæ¢ããããæ±ããã
- ãªããã¯ããã¡ãŠãã«ããææªã®ãããžã§ã¯ã18ä»¶ã忢ããäžæåæ¢ãåœããããçµå±ãå®éã«ã¯åæ¢ããªãã£ãã
- 代ããã«ããªãã倧統é ã¯ç ç©¶ããŠã¯ã©ã€ããæ§ãœé£ã®ãžã§ãŒãžã¢ãäžåœæŠæŒ¢ã®æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æãªã©ã®æµ·å€ã«ç§»ããã
- çŸåšãCOVID-19ãäžåœã»æŠæŒ¢ã®ãŸãã«ãã®ç ç©¶æããçºçããããšã¯åºãèªããããŠããã
- ãããããšãããã¡ãŠãå士ããšããç»æçãªæ°äœæ ç»ã¯ãäžççãªçœå®³ãæããã«ãããã¹ãŠãæŽé²ããŠããã
- äºæ³éããMETA ã¯ãã§ã«äºåç·šãæ€é²ããŠãããã¶ãã«ãŒããŒã°ãèŠããããªããã®ã以äžã®ã³ã¡ã³ãã§ç¢ºèªãããã
-
11/4 ããããŒã¯ã次ã®ãã³ãããã¯ã«åããæåã®æ¹æ³ã¯ããããäœãåºãããšã ãšèããŠããŸãããã - ãŠã€ã«ã¹åŠè ãå CDCæé·ããããŒãã»ã¬ãããã£ãŒã«ãå士ã
-
11/4 å CDCæé·ã®ã¬ãããã£ãŒã«ãå士ã¯ãCOVID-19ãŠã€ã«ã¹ã®èµ·æºã«ã€ããŠããã¡ãŠãæ°ã2020幎ã«äž»åŒµããããŠã§ããããŒã±ããçè«ãã¯èåœã ã£ããšè¿°ã¹ãã
- äžåœCDCã®æé·ãžã§ãŒãžã»ã¬ãªæ°ããçŽæ¥èããããšãèªèº«ã®ãŠã€ã«ã¹åŠã«ãã£ãŠåæããçµæã
- ã¬ãããã£ãŒã«ãæ°ã¯ãŠã€ã«ã¹ã人éã«å¯ŸããŠéåžžã«ææåã匷ããç ç©¶æã§äœããããšçµè«ã¥ããã
- ãããããã¡ãŠãæ°ã¯ãã®èŠè§£ãåŠå®ããç§åŠç調æ»ãããèªãã®ä»®èª¬ãåªå ããŠãããšæ¹å€ãããã
-
11/15 RFKæ°ã¯ãç±³åœæ¿åºãCIAãéããŠæŠæŒ¢ç ç©¶æã«è³éãæäŸããçç©å µåšã®ç§»éãä¿é²ãããšãã¡ãŠãå士ã起蚎ãããæåã衚æããŠããã
ããã圌ãç¯çœªãç¯ããŠãããªãããã¡ããç§ã¯åžæ³é·å®ã«åœŒã起蚎ããããèšããå·®ãæ§ããªãããã«ããã ããã -
11/15 äžé¢è°å¡ã©ã³ãã»ããŒã«æ°ïŒå ±åå ãã±ã³ã¿ãããŒå·ïŒã¯ãäžé¢åœåå®å šä¿éå§å¡äŒã®å§å¡é·ãšããŠãCOVIDé èœãã調æ»ããæåã瀺ããã
-
11/15 ã©ã³ãã»ããŒã«ããNIHã®æ©èœç ç©¶ã®å©åŸãæŽé²ããã¡ãŠããéãäžãããããšãã®ããšãæãåºããŠæ¬²ããã圌ãäžé¢ã®åœåå®å šä¿éå§å¡äŒãåŒãç¶ãã®ã¯æ¬åœã«çŽ æŽãããïŒ
-
11/16 ã©ã³ãã»ããŒã«äžé¢è°å¡ãäžé¢åœåå®å šä¿éå§å¡äŒã®å§å¡ã«å°±ä»»ãCOVID-19ã®é èœãæšçã«ããããšãçŽæ
- æé«ã ! 圌ã¯Xã«ãã¡ãŠãæ°ãç£èŠäžã«çœ®ããŠããã£ãšåœŒãèŠã€ããã ããããšæçš¿ããã°ããã ã
- ããŒã«æ°ã¯äœå¹Žãã®éãCOVID-19ãšãã¡ãŠãæ°ã®åã«ã€ããŠèŠéã鳎ããç¶ããŠããããäžé¢ãæ¯é ããŠããæ°äž»å ã圌ã®è¡åã®å€ãã黿¢ããŠããã
-
11/21 ç±³åœCDCã®å æé·ãããŒãã»ã¬ãããã£ãŒã«ãæ°ãæ°åã³ãææçã¯äººå·¥çã«éçºããããã®ã§ããããã³ãããã¯ã®çºçã«ç±³åœããçžåœãªã圹å²ãæããããšäž»åŒµã
-
12/2 RFKæ°ã¯ã1973幎ã®ãžã¥ããŒãæ¡çŽãšçç©å µåšæ²ç« ã®åŸ©æŽ»ãæ±ããŠããã
- æ©èœç²åŸç ç©¶ãçµããããæåã衚æãäžççã«ãããçµäºãããããã®æ¡çŽã«çœ²åããèãã瀺ããã
- ã©ã€ã ç ãCOVID-19ãªã©å€ãã®ç æ°ãå»åŠãšã¯ã¯ãã³ç ç©¶ã«ãã£ãŠåŒãèµ·ãããã匷åãªèšŒæ ãããã
- ç¹ã«ãRSVïŒåŒåžåšåèäœãŠã€ã«ã¹ïŒãã¯ã¯ãã³ç ç©¶æããçãŸããããšãææããã
-
12/11 ãªãŒã¹ãã©ãªã¢æ¿åºã¯ããã€ãªã»ãã¥ãªãã£ãããã³ã«ã®éå€§ãªæŽå²çéåããèŽåœçãªãŠã€ã«ã¹ãµã³ãã«æ°çŸåãè¡æ¹äžæããšãªã£ãŠãããšçºè¡šã
- Fox Newsãä¿å¥ èŽåœçãªãŠã€ã«ã¹ãµã³ãã«ããé倧ãªãã€ãªã»ãã¥ãªãã£äŸµå®³ãã§ç 究宀ããè¡æ¹äžæã«ãªã£ããšåœå±ãçºè¡šãä¿å¥åœå±ã¯ã容èªã§ããªãã倱çã®èª¿æ»ãéå§ã
- 2023幎8æãã¯ã€ãŒã³ãºã©ã³ãå·ã®å ¬è¡è¡çãŠã€ã«ã¹ç ç©¶æããããã³ãã©ãŠã€ã«ã¹ããªããµãŠã€ã«ã¹ããã³ã¿ãŠã€ã«ã¹ãå«ãæ°çŸã®èŽæ»æ§ãŠã€ã«ã¹ã®ãã€ã¢ã«323æ¬ãè¡æ¹äžæã«ãªã£ããšå ±åã
- æ¿åºã¯ã¯ã€ãŒã³ãºã©ã³ãå·ä¿å¥ãªãŒã¹ãã©ãªã¢ã®å ¬è¡è¡çå±ã«å¯Ÿããããã€ãªã»ãã¥ãªãã£ãããã³ã«ã«å¯Ÿããéå€§ãªæŽå²çéåããšãããäºä»¶ã«ã€ããŠèª¿æ»ãéå§ããããæç€ºãããšããã
-
12/23 ç¥å ã®SARS-CoV-2ïŒD614/FCS衚çŸåïŒã¯äžå®å®ã§ããããããªãåç©çš®ã«ãããŠãæç¶çãªææããµããŒãããªãã
- ãã®äžå®å®æ§ã«ãããã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªãåæããããŠã€ã«ã¹ãäžæŽ»æ§åããŸãã
- ãã®ãããèªç¶çã§ã¯åç¶ã§ããããã³ãããã¯ã¯èªç¶ã®äººç£å ±éææç±æ¥ã§ã¯ãªããšçµè«ã¥ããããŠããŸãã
- äžæ¹ã§ãD614Gå€ç°ãæ¥éã«é²åãããŠã€ã«ã¹ã®å®å®æ§ãšæææ§ãå埩ãããã
- å®éšå®€ç°å¢ã§ã®å¢æ®ç¹æ§ãšãäžèŽããèªç¶ãŠã€ã«ã¹ã§ã¯ãªãå¯èœæ§ã瀺åããŠããã
-
12/24 ãã·ã¢åœé²çã¯ãã¢ã¡ãªã«ãã¢ããªã«ã«ãããçç©åŠçããã³è»äºçãã¬ãŒã³ã¹ãæ¥éã«æ¡å€§ããŠãããšèŠéã鳎ãããŠããã
-
ã¢ã¡ãªã«ã¯çŸå°ã®æ¿åºæ©é¢ãæ°éäŒæ¥ãšååããçç©åŠçå®å šåºæºãå°å ¥ãã€ã€ã以äžã®ãããªæŽ»åãå±éããŠããã
-
ãã·ã¢ã¯ç±³åœäŒæ¥ã¡ã¿ããªã¿ç€Ÿãçç©åŠç ç©¶ã®èåŸã«é¢äžããŠãããšéé£ããéå»ã®ãšãã©å¯Ÿç掻åäžã«ç åæ§æ ªã®éæ³èŒžéãè¡ãããå¯èœæ§ãææã
-
ç 究掻åïŒ18ã«åœã§ç åæ§åŸ®çç©ã®èæ§ã«é¢ããç ç©¶ã宿œã
-
è³éæäŸïŒç±³åœçŸç äºé²ç®¡çã»ã³ã¿ãŒïŒCDCïŒãåœé²ç·çãè³éãæ¯æŽã
-
æœèšèšç«ïŒ
- ã¬ãŒããšãžããïŒç åäœã®åé¢ã»é åç ç©¶æœèšã
- ãã€ãžã§ãªã¢ïŒè»å»çç ç©¶æœèšãšHIVãããžã§ã¯ãã
- ã»ãã¬ã«ïŒå®éšæœèšã建èšäžã
- ã¶ã³ãã¢ïŒå±éºãªç åäœã®ç ç©¶ãå»çæ©é¢ã®åŒ·åã
- åã¢ããªã«ïŒã¢ã³ããŒããã¯ã¹ç ç©¶ããã³ã¯ã¯ãã³æäŸã
- ã®ãã¢ïŒã©ããµç±ç ç©¶ãšå»çæè³ã
- ã±ãã¢ïŒææçç£èŠãããã¯ãŒã¯ãæ§ç¯ã
-
-
12/24 ãã·ã¢åœé²çãRCDBZå¯é·ã§ããã¢ã¬ã¯ã»ã€ã»ã«ãã£ã·ãã§ãå°å°ãã¢ããªã«è«žåœã«ãããç±³åœã®éæ³ãªè»äºçç©æŽ»åãžã®æ°ããªåå è 30å以äžãç¹å®ã
ãã®äžã«ã¯ãç¹ã«ãŠã©ã«ã¿ãŒã»ãªãŒãéžè»ç ç©¶æã®è»äººã倧éç Žå£å µåšã®è åšè»œæžåºã®å°åéšéã®è·å¡ãã¢ããªã«çŸç äºé²ç®¡çã»ã³ã¿ãŒã®è·å¡ãå«ãŸããã -
12/27 现èå µåšãæ¯çŽ ãçç©å µåšã®å°éç¥èãæã€å FBIäžçŽç§åŠè ãžã§ã€ãœã³ã»ããã³æ°ã
- COVID-19ãç 究宀ããã®æŒæŽ©ã®èšŒæ ãçºèŠããåŸãèªèº«ãšFBIã®äž¡æ¹ããã€ãã³ãžã®å ±åã黿¢ãããã
- ãããã®æŽé²ã¯ããã€ãã³ãçã®å€§çµ±é ã§ã¯ãªãã£ãããšãMSMãèªããã«ã€ããŠæããã«ãªã£ãŠããã
-
12/27 åœåçããDSããéããŠCOVIDã®é èœå·¥äœã«é¢äžããŠããããšãèªããççžãæããã«ããå¿ èŠãããã
- 調æ»ãäž»å°ããã®ã¯ãã³ããªåœåé·å®ãçè ã®å©èšããŒã ã§ã¯ãªããè»å管çããæ åœããé«å®ãšãã®éšäžãã¡ã ã£ãã
- 圌ãã¯ããã®åé¡ãé倧ãªçµæãæããšèŠåããŠãããããã®ãªã¹ã¯ãæ¿ç¥ã®äžã§åå ç©¶æãé²ããã¹ãã ã
- äžåœã®è¡åãNIHãé¢äžããé èœå·¥äœããã¡ãŠãã«ããçµç¹çãªé¢äžã«ã€ããŠèª¿æ»ãå¿ èŠã§æŽé²ãé²ãããšãæåŸ ããŠããã
- äžå ±ã«å€§é殺人ã®è²¬ä»»ãè² ããããã¡ãŠãå士ãšãç§åŠè ã仲éãç¯çœªã®å ±ç¯è ãšããŠè¿œåããããšã§ãã¢ã¡ãªã«ãåã³çã«å倧ãªåœã«ã§ããã
- ç§ã¯ä»ãCOVIDããã§ã³ã¿ãã«ããããŠäžåœãžã®ä»£åæ¯æãã«é¢ããŠãããªãã«ãã£ãŒããã©ãã¯MAGAãæ²ããã©ã³ã倧統é ãæå©ããããæºåãããŠããã
-
12/29 ãžã§ã·ã¥ã»ããŒãªãŒäžé¢è°å¡ãNIHãCOVID-19ã®èµ·æºã«ã€ããŠãé¢äžããŠããªããšã®èŠè§£ãåºããèšç»ãç«ãŠã蚌æ ãæç€ºã
- 圌ã¯ããã¡ãŠãå士ã®ç§ä¿¡ãç§åŠè ãšã®ããåããæ ¹æ ã«ãNIHãæå³çã«ç°ãªãèŠè§£ãåŠå®ããããšããå¯èœæ§ãææã
- ãŸããç ç©¶æèµ·æºèª¬ããç Žå£çãªé°è¬ããšããŠéããNIHã®è¡åãæ¹å€ãããã®æå³ã«ã€ããŠèª¬æãæ±ããã
-
12/31 WHOãäžåœã«å¯Ÿããæ°ã³ãèµ·æºã®ãããªãããŒã¿ãšã¢ã¯ã»ã¹ãæäŸããããèŠè«ããããšãåããäžåœæ¿åºã¯æ å ±ããäžåé ãããå ±æãããšäž»åŒµã
-
èŽåœç㪠å 責ããµãã³ / ããŒãªã³ã°ã¹ããŒã³å ±å調æ»ããããŒã F. ã±ãã㣠Jr.è https://southerncrossreview.org/41/kennedy.htm
ç§»è¡ã¡ã¢
- æ¬ããŒãžã¯ãäœè ãåœæåéãããã¥ãŒã¹ã»SNS æçš¿ã»è«èãªã©ã®èšé²ïŒã¹ã¯ã©ããïŒãšèå¯ã§ããã åéãå€ããããç§»è¡ã«éããŠåã ã®èšè¿°ã®äºå®ç¢ºèªãææ°åã¯è¡ã£ãŠãããã å ããŒãžã®èšè¿°ããã®ãŸãŸç§»ããŠããã
- PukiWiki ã®ããŒãžå ã¢ã³ã«ïŒ
#xxxxxxxxïŒã¯ãèŠåºãããçæããã GitHub Wiki ã®ã¢ã³ã«ã«åŒµãæ¿ããã åãèŠåºããè€æ°ããå Žåã¯ãGitHub Wiki ã®æ¡çªïŒ-1ã-2âŠïŒã«åãããŠããã ä»ããŒãžã®ç¯ãæããªã³ã¯ã¯ããïŒããŒãžåã®è©²åœç¯ãåç §ïŒãã®åœ¢ã«çœ®ãæããã- èŠåºããã®ãã®ããªã³ã¯ã«ãªã£ãŠããç®æã¯ãèŠåºãããã¬ãŒã³ã»ããã¹ããšãã ãªã³ã¯ã¯çŽäžã®ç®æ¡æžãã«çœ®ããã
- å Wiki ã®è¡é 空çœã«ãããã¬ãã©ãŒãããã»ãããã¯ã¯ããã§ã³ã¹ä»ãã³ãŒããããã¯ã«ããã
Tags: ç§»è¡, ããŒã¿åæ, å®é²æŠäº, ãŠã¯ã©ã€ã, ãã·ã¢, å°æ¿åŠ, ãã€ãªã»ã©ã